id	sid	tid	token	lemma	pos
iajs-2645	1	1	special	special	ADJ
iajs-2645	1	2	issue	issue	NOUN
iajs-2645	1	3	1ihicpas	1ihicpas	NUM
iajs-2645	1	4	202	202	NUM
iajs-2645	1	5	ibn	ibn	PROPN
iajs-2645	1	6	al	al	PROPN
iajs-2645	1	7	-	-	PUNCT
iajs-2645	1	8	haitham	haitham	PROPN
iajs-2645	1	9	journal	journal	PROPN
iajs-2645	1	10	for	for	ADP
iajs-2645	1	11	pure	pure	ADJ
iajs-2645	1	12	and	and	CCONJ
iajs-2645	1	13	applied	apply	VERB
iajs-2645	1	14	science	science	NOUN
iajs-2645	1	15	https://doi.org/10.30526/2021.ihicpas.2645	https://doi.org/10.30526/2021.ihicpas.2645	PROPN
iajs-2645	1	16	for	for	ADP
iajs-2645	1	17	more	more	ADJ
iajs-2645	1	18	information	information	NOUN
iajs-2645	1	19	about	about	ADP
iajs-2645	1	20	the	the	DET
iajs-2645	1	21	conference	conference	NOUN
iajs-2645	1	22	please	please	INTJ
iajs-2645	1	23	visit	visit	VERB
iajs-2645	1	24	the	the	DET
iajs-2645	1	25	websites	website	NOUN
iajs-2645	1	26	:	:	PUNCT
iajs-2645	1	27	http://ihicps.com/	http://ihicps.com/	NOUN
iajs-2645	1	28	b	b	NOUN
iajs-2645	2	1	i	i	NOUN
iajs-2645	2	2	o	o	NOUN
iajs-2645	3	1	l	l	NOUN
iajs-2645	3	2	o	o	X
iajs-2645	3	3	g	g	NOUN
iajs-2645	3	4	y	y	PROPN
iajs-2645	3	5	|	|	ADV
iajs-2645	3	6	15	15	NUM
iajs-2645	3	7	gene	gene	NOUN
iajs-2645	3	8	expression	expression	NOUN
iajs-2645	3	9	of	of	ADP
iajs-2645	3	10	nlrp3	nlrp3	ADJ
iajs-2645	3	11	inflammasome	inflammasome	NOUN
iajs-2645	3	12	in	in	ADP
iajs-2645	3	13	celiac	celiac	ADJ
iajs-2645	3	14	disease	disease	NOUN
iajs-2645	3	15	of	of	ADP
iajs-2645	3	16	iraqi	iraqi	ADJ
iajs-2645	3	17	children	child	NOUN
iajs-2645	3	18	abstract	abstract	ADJ
iajs-2645	3	19	celiac	celiac	ADJ
iajs-2645	3	20	disease	disease	NOUN
iajs-2645	3	21	(	(	PUNCT
iajs-2645	3	22	cd	cd	PROPN
iajs-2645	3	23	)	)	PUNCT
iajs-2645	3	24	is	be	AUX
iajs-2645	3	25	an	an	DET
iajs-2645	3	26	autoimmune	autoimmune	ADJ
iajs-2645	3	27	disorder	disorder	NOUN
iajs-2645	3	28	characterized	characterize	VERB
iajs-2645	3	29	by	by	ADP
iajs-2645	3	30	chronic	chronic	ADJ
iajs-2645	3	31	inflammation	inflammation	NOUN
iajs-2645	3	32	that	that	SCONJ
iajs-2645	3	33	essentially	essentially	ADV
iajs-2645	3	34	affects	affect	VERB
iajs-2645	3	35	the	the	DET
iajs-2645	3	36	small	small	ADJ
iajs-2645	3	37	intestine	intestine	NOUN
iajs-2645	3	38	and	and	CCONJ
iajs-2645	3	39	is	be	AUX
iajs-2645	3	40	caused	cause	VERB
iajs-2645	3	41	by	by	ADP
iajs-2645	3	42	eating	eat	VERB
iajs-2645	3	43	gluten	gluten	NOUN
iajs-2645	3	44	-	-	PUNCT
iajs-2645	3	45	containing	contain	VERB
iajs-2645	3	46	foods	food	NOUN
iajs-2645	3	47	.	.	PUNCT
iajs-2645	4	1	this	this	DET
iajs-2645	4	2	study	study	NOUN
iajs-2645	4	3	sought	seek	VERB
iajs-2645	4	4	to	to	PART
iajs-2645	4	5	determine	determine	VERB
iajs-2645	4	6	gene	gene	NOUN
iajs-2645	4	7	expression	expression	NOUN
iajs-2645	4	8	of	of	ADP
iajs-2645	4	9	nlrp3	nlrp3	ADJ
iajs-2645	4	10	inflammasome	inflammasome	NOUN
iajs-2645	4	11	in	in	ADP
iajs-2645	4	12	peripheral	peripheral	ADJ
iajs-2645	4	13	blood	blood	NOUN
iajs-2645	4	14	of	of	ADP
iajs-2645	4	15	iraqi	iraqi	ADJ
iajs-2645	4	16	cd	cd	NOUN
iajs-2645	4	17	children	child	NOUN
iajs-2645	4	18	using	use	VERB
iajs-2645	4	19	quantitative	quantitative	ADJ
iajs-2645	4	20	real	real	ADJ
iajs-2645	4	21	-	-	PUNCT
iajs-2645	4	22	time	time	NOUN
iajs-2645	4	23	pcr	pcr	NOUN
iajs-2645	4	24	(	(	PUNCT
iajs-2645	4	25	qrt	qrt	NOUN
iajs-2645	4	26	-	-	PUNCT
iajs-2645	4	27	pcr	pcr	ADJ
iajs-2645	4	28	)	)	PUNCT
iajs-2645	4	29	assay	assay	VERB
iajs-2645	4	30	.	.	PUNCT
iajs-2645	5	1	thirty	thirty	NUM
iajs-2645	5	2	children	child	NOUN
iajs-2645	5	3	with	with	ADP
iajs-2645	5	4	cd	cd	PROPN
iajs-2645	5	5	(	(	PUNCT
iajs-2645	5	6	12	12	NUM
iajs-2645	5	7	males	male	NOUN
iajs-2645	5	8	and	and	CCONJ
iajs-2645	5	9	18	18	NUM
iajs-2645	5	10	females	female	NOUN
iajs-2645	5	11	)	)	PUNCT
iajs-2645	5	12	were	be	AUX
iajs-2645	5	13	enrolled	enrol	VERB
iajs-2645	5	14	in	in	ADP
iajs-2645	5	15	the	the	DET
iajs-2645	5	16	study	study	NOUN
iajs-2645	5	17	and	and	CCONJ
iajs-2645	5	18	their	their	PRON
iajs-2645	5	19	age	age	NOUN
iajs-2645	5	20	range	range	NOUN
iajs-2645	5	21	was	be	AUX
iajs-2645	5	22	3	3	NUM
iajs-2645	5	23	-	-	SYM
iajs-2645	5	24	15	15	NUM
iajs-2645	5	25	years	year	NOUN
iajs-2645	5	26	.	.	PUNCT
iajs-2645	6	1	the	the	DET
iajs-2645	6	2	diagnosis	diagnosis	NOUN
iajs-2645	6	3	of	of	ADP
iajs-2645	6	4	the	the	DET
iajs-2645	6	5	disease	disease	NOUN
iajs-2645	6	6	was	be	AUX
iajs-2645	6	7	confirmed	confirm	VERB
iajs-2645	6	8	by	by	ADP
iajs-2645	6	9	serological	serological	ADJ
iajs-2645	6	10	examinations	examination	NOUN
iajs-2645	6	11	and	and	CCONJ
iajs-2645	6	12	intestinal	intestinal	ADJ
iajs-2645	6	13	endoscopy	endoscopy	NOUN
iajs-2645	6	14	.	.	PUNCT
iajs-2645	7	1	a	a	DET
iajs-2645	7	2	control	control	NOUN
iajs-2645	7	3	sample	sample	NOUN
iajs-2645	7	4	of	of	ADP
iajs-2645	7	5	20	20	NUM
iajs-2645	7	6	age	age	NOUN
iajs-2645	7	7	-	-	PUNCT
iajs-2645	7	8	matched	match	VERB
iajs-2645	7	9	healthy	healthy	ADJ
iajs-2645	7	10	children	child	NOUN
iajs-2645	7	11	was	be	AUX
iajs-2645	7	12	also	also	ADV
iajs-2645	7	13	included	include	VERB
iajs-2645	7	14	.	.	PUNCT
iajs-2645	8	1	the	the	DET
iajs-2645	8	2	children	child	NOUN
iajs-2645	8	3	were	be	AUX
iajs-2645	8	4	stratified	stratify	VERB
iajs-2645	8	5	for	for	ADP
iajs-2645	8	6	age	age	NOUN
iajs-2645	8	7	,	,	PUNCT
iajs-2645	8	8	gender	gender	NOUN
iajs-2645	8	9	,	,	PUNCT
iajs-2645	8	10	body	body	NOUN
iajs-2645	8	11	max	max	PROPN
iajs-2645	8	12	index	index	NOUN
iajs-2645	8	13	(	(	PUNCT
iajs-2645	8	14	bmi	bmi	PROPN
iajs-2645	8	15	)	)	PUNCT
iajs-2645	8	16	,	,	PUNCT
iajs-2645	8	17	histological	histological	ADJ
iajs-2645	8	18	findings	finding	NOUN
iajs-2645	8	19	,	,	PUNCT
iajs-2645	8	20	and	and	CCONJ
iajs-2645	8	21	marsh	marsh	PROPN
iajs-2645	8	22	classification	classification	NOUN
iajs-2645	8	23	.	.	PUNCT
iajs-2645	9	1	further	far	ADV
iajs-2645	9	2	,	,	PUNCT
iajs-2645	9	3	the	the	DET
iajs-2645	9	4	sera	sera	NOUN
iajs-2645	9	5	were	be	AUX
iajs-2645	9	6	examined	examine	VERB
iajs-2645	9	7	for	for	ADP
iajs-2645	9	8	iga	iga	PROPN
iajs-2645	9	9	anti	anti	ADJ
iajs-2645	9	10	-	-	ADJ
iajs-2645	9	11	tissue	tissue	ADJ
iajs-2645	9	12	transglutaminase	transglutaminase	NOUN
iajs-2645	9	13	(	(	PUNCT
iajs-2645	9	14	ttg	ttg	NOUN
iajs-2645	9	15	)	)	PUNCT
iajs-2645	9	16	antibody	antibody	NOUN
iajs-2645	9	17	,	,	PUNCT
iajs-2645	9	18	iga	iga	PROPN
iajs-2645	9	19	anti	anti	ADJ
iajs-2645	9	20	-	-	ADJ
iajs-2645	9	21	gliadin	gliadin	ADJ
iajs-2645	9	22	antibody	antibody	NOUN
iajs-2645	9	23	,	,	PUNCT
iajs-2645	9	24	and	and	CCONJ
iajs-2645	9	25	interleukin-1	interleukin-1	NUM
iajs-2645	9	26	beta	beta	NOUN
iajs-2645	9	27	(	(	PUNCT
iajs-2645	9	28	il-1β	il-1β	PROPN
iajs-2645	9	29	)	)	PUNCT
iajs-2645	9	30	.	.	PUNCT
iajs-2645	10	1	based	base	VERB
iajs-2645	10	2	on	on	ADP
iajs-2645	10	3	marsh	marsh	PROPN
iajs-2645	10	4	classification	classification	NOUN
iajs-2645	10	5	,	,	PUNCT
iajs-2645	10	6	the	the	DET
iajs-2645	10	7	results	result	NOUN
iajs-2645	10	8	revealed	reveal	VERB
iajs-2645	10	9	that	that	SCONJ
iajs-2645	10	10	the	the	DET
iajs-2645	10	11	majority	majority	NOUN
iajs-2645	10	12	of	of	ADP
iajs-2645	10	13	patients	patient	NOUN
iajs-2645	10	14	(	(	PUNCT
iajs-2645	10	15	70	70	NUM
iajs-2645	10	16	%	%	NOUN
iajs-2645	10	17	)	)	PUNCT
iajs-2645	10	18	had	have	VERB
iajs-2645	10	19	partial	partial	ADJ
iajs-2645	10	20	villous	villous	ADJ
iajs-2645	10	21	atrophy	atrophy	NOUN
iajs-2645	10	22	(	(	PUNCT
iajs-2645	10	23	marsh	marsh	PROPN
iajs-2645	10	24	ш	ш	PROPN
iajs-2645	10	25	3a	3a	NUM
iajs-2645	10	26	)	)	PUNCT
iajs-2645	10	27	,	,	PUNCT
iajs-2645	10	28	while	while	SCONJ
iajs-2645	10	29	children	child	NOUN
iajs-2645	10	30	with	with	ADP
iajs-2645	10	31	subtotal	subtotal	ADJ
iajs-2645	10	32	and	and	CCONJ
iajs-2645	10	33	total	total	ADJ
iajs-2645	10	34	villous	villous	ADJ
iajs-2645	10	35	atrophy	atrophy	NOUN
iajs-2645	10	36	(	(	PUNCT
iajs-2645	10	37	marsh	marsh	PROPN
iajs-2645	10	38	iii	iii	PROPN
iajs-2645	10	39	:	:	PUNCT
iajs-2645	10	40	3b/3c	3b/3c	NUM
iajs-2645	10	41	)	)	PUNCT
iajs-2645	10	42	were	be	AUX
iajs-2645	10	43	presented	present	VERB
iajs-2645	10	44	with	with	ADP
iajs-2645	10	45	a	a	DET
iajs-2645	10	46	lower	low	ADJ
iajs-2645	10	47	frequency	frequency	NOUN
iajs-2645	10	48	(	(	PUNCT
iajs-2645	10	49	30.0	30.0	NUM
iajs-2645	10	50	%	%	NOUN
iajs-2645	10	51	)	)	PUNCT
iajs-2645	10	52	.	.	PUNCT
iajs-2645	11	1	neither	neither	CCONJ
iajs-2645	11	2	marsh	marsh	PROPN
iajs-2645	11	3	i	i	PROPN
iajs-2645	11	4	nor	nor	CCONJ
iajs-2645	11	5	marsh	marsh	PROPN
iajs-2645	11	6	ii	ii	PROPN
iajs-2645	11	7	has	have	AUX
iajs-2645	11	8	been	be	AUX
iajs-2645	11	9	observed	observe	VERB
iajs-2645	11	10	among	among	ADP
iajs-2645	11	11	the	the	DET
iajs-2645	11	12	patients	patient	NOUN
iajs-2645	11	13	studied	study	VERB
iajs-2645	11	14	.	.	PUNCT
iajs-2645	12	1	serum	serum	NOUN
iajs-2645	12	2	levels	level	NOUN
iajs-2645	12	3	of	of	ADP
iajs-2645	12	4	anti	anti	ADJ
iajs-2645	12	5	-	-	ADJ
iajs-2645	12	6	ttg	ttg	NOUN
iajs-2645	12	7	and	and	CCONJ
iajs-2645	12	8	anti	anti	ADJ
iajs-2645	12	9	-	-	ADJ
iajs-2645	12	10	gliadin	gliadin	ADJ
iajs-2645	12	11	iga	iga	PROPN
iajs-2645	12	12	antibodies	antibody	NOUN
iajs-2645	12	13	were	be	AUX
iajs-2645	12	14	significantly	significantly	ADV
iajs-2645	12	15	higher	high	ADJ
iajs-2645	12	16	in	in	ADP
iajs-2645	12	17	cd	cd	NOUN
iajs-2645	12	18	children	child	NOUN
iajs-2645	12	19	than	than	ADP
iajs-2645	12	20	in	in	ADP
iajs-2645	12	21	control	control	NOUN
iajs-2645	12	22	children	child	NOUN
iajs-2645	12	23	(	(	PUNCT
iajs-2645	12	24	73.8	73.8	NUM
iajs-2645	12	25	and	and	CCONJ
iajs-2645	12	26	31.8	31.8	NUM
iajs-2645	12	27	vs.	vs.	ADP
iajs-2645	12	28	0.8	0.8	NUM
iajs-2645	12	29	u//ml	u//ml	NOUN
iajs-2645	12	30	,	,	PUNCT
iajs-2645	12	31	respectively	respectively	ADV
iajs-2645	12	32	;	;	PUNCT
iajs-2645	12	33	p	p	X
iajs-2645	12	34	<	<	X
iajs-2645	12	35	0.001	0.001	NUM
iajs-2645	12	36	)	)	PUNCT
iajs-2645	12	37	.	.	PUNCT
iajs-2645	13	1	conversely	conversely	ADV
iajs-2645	13	2	,	,	PUNCT
iajs-2645	13	3	il-1β	il-1β	PROPN
iajs-2645	13	4	serum	serum	NOUN
iajs-2645	13	5	level	level	NOUN
iajs-2645	13	6	was	be	AUX
iajs-2645	13	7	decreased	decrease	VERB
iajs-2645	13	8	in	in	ADP
iajs-2645	13	9	cd	cd	NOUN
iajs-2645	13	10	children	child	NOUN
iajs-2645	13	11	but	but	CCONJ
iajs-2645	13	12	the	the	DET
iajs-2645	13	13	difference	difference	NOUN
iajs-2645	13	14	was	be	AUX
iajs-2645	13	15	not	not	PART
iajs-2645	13	16	significant	significant	ADJ
iajs-2645	13	17	(	(	PUNCT
iajs-2645	13	18	35.5vs	35.5vs	NUM
iajs-2645	13	19	.	.	PUNCT
iajs-2645	14	1	53.4	53.4	NUM
iajs-2645	14	2	pg	pg	NOUN
iajs-2645	14	3	/	/	SYM
iajs-2645	14	4	ml	ml	NOUN
iajs-2645	14	5	;	;	PUNCT
iajs-2645	14	6	p	p	X
iajs-2645	14	7	=	=	NOUN
iajs-2645	14	8	0.285	0.285	NUM
iajs-2645	14	9	)	)	PUNCT
iajs-2645	14	10	.	.	PUNCT
iajs-2645	15	1	in	in	ADP
iajs-2645	15	2	the	the	DET
iajs-2645	15	3	case	case	NOUN
iajs-2645	15	4	of	of	ADP
iajs-2645	15	5	nlrp3	nlrp3	ADJ
iajs-2645	15	6	inflammasome	inflammasome	NOUN
iajs-2645	15	7	,	,	PUNCT
iajs-2645	15	8	the	the	DET
iajs-2645	15	9	relative	relative	ADJ
iajs-2645	15	10	fold	fold	ADJ
iajs-2645	15	11	change	change	NOUN
iajs-2645	15	12	method	method	NOUN
iajs-2645	15	13	(	(	PUNCT
iajs-2645	15	14	2-∆∆ct	2-∆∆ct	PROPN
iajs-2645	15	15	)	)	PUNCT
iajs-2645	15	16	was	be	AUX
iajs-2645	15	17	used	use	VERB
iajs-2645	15	18	to	to	PART
iajs-2645	15	19	assess	assess	VERB
iajs-2645	15	20	the	the	DET
iajs-2645	15	21	gene	gene	NOUN
iajs-2645	15	22	expression	expression	NOUN
iajs-2645	15	23	.	.	PUNCT
iajs-2645	16	1	the	the	DET
iajs-2645	16	2	results	result	NOUN
iajs-2645	16	3	revealed	reveal	VERB
iajs-2645	16	4	that	that	SCONJ
iajs-2645	16	5	the	the	DET
iajs-2645	16	6	expression	expression	NOUN
iajs-2645	16	7	of	of	ADP
iajs-2645	16	8	nlrp3	nlrp3	ADJ
iajs-2645	16	9	inflammasome	inflammasome	NOUN
iajs-2645	16	10	was	be	AUX
iajs-2645	16	11	decreased	decrease	VERB
iajs-2645	16	12	by	by	ADP
iajs-2645	16	13	0.594	0.594	NUM
iajs-2645	16	14	fold	fold	NOUN
iajs-2645	16	15	in	in	ADP
iajs-2645	16	16	cd	cd	NOUN
iajs-2645	16	17	children	child	NOUN
iajs-2645	16	18	.	.	PUNCT
iajs-2645	17	1	in	in	ADP
iajs-2645	17	2	conclusion	conclusion	NOUN
iajs-2645	17	3	,	,	PUNCT
iajs-2645	17	4	the	the	DET
iajs-2645	17	5	nlrp3	nlrp3	NOUN
iajs-2645	17	6	inflammasome	inflammasome	NOUN
iajs-2645	17	7	was	be	AUX
iajs-2645	17	8	down	down	ADV
iajs-2645	17	9	-	-	PUNCT
iajs-2645	17	10	regulated	regulate	VERB
iajs-2645	17	11	in	in	ADP
iajs-2645	17	12	the	the	DET
iajs-2645	17	13	present	present	ADJ
iajs-2645	17	14	sample	sample	NOUN
iajs-2645	17	15	of	of	ADP
iajs-2645	17	16	cd	cd	PROPN
iajs-2645	17	17	children	child	NOUN
iajs-2645	17	18	,	,	PUNCT
iajs-2645	17	19	and	and	CCONJ
iajs-2645	17	20	it	it	PRON
iajs-2645	17	21	was	be	AUX
iajs-2645	17	22	accompanied	accompany	VERB
iajs-2645	17	23	by	by	ADP
iajs-2645	17	24	a	a	DET
iajs-2645	17	25	decreased	decrease	VERB
iajs-2645	17	26	serum	serum	NOUN
iajs-2645	17	27	level	level	NOUN
iajs-2645	17	28	of	of	ADP
iajs-2645	17	29	il-1β	il-1β	PROPN
iajs-2645	17	30	.	.	PUNCT
iajs-2645	18	1	keywords	keyword	NOUN
iajs-2645	18	2	:	:	PUNCT
iajs-2645	18	3	celiac	celiac	ADJ
iajs-2645	18	4	disease	disease	NOUN
iajs-2645	18	5	;	;	PUNCT
iajs-2645	18	6	nlrp3	nlrp3	ADJ
iajs-2645	18	7	inflammasome	inflammasome	NOUN
iajs-2645	18	8	,	,	PUNCT
iajs-2645	18	9	il-1β	il-1β	PROPN
iajs-2645	18	10	;	;	PUNCT
iajs-2645	18	11	gene	gene	NOUN
iajs-2645	18	12	expression	expression	NOUN
iajs-2645	18	13	.	.	PUNCT
iajs-2645	19	1	1	1	X
iajs-2645	19	2	.	.	X
iajs-2645	19	3	introduction	introduction	NOUN
iajs-2645	19	4	celiac	celiac	ADJ
iajs-2645	19	5	disease	disease	NOUN
iajs-2645	19	6	(	(	PUNCT
iajs-2645	19	7	cd	cd	PROPN
iajs-2645	19	8	)	)	PUNCT
iajs-2645	19	9	is	be	AUX
iajs-2645	19	10	an	an	DET
iajs-2645	19	11	autoimmune	autoimmune	ADJ
iajs-2645	19	12	disorder	disorder	NOUN
iajs-2645	19	13	that	that	PRON
iajs-2645	19	14	occurs	occur	VERB
iajs-2645	19	15	in	in	ADP
iajs-2645	19	16	genetically	genetically	ADV
iajs-2645	19	17	predisposed	predispose	VERB
iajs-2645	19	18	individuals	individual	NOUN
iajs-2645	19	19	who	who	PRON
iajs-2645	19	20	develop	develop	VERB
iajs-2645	19	21	an	an	DET
iajs-2645	19	22	immune	immune	ADJ
iajs-2645	19	23	reaction	reaction	NOUN
iajs-2645	19	24	to	to	ADP
iajs-2645	19	25	the	the	DET
iajs-2645	19	26	ingestion	ingestion	NOUN
iajs-2645	19	27	of	of	ADP
iajs-2645	19	28	gluten	gluten	NOUN
iajs-2645	19	29	-	-	PUNCT
iajs-2645	19	30	containing	contain	VERB
iajs-2645	19	31	foods	food	NOUN
iajs-2645	19	32	(	(	PUNCT
iajs-2645	19	33	wheat	wheat	NOUN
iajs-2645	19	34	,	,	PUNCT
iajs-2645	19	35	barley	barley	NOUN
iajs-2645	19	36	,	,	PUNCT
iajs-2645	19	37	and	and	CCONJ
iajs-2645	19	38	rye	rye	NOUN
iajs-2645	19	39	)	)	PUNCT
iajs-2645	20	1	[	[	X
iajs-2645	20	2	1	1	NUM
iajs-2645	20	3	]	]	PUNCT
iajs-2645	20	4	.	.	PUNCT
iajs-2645	21	1	it	it	PRON
iajs-2645	21	2	is	be	AUX
iajs-2645	21	3	also	also	ADV
iajs-2645	21	4	characterized	characterize	VERB
iajs-2645	21	5	by	by	ADP
iajs-2645	21	6	chronic	chronic	ADJ
iajs-2645	21	7	inflammation	inflammation	NOUN
iajs-2645	21	8	that	that	SCONJ
iajs-2645	21	9	primarily	primarily	ADV
iajs-2645	21	10	affects	affect	VERB
iajs-2645	21	11	the	the	DET
iajs-2645	21	12	small	small	ADJ
iajs-2645	21	13	intestine	intestine	NOUN
iajs-2645	21	14	and	and	CCONJ
iajs-2645	21	15	can	can	AUX
iajs-2645	21	16	lead	lead	VERB
iajs-2645	21	17	to	to	ADP
iajs-2645	21	18	malabsorption	malabsorption	NOUN
iajs-2645	21	19	of	of	ADP
iajs-2645	21	20	nutrients	nutrient	NOUN
iajs-2645	21	21	,	,	PUNCT
iajs-2645	21	22	chronic	chronic	ADJ
iajs-2645	21	23	or	or	CCONJ
iajs-2645	21	24	intermittent	intermittent	ADJ
iajs-2645	21	25	diarrhea	diarrhea	NOUN
iajs-2645	21	26	,	,	PUNCT
iajs-2645	21	27	growth	growth	NOUN
iajs-2645	21	28	failure	failure	NOUN
iajs-2645	21	29	or	or	CCONJ
iajs-2645	21	30	short	short	ADJ
iajs-2645	21	31	stature	stature	NOUN
iajs-2645	21	32	,	,	PUNCT
iajs-2645	21	33	weight	weight	NOUN
iajs-2645	21	34	loss	loss	NOUN
iajs-2645	21	35	,	,	PUNCT
iajs-2645	21	36	iron	iron	NOUN
iajs-2645	21	37	deficiency	deficiency	NOUN
iajs-2645	21	38	,	,	PUNCT
iajs-2645	21	39	and	and	CCONJ
iajs-2645	21	40	osteopenia	osteopenia	NOUN
iajs-2645	22	1	[	[	X
iajs-2645	22	2	2	2	NUM
iajs-2645	22	3	]	]	PUNCT
iajs-2645	22	4	.	.	PUNCT
iajs-2645	23	1	the	the	DET
iajs-2645	23	2	global	global	ADJ
iajs-2645	23	3	prevalence	prevalence	NOUN
iajs-2645	23	4	of	of	ADP
iajs-2645	23	5	cd	cd	PROPN
iajs-2645	23	6	is	be	AUX
iajs-2645	23	7	1.4	1.4	NUM
iajs-2645	23	8	%	%	NOUN
iajs-2645	23	9	,	,	PUNCT
iajs-2645	23	10	and	and	CCONJ
iajs-2645	23	11	it	it	PRON
iajs-2645	23	12	is	be	AUX
iajs-2645	23	13	more	more	ADV
iajs-2645	23	14	common	common	ADJ
iajs-2645	23	15	in	in	ADP
iajs-2645	23	16	children	child	NOUN
iajs-2645	23	17	than	than	ADP
iajs-2645	23	18	in	in	ADP
iajs-2645	23	19	adults	adult	NOUN
iajs-2645	23	20	.	.	PUNCT
iajs-2645	24	1	further	far	ADV
iajs-2645	24	2	,	,	PUNCT
iajs-2645	24	3	the	the	DET
iajs-2645	24	4	prevalence	prevalence	NOUN
iajs-2645	24	5	of	of	ADP
iajs-2645	24	6	cd	cd	PROPN
iajs-2645	24	7	varies	vary	VERB
iajs-2645	24	8	with	with	ADP
iajs-2645	24	9	age	age	NOUN
iajs-2645	24	10	,	,	PUNCT
iajs-2645	24	11	gender	gender	NOUN
iajs-2645	24	12	,	,	PUNCT
iajs-2645	24	13	and	and	CCONJ
iajs-2645	24	14	geographical	geographical	ADJ
iajs-2645	24	15	location	location	NOUN
iajs-2645	24	16	[	[	X
iajs-2645	24	17	3	3	NUM
iajs-2645	24	18	]	]	PUNCT
iajs-2645	24	19	.	.	PUNCT
iajs-2645	25	1	in	in	ADP
iajs-2645	25	2	iraq	iraq	PROPN
iajs-2645	25	3	,	,	PUNCT
iajs-2645	25	4	the	the	DET
iajs-2645	25	5	prevalence	prevalence	NOUN
iajs-2645	25	6	was	be	AUX
iajs-2645	25	7	found	find	VERB
iajs-2645	25	8	to	to	PART
iajs-2645	25	9	be	be	AUX
iajs-2645	25	10	0.25	0.25	NUM
iajs-2645	25	11	%	%	NOUN
iajs-2645	25	12	among	among	ADP
iajs-2645	25	13	healthy	healthy	ADJ
iajs-2645	25	14	blood	blood	NOUN
iajs-2645	25	15	donors	donor	NOUN
iajs-2645	25	16	[	[	X
iajs-2645	25	17	4	4	NUM
iajs-2645	25	18	]	]	PUNCT
iajs-2645	25	19	.	.	PUNCT
iajs-2645	26	1	human	human	ADJ
iajs-2645	26	2	autoimmune	autoimmune	PROPN
iajs-2645	26	3	anwar	anwar	PROPN
iajs-2645	26	4	i.	i.	PROPN
iajs-2645	26	5	s.	s.	PROPN
iajs-2645	26	6	al	al	PROPN
iajs-2645	26	7	-	-	PUNCT
iajs-2645	26	8	assaf	assaf	PROPN
iajs-2645	26	9	anwar.idrees@yahoo.com	anwar.idrees@yahoo.com	PROPN
iajs-2645	26	10	department	department	PROPN
iajs-2645	26	11	of	of	ADP
iajs-2645	26	12	biology	biology	NOUN
iajs-2645	26	13	,	,	PUNCT
iajs-2645	26	14	college	college	NOUN
iajs-2645	26	15	of	of	ADP
iajs-2645	26	16	education	education	NOUN
iajs-2645	26	17	for	for	ADP
iajs-2645	26	18	pure	pure	ADJ
iajs-2645	26	19	science	science	NOUN
iajs-2645	26	20	(	(	PUNCT
iajs-2645	26	21	ibn	ibn	PROPN
iajs-2645	26	22	al	al	PROPN
iajs-2645	26	23	-	-	PUNCT
iajs-2645	26	24	haitham	haitham	PROPN
iajs-2645	26	25	)	)	PUNCT
iajs-2645	26	26	,	,	PUNCT
iajs-2645	26	27	university	university	NOUN
iajs-2645	26	28	of	of	ADP
iajs-2645	26	29	baghdad	baghdad	PROPN
iajs-2645	26	30	,	,	PUNCT
iajs-2645	26	31	baghdad	baghdad	PROPN
iajs-2645	26	32	,	,	PUNCT
iajs-2645	26	33	iraq	iraq	PROPN
iajs-2645	26	34	.	.	PUNCT
iajs-2645	27	1	hiba	hiba	PROPN
iajs-2645	27	2	m.	m.	PROPN
iajs-2645	27	3	ali	ali	PROPN
iajs-2645	27	4	hibamn19921992@gmail.com	hibamn19921992@gmail.com	PROPN
iajs-2645	27	5	department	department	PROPN
iajs-2645	27	6	of	of	ADP
iajs-2645	27	7	biology	biology	NOUN
iajs-2645	27	8	,	,	PUNCT
iajs-2645	27	9	college	college	NOUN
iajs-2645	27	10	of	of	ADP
iajs-2645	27	11	education	education	NOUN
iajs-2645	27	12	for	for	ADP
iajs-2645	27	13	pure	pure	ADJ
iajs-2645	27	14	science	science	NOUN
iajs-2645	27	15	(	(	PUNCT
iajs-2645	27	16	ibn	ibn	PROPN
iajs-2645	27	17	al	al	PROPN
iajs-2645	27	18	-	-	PUNCT
iajs-2645	27	19	haitham	haitham	PROPN
iajs-2645	27	20	)	)	PUNCT
iajs-2645	27	21	,	,	PUNCT
iajs-2645	27	22	university	university	NOUN
iajs-2645	27	23	of	of	ADP
iajs-2645	27	24	baghdad	baghdad	PROPN
iajs-2645	27	25	,	,	PUNCT
iajs-2645	27	26	baghdad	baghdad	PROPN
iajs-2645	27	27	,	,	PUNCT
iajs-2645	27	28	iraq	iraq	PROPN
iajs-2645	27	29	.	.	PUNCT
iajs-2645	28	1	ali	ali	PROPN
iajs-2645	28	2	h.	h.	PROPN
iajs-2645	28	3	ad'hiah	ad'hiah	PROPN
iajs-2645	28	4	dr.ahadhiah@sc.uobaghdad.edu.iq	dr.ahadhiah@sc.uobaghdad.edu.iq	ADJ
iajs-2645	28	5	tropical	tropical	ADJ
iajs-2645	28	6	-	-	PUNCT
iajs-2645	28	7	biological	biological	ADJ
iajs-2645	28	8	research	research	NOUN
iajs-2645	28	9	unit	unit	NOUN
iajs-2645	28	10	,	,	PUNCT
iajs-2645	28	11	college	college	NOUN
iajs-2645	28	12	of	of	ADP
iajs-2645	28	13	science	science	NOUN
iajs-2645	28	14	,	,	PUNCT
iajs-2645	28	15	university	university	NOUN
iajs-2645	28	16	of	of	ADP
iajs-2645	28	17	baghdad	baghdad	PROPN
iajs-2645	28	18	,	,	PUNCT
iajs-2645	28	19	baghdad	baghdad	PROPN
iajs-2645	28	20	,	,	PUNCT
iajs-2645	28	21	iraq	iraq	PROPN
iajs-2645	28	22	http://ihicps.com/	http://ihicps.com/	PROPN
iajs-2645	28	23	mailto:anwar.idrees@yahoo.com	mailto:anwar.idrees@yahoo.com	PROPN
iajs-2645	28	24	mailto:hibamn19921992@gmail.com	mailto:hibamn19921992@gmail.com	PROPN
iajs-2645	28	25	mailto:dr.ahadhiah@sc.uobaghdad.edu.iq	mailto:dr.ahadhiah@sc.uobaghdad.edu.iq	ADJ
iajs-2645	28	26	special	special	ADJ
iajs-2645	28	27	issue	issue	NOUN
iajs-2645	28	28	1ihicpas	1ihicpas	NUM
iajs-2645	28	29	202	202	NUM
iajs-2645	28	30	ibn	ibn	PROPN
iajs-2645	28	31	al	al	PROPN
iajs-2645	28	32	-	-	PUNCT
iajs-2645	28	33	haitham	haitham	PROPN
iajs-2645	28	34	journal	journal	PROPN
iajs-2645	28	35	for	for	ADP
iajs-2645	28	36	pure	pure	ADJ
iajs-2645	28	37	and	and	CCONJ
iajs-2645	28	38	applied	apply	VERB
iajs-2645	28	39	science	science	NOUN
iajs-2645	28	40	https://doi.org/10.30526/2021.ihicpas.2645	https://doi.org/10.30526/2021.ihicpas.2645	PROPN
iajs-2645	28	41	for	for	ADP
iajs-2645	28	42	more	more	ADJ
iajs-2645	28	43	information	information	NOUN
iajs-2645	28	44	about	about	ADP
iajs-2645	28	45	the	the	DET
iajs-2645	28	46	conference	conference	NOUN
iajs-2645	28	47	please	please	INTJ
iajs-2645	28	48	visit	visit	VERB
iajs-2645	28	49	the	the	DET
iajs-2645	28	50	websites	website	NOUN
iajs-2645	28	51	:	:	PUNCT
iajs-2645	28	52	http://ihicps.com/	http://ihicps.com/	NOUN
iajs-2645	28	53	b	b	NOUN
iajs-2645	29	1	i	i	NOUN
iajs-2645	29	2	o	o	NOUN
iajs-2645	30	1	l	l	NOUN
iajs-2645	30	2	o	o	X
iajs-2645	31	1	g	g	NOUN
iajs-2645	31	2	y	y	PROPN
iajs-2645	31	3	|	|	ADV
iajs-2645	31	4	16	16	NUM
iajs-2645	31	5	diseases	disease	NOUN
iajs-2645	31	6	affect	affect	VERB
iajs-2645	31	7	3	3	NUM
iajs-2645	31	8	-	-	SYM
iajs-2645	31	9	5	5	NUM
iajs-2645	31	10	%	%	NOUN
iajs-2645	31	11	of	of	ADP
iajs-2645	31	12	the	the	DET
iajs-2645	31	13	population	population	NOUN
iajs-2645	31	14	and	and	CCONJ
iajs-2645	31	15	arise	arise	VERB
iajs-2645	31	16	from	from	ADP
iajs-2645	31	17	complex	complex	ADJ
iajs-2645	31	18	interactions	interaction	NOUN
iajs-2645	31	19	between	between	ADP
iajs-2645	31	20	genetic	genetic	ADJ
iajs-2645	31	21	and	and	CCONJ
iajs-2645	31	22	environmental	environmental	ADJ
iajs-2645	31	23	factors	factor	NOUN
iajs-2645	31	24	,	,	PUNCT
iajs-2645	31	25	which	which	PRON
iajs-2645	31	26	consequence	consequence	VERB
iajs-2645	31	27	in	in	ADP
iajs-2645	31	28	immune	immune	ADJ
iajs-2645	31	29	dysregulation	dysregulation	NOUN
iajs-2645	31	30	and	and	CCONJ
iajs-2645	31	31	immune	immune	ADJ
iajs-2645	31	32	attack	attack	NOUN
iajs-2645	31	33	to	to	PART
iajs-2645	31	34	target	target	VERB
iajs-2645	31	35	tissues	tissue	NOUN
iajs-2645	31	36	[	[	X
iajs-2645	31	37	5	5	NUM
iajs-2645	31	38	]	]	PUNCT
iajs-2645	31	39	.	.	PUNCT
iajs-2645	32	1	the	the	DET
iajs-2645	32	2	innate	innate	ADJ
iajs-2645	32	3	immune	immune	ADJ
iajs-2645	32	4	system	system	NOUN
iajs-2645	32	5	works	work	VERB
iajs-2645	32	6	as	as	ADP
iajs-2645	32	7	the	the	DET
iajs-2645	32	8	first	first	ADJ
iajs-2645	32	9	line	line	NOUN
iajs-2645	32	10	of	of	ADP
iajs-2645	32	11	defense	defense	NOUN
iajs-2645	32	12	in	in	ADP
iajs-2645	32	13	protection	protection	NOUN
iajs-2645	32	14	from	from	ADP
iajs-2645	32	15	pathogenic	pathogenic	ADJ
iajs-2645	32	16	microbes	microbe	NOUN
iajs-2645	32	17	and	and	CCONJ
iajs-2645	32	18	host	host	NOUN
iajs-2645	32	19	-	-	PUNCT
iajs-2645	32	20	derived	derive	VERB
iajs-2645	32	21	signals	signal	NOUN
iajs-2645	32	22	of	of	ADP
iajs-2645	32	23	cellular	cellular	ADJ
iajs-2645	32	24	distress	distress	NOUN
iajs-2645	32	25	.	.	PUNCT
iajs-2645	33	1	one	one	NUM
iajs-2645	33	2	way	way	NOUN
iajs-2645	33	3	in	in	ADP
iajs-2645	33	4	which	which	PRON
iajs-2645	33	5	these	these	DET
iajs-2645	33	6	“	"	PUNCT
iajs-2645	33	7	danger	danger	NOUN
iajs-2645	33	8	”	"	PUNCT
iajs-2645	33	9	signals	signal	NOUN
iajs-2645	33	10	trigger	trigger	NOUN
iajs-2645	33	11	inflammation	inflammation	NOUN
iajs-2645	33	12	is	be	AUX
iajs-2645	33	13	through	through	ADP
iajs-2645	33	14	activation	activation	NOUN
iajs-2645	33	15	of	of	ADP
iajs-2645	33	16	inflammasomes	inflammasome	NOUN
iajs-2645	33	17	,	,	PUNCT
iajs-2645	33	18	which	which	PRON
iajs-2645	33	19	are	be	AUX
iajs-2645	33	20	multi	multi	ADJ
iajs-2645	33	21	-	-	ADJ
iajs-2645	33	22	protein	protein	ADJ
iajs-2645	33	23	complexes	complex	NOUN
iajs-2645	33	24	that	that	PRON
iajs-2645	33	25	assemble	assemble	VERB
iajs-2645	33	26	in	in	ADP
iajs-2645	33	27	the	the	DET
iajs-2645	33	28	cytosol	cytosol	NOUN
iajs-2645	33	29	after	after	ADP
iajs-2645	33	30	exposure	exposure	NOUN
iajs-2645	33	31	to	to	AUX
iajs-2645	33	32	pathogenassociated	pathogenassociated	VERB
iajs-2645	33	33	molecular	molecular	ADJ
iajs-2645	33	34	patterns	pattern	NOUN
iajs-2645	33	35	(	(	PUNCT
iajs-2645	33	36	pamps	pamp	NOUN
iajs-2645	33	37	)	)	PUNCT
iajs-2645	33	38	or	or	CCONJ
iajs-2645	33	39	danger	danger	NOUN
iajs-2645	33	40	-	-	PUNCT
iajs-2645	33	41	associated	associate	VERB
iajs-2645	33	42	molecular	molecular	ADJ
iajs-2645	33	43	patterns	pattern	NOUN
iajs-2645	33	44	(	(	PUNCT
iajs-2645	33	45	damps	damps	VERB
iajs-2645	33	46	)	)	PUNCT
iajs-2645	34	1	[	[	X
iajs-2645	34	2	6	6	NUM
iajs-2645	34	3	]	]	PUNCT
iajs-2645	34	4	.	.	PUNCT
iajs-2645	35	1	they	they	PRON
iajs-2645	35	2	result	result	VERB
iajs-2645	35	3	in	in	ADP
iajs-2645	35	4	activation	activation	NOUN
iajs-2645	35	5	of	of	ADP
iajs-2645	35	6	caspase-1and	caspase-1and	PROPN
iajs-2645	35	7	subsequent	subsequent	ADJ
iajs-2645	35	8	cleavage	cleavage	NOUN
iajs-2645	35	9	of	of	ADP
iajs-2645	35	10	the	the	DET
iajs-2645	35	11	pro	pro	ADJ
iajs-2645	35	12	-	-	ADJ
iajs-2645	35	13	inflammatory	inflammatory	ADJ
iajs-2645	35	14	cytokines	cytokine	NOUN
iajs-2645	35	15	il-1β	il-1β	ADJ
iajs-2645	35	16	and	and	CCONJ
iajs-2645	35	17	il-18	il-18	ADP
iajs-2645	35	18	,	,	PUNCT
iajs-2645	35	19	and	and	CCONJ
iajs-2645	35	20	this	this	PRON
iajs-2645	35	21	may	may	AUX
iajs-2645	35	22	be	be	AUX
iajs-2645	35	23	destructive	destructive	ADJ
iajs-2645	35	24	to	to	ADP
iajs-2645	35	25	tissues	tissue	NOUN
iajs-2645	35	26	;	;	PUNCT
iajs-2645	35	27	however	however	ADV
iajs-2645	35	28	,	,	PUNCT
iajs-2645	35	29	the	the	DET
iajs-2645	35	30	specific	specific	ADJ
iajs-2645	35	31	regulatory	regulatory	ADJ
iajs-2645	35	32	mechanisms	mechanism	NOUN
iajs-2645	35	33	of	of	ADP
iajs-2645	35	34	nlrp3	nlrp3	NOUN
iajs-2645	35	35	inflammasome	inflammasome	NOUN
iajs-2645	35	36	activation	activation	NOUN
iajs-2645	35	37	remain	remain	VERB
iajs-2645	35	38	unclear	unclear	ADJ
iajs-2645	35	39	[	[	X
iajs-2645	35	40	7	7	NUM
iajs-2645	35	41	]	]	PUNCT
iajs-2645	35	42	.	.	PUNCT
iajs-2645	36	1	a	a	DET
iajs-2645	36	2	role	role	NOUN
iajs-2645	36	3	for	for	ADP
iajs-2645	36	4	the	the	DET
iajs-2645	36	5	nlrp3	nlrp3	ADJ
iajs-2645	36	6	inflammasome	inflammasome	NOUN
iajs-2645	36	7	in	in	ADP
iajs-2645	36	8	recurrent	recurrent	ADJ
iajs-2645	36	9	and	and	CCONJ
iajs-2645	36	10	chronic	chronic	ADJ
iajs-2645	36	11	inflammation	inflammation	NOUN
iajs-2645	36	12	was	be	AUX
iajs-2645	36	13	initially	initially	ADV
iajs-2645	36	14	described	describe	VERB
iajs-2645	36	15	in	in	ADP
iajs-2645	36	16	a	a	DET
iajs-2645	36	17	group	group	NOUN
iajs-2645	36	18	of	of	ADP
iajs-2645	36	19	rare	rare	ADJ
iajs-2645	36	20	auto	auto	NOUN
iajs-2645	36	21	-	-	PUNCT
iajs-2645	36	22	inflammatory	inflammatory	ADJ
iajs-2645	36	23	conditions	condition	NOUN
iajs-2645	36	24	,	,	PUNCT
iajs-2645	36	25	such	such	ADJ
iajs-2645	36	26	as	as	ADP
iajs-2645	36	27	rheumatoid	rheumatoid	NOUN
iajs-2645	36	28	arthritis	arthritis	NOUN
iajs-2645	36	29	,	,	PUNCT
iajs-2645	36	30	multiple	multiple	ADJ
iajs-2645	36	31	sclerosis	sclerosis	NOUN
iajs-2645	36	32	,	,	PUNCT
iajs-2645	36	33	and	and	CCONJ
iajs-2645	36	34	celiac	celiac	ADJ
iajs-2645	36	35	disease	disease	NOUN
iajs-2645	36	36	[	[	X
iajs-2645	36	37	8	8	NUM
iajs-2645	36	38	]	]	PUNCT
iajs-2645	36	39	.	.	PUNCT
iajs-2645	37	1	further	far	ADV
iajs-2645	37	2	,	,	PUNCT
iajs-2645	37	3	the	the	DET
iajs-2645	37	4	nlrp3	nlrp3	NOUN
iajs-2645	37	5	inflammasome	inflammasome	NOUN
iajs-2645	37	6	has	have	AUX
iajs-2645	37	7	been	be	AUX
iajs-2645	37	8	implicated	implicate	VERB
iajs-2645	37	9	in	in	ADP
iajs-2645	37	10	many	many	ADJ
iajs-2645	37	11	common	common	ADJ
iajs-2645	37	12	diseases	disease	NOUN
iajs-2645	37	13	,	,	PUNCT
iajs-2645	37	14	including	include	VERB
iajs-2645	37	15	cancer	cancer	NOUN
iajs-2645	37	16	,	,	PUNCT
iajs-2645	37	17	gout	gout	NOUN
iajs-2645	37	18	,	,	PUNCT
iajs-2645	37	19	and	and	CCONJ
iajs-2645	37	20	diabetes	diabetes	NOUN
iajs-2645	37	21	[	[	X
iajs-2645	37	22	9	9	NUM
iajs-2645	37	23	]	]	PUNCT
iajs-2645	37	24	.	.	PUNCT
iajs-2645	38	1	being	be	AUX
iajs-2645	38	2	able	able	ADJ
iajs-2645	38	3	to	to	PART
iajs-2645	38	4	analyze	analyze	VERB
iajs-2645	38	5	gene	gene	NOUN
iajs-2645	38	6	expression	expression	NOUN
iajs-2645	38	7	patterns	pattern	NOUN
iajs-2645	38	8	is	be	AUX
iajs-2645	38	9	essential	essential	ADJ
iajs-2645	38	10	for	for	ADP
iajs-2645	38	11	understanding	understand	VERB
iajs-2645	38	12	protein	protein	NOUN
iajs-2645	38	13	function	function	NOUN
iajs-2645	38	14	,	,	PUNCT
iajs-2645	38	15	biological	biological	ADJ
iajs-2645	38	16	pathways	pathway	NOUN
iajs-2645	38	17	and	and	CCONJ
iajs-2645	38	18	cellular	cellular	ADJ
iajs-2645	38	19	responses	response	NOUN
iajs-2645	38	20	to	to	ADP
iajs-2645	38	21	external	external	ADJ
iajs-2645	38	22	and	and	CCONJ
iajs-2645	38	23	internal	internal	ADJ
iajs-2645	38	24	stimuli	stimulus	NOUN
iajs-2645	38	25	[	[	X
iajs-2645	38	26	10	10	NUM
iajs-2645	38	27	]	]	PUNCT
iajs-2645	38	28	.	.	PUNCT
iajs-2645	39	1	to	to	PART
iajs-2645	39	2	elucidate	elucidate	VERB
iajs-2645	39	3	the	the	DET
iajs-2645	39	4	role	role	NOUN
iajs-2645	39	5	of	of	ADP
iajs-2645	39	6	the	the	DET
iajs-2645	39	7	nlrp3	nlrp3	ADJ
iajs-2645	39	8	inflammasome	inflammasome	NOUN
iajs-2645	39	9	in	in	ADP
iajs-2645	39	10	celiac	celiac	ADJ
iajs-2645	39	11	disease	disease	NOUN
iajs-2645	39	12	,	,	PUNCT
iajs-2645	39	13	this	this	DET
iajs-2645	39	14	study	study	NOUN
iajs-2645	39	15	examined	examine	VERB
iajs-2645	39	16	the	the	DET
iajs-2645	39	17	gene	gene	NOUN
iajs-2645	39	18	expression	expression	NOUN
iajs-2645	39	19	of	of	ADP
iajs-2645	39	20	nlrp3	nlrp3	ADJ
iajs-2645	39	21	inflammasome	inflammasome	NOUN
iajs-2645	39	22	in	in	ADP
iajs-2645	39	23	peripheral	peripheral	ADJ
iajs-2645	39	24	blood	blood	NOUN
iajs-2645	39	25	within	within	ADP
iajs-2645	39	26	the	the	DET
iajs-2645	39	27	downstream	downstream	ADJ
iajs-2645	39	28	regulatory	regulatory	ADJ
iajs-2645	39	29	region	region	NOUN
iajs-2645	39	30	of	of	ADP
iajs-2645	39	31	the	the	DET
iajs-2645	39	32	nlrp3	nlrp3	ADJ
iajs-2645	39	33	gene	gene	NOUN
iajs-2645	39	34	for	for	ADP
iajs-2645	39	35	association	association	NOUN
iajs-2645	39	36	with	with	ADP
iajs-2645	39	37	the	the	DET
iajs-2645	39	38	expression	expression	NOUN
iajs-2645	39	39	of	of	ADP
iajs-2645	39	40	nlrp3	nlrp3	NOUN
iajs-2645	39	41	in	in	ADP
iajs-2645	39	42	addition	addition	NOUN
iajs-2645	39	43	to	to	ADP
iajs-2645	39	44	the	the	DET
iajs-2645	39	45	pro	pro	ADJ
iajs-2645	39	46	-	-	ADJ
iajs-2645	39	47	inflammatory	inflammatory	ADJ
iajs-2645	39	48	marker	marker	NOUN
iajs-2645	39	49	il-1β	il-1β	PROPN
iajs-2645	39	50	.	.	PUNCT
iajs-2645	40	1	2	2	X
iajs-2645	40	2	.	.	X
iajs-2645	40	3	materials	material	NOUN
iajs-2645	40	4	method	method	VERB
iajs-2645	40	5	2.1	2.1	NUM
iajs-2645	40	6	.	.	PUNCT
iajs-2645	41	1	children	child	NOUN
iajs-2645	41	2	studied	study	VERB
iajs-2645	41	3	a	a	DET
iajs-2645	41	4	total	total	NOUN
iajs-2645	41	5	of	of	ADP
iajs-2645	41	6	30	30	NUM
iajs-2645	41	7	iraqi	iraqi	ADJ
iajs-2645	41	8	children	child	NOUN
iajs-2645	41	9	(	(	PUNCT
iajs-2645	41	10	12	12	NUM
iajs-2645	41	11	males	male	NOUN
iajs-2645	41	12	and	and	CCONJ
iajs-2645	41	13	18	18	NUM
iajs-2645	41	14	females	female	NOUN
iajs-2645	41	15	;	;	PUNCT
iajs-2645	41	16	mean	mean	VERB
iajs-2645	41	17	age	age	NOUN
iajs-2645	41	18	±	±	PROPN
iajs-2645	41	19	sd	sd	NOUN
iajs-2645	41	20	:	:	PUNCT
iajs-2645	41	21	9.60	9.60	NUM
iajs-2645	41	22	±	±	NUM
iajs-2645	41	23	0.55	0.55	NUM
iajs-2645	41	24	years	year	NOUN
iajs-2645	41	25	)	)	PUNCT
iajs-2645	41	26	with	with	ADP
iajs-2645	41	27	cd	cd	PROPN
iajs-2645	41	28	attending	attend	VERB
iajs-2645	41	29	the	the	DET
iajs-2645	41	30	consultant	consultant	NOUN
iajs-2645	41	31	clinic	clinic	NOUN
iajs-2645	41	32	at	at	ADP
iajs-2645	41	33	the	the	DET
iajs-2645	41	34	central	central	ADJ
iajs-2645	41	35	pediatrics	pediatric	NOUN
iajs-2645	41	36	hospital	hospital	NOUN
iajs-2645	41	37	,	,	PUNCT
iajs-2645	41	38	private	private	ADJ
iajs-2645	41	39	nursing	nursing	NOUN
iajs-2645	41	40	hospital	hospital	NOUN
iajs-2645	41	41	,	,	PUNCT
iajs-2645	41	42	and	and	CCONJ
iajs-2645	41	43	specialist	specialist	ADJ
iajs-2645	41	44	center	center	NOUN
iajs-2645	41	45	for	for	ADP
iajs-2645	41	46	endocrinology	endocrinology	NOUN
iajs-2645	41	47	and	and	CCONJ
iajs-2645	41	48	diabetes	diabetes	NOUN
iajs-2645	41	49	in	in	ADP
iajs-2645	41	50	iraq	iraq	PROPN
iajs-2645	41	51	-	-	PUNCT
iajs-2645	41	52	baghdad	baghdad	PROPN
iajs-2645	41	53	during	during	ADP
iajs-2645	41	54	the	the	DET
iajs-2645	41	55	period	period	NOUN
iajs-2645	41	56	august	august	PROPN
iajs-2645	41	57	2018	2018	NUM
iajs-2645	41	58	march	march	PROPN
iajs-2645	41	59	2019	2019	NUM
iajs-2645	41	60	were	be	AUX
iajs-2645	41	61	enrolled	enrol	VERB
iajs-2645	41	62	in	in	ADP
iajs-2645	41	63	this	this	DET
iajs-2645	41	64	study	study	NOUN
iajs-2645	41	65	.	.	PUNCT
iajs-2645	42	1	they	they	PRON
iajs-2645	42	2	were	be	AUX
iajs-2645	42	3	clinically	clinically	ADV
iajs-2645	42	4	examined	examine	VERB
iajs-2645	42	5	and	and	CCONJ
iajs-2645	42	6	evaluated	evaluate	VERB
iajs-2645	42	7	by	by	ADP
iajs-2645	42	8	the	the	DET
iajs-2645	42	9	consultant	consultant	NOUN
iajs-2645	42	10	medical	medical	ADJ
iajs-2645	42	11	staff	staff	NOUN
iajs-2645	42	12	at	at	ADP
iajs-2645	42	13	these	these	DET
iajs-2645	42	14	hospitals	hospital	NOUN
iajs-2645	42	15	,	,	PUNCT
iajs-2645	42	16	and	and	CCONJ
iajs-2645	42	17	the	the	DET
iajs-2645	42	18	diagnosis	diagnosis	NOUN
iajs-2645	42	19	was	be	AUX
iajs-2645	42	20	confirmed	confirm	VERB
iajs-2645	42	21	through	through	ADP
iajs-2645	42	22	serological	serological	ADJ
iajs-2645	42	23	and	and	CCONJ
iajs-2645	42	24	histological	histological	ADJ
iajs-2645	42	25	tests	test	NOUN
iajs-2645	42	26	[	[	X
iajs-2645	42	27	11	11	NUM
iajs-2645	42	28	]	]	PUNCT
iajs-2645	42	29	.	.	PUNCT
iajs-2645	43	1	serological	serological	ADJ
iajs-2645	43	2	diagnosis	diagnosis	NOUN
iajs-2645	43	3	of	of	ADP
iajs-2645	43	4	cd	cd	PROPN
iajs-2645	43	5	was	be	AUX
iajs-2645	43	6	based	base	VERB
iajs-2645	43	7	on	on	ADP
iajs-2645	43	8	the	the	DET
iajs-2645	43	9	presence	presence	NOUN
iajs-2645	43	10	of	of	ADP
iajs-2645	43	11	iga	iga	PROPN
iajs-2645	43	12	antibodies	antibodie	VERB
iajs-2645	43	13	against	against	ADP
iajs-2645	43	14	gliadin	gliadin	NOUN
iajs-2645	43	15	and	and	CCONJ
iajs-2645	43	16	tissue	tissue	NOUN
iajs-2645	43	17	transglutaminase	transglutaminase	NOUN
iajs-2645	43	18	(	(	PUNCT
iajs-2645	43	19	ttg	ttg	PROPN
iajs-2645	43	20	)	)	PUNCT
iajs-2645	43	21	.	.	PUNCT
iajs-2645	44	1	this	this	PRON
iajs-2645	44	2	was	be	AUX
iajs-2645	44	3	followed	follow	VERB
iajs-2645	44	4	by	by	ADP
iajs-2645	44	5	an	an	DET
iajs-2645	44	6	examination	examination	NOUN
iajs-2645	44	7	of	of	ADP
iajs-2645	44	8	an	an	DET
iajs-2645	44	9	intestinal	intestinal	ADJ
iajs-2645	44	10	biopsy	biopsy	NOUN
iajs-2645	44	11	.	.	PUNCT
iajs-2645	45	1	cases	case	NOUN
iajs-2645	45	2	seropositive	seropositive	ADJ
iajs-2645	45	3	for	for	ADP
iajs-2645	45	4	the	the	DET
iajs-2645	45	5	two	two	NUM
iajs-2645	45	6	antibodies	antibody	NOUN
iajs-2645	45	7	but	but	CCONJ
iajs-2645	45	8	their	their	PRON
iajs-2645	45	9	intestinal	intestinal	ADJ
iajs-2645	45	10	biopsy	biopsy	NOUN
iajs-2645	45	11	did	do	AUX
iajs-2645	45	12	not	not	PART
iajs-2645	45	13	confirm	confirm	VERB
iajs-2645	45	14	the	the	DET
iajs-2645	45	15	disease	disease	NOUN
iajs-2645	45	16	were	be	AUX
iajs-2645	45	17	excluded	exclude	VERB
iajs-2645	45	18	from	from	ADP
iajs-2645	45	19	the	the	DET
iajs-2645	45	20	study	study	NOUN
iajs-2645	45	21	.	.	PUNCT
iajs-2645	46	1	children	child	NOUN
iajs-2645	46	2	with	with	ADP
iajs-2645	46	3	giardiasis	giardiasis	NOUN
iajs-2645	46	4	were	be	AUX
iajs-2645	46	5	also	also	ADV
iajs-2645	46	6	excluded	exclude	VERB
iajs-2645	46	7	.	.	PUNCT
iajs-2645	47	1	a	a	DET
iajs-2645	47	2	control	control	NOUN
iajs-2645	47	3	sample	sample	NOUN
iajs-2645	47	4	of	of	ADP
iajs-2645	47	5	20	20	NUM
iajs-2645	47	6	healthy	healthy	ADJ
iajs-2645	47	7	children	child	NOUN
iajs-2645	47	8	(	(	PUNCT
iajs-2645	47	9	12	12	NUM
iajs-2645	47	10	male	male	NOUN
iajs-2645	47	11	and	and	CCONJ
iajs-2645	47	12	8	8	NUM
iajs-2645	47	13	females	female	NOUN
iajs-2645	47	14	;	;	PUNCT
iajs-2645	47	15	9.99	9.99	NUM
iajs-2645	47	16	±	±	NUM
iajs-2645	47	17	0.77	0.77	NUM
iajs-2645	47	18	years	year	NOUN
iajs-2645	47	19	)	)	PUNCT
iajs-2645	47	20	was	be	AUX
iajs-2645	47	21	included	include	VERB
iajs-2645	47	22	.	.	PUNCT
iajs-2645	48	1	they	they	PRON
iajs-2645	48	2	were	be	AUX
iajs-2645	48	3	randomly	randomly	ADV
iajs-2645	48	4	selected	select	VERB
iajs-2645	48	5	from	from	ADP
iajs-2645	48	6	healthcare	healthcare	NOUN
iajs-2645	48	7	units	unit	NOUN
iajs-2645	48	8	in	in	ADP
iajs-2645	48	9	baghdad	baghdad	PROPN
iajs-2645	48	10	and	and	CCONJ
iajs-2645	48	11	had	have	VERB
iajs-2645	48	12	no	no	DET
iajs-2645	48	13	clinical	clinical	ADJ
iajs-2645	48	14	evidence	evidence	NOUN
iajs-2645	48	15	or	or	CCONJ
iajs-2645	48	16	family	family	NOUN
iajs-2645	48	17	history	history	NOUN
iajs-2645	48	18	of	of	ADP
iajs-2645	48	19	cd	cd	PROPN
iajs-2645	48	20	or	or	CCONJ
iajs-2645	48	21	other	other	ADJ
iajs-2645	48	22	autoimmune	autoimmune	ADJ
iajs-2645	48	23	diseases	disease	NOUN
iajs-2645	48	24	.	.	PUNCT
iajs-2645	49	1	2.2	2.2	NUM
iajs-2645	49	2	.	.	PUNCT
iajs-2645	50	1	immunological	immunological	ADJ
iajs-2645	50	2	parameters	parameter	NOUN
iajs-2645	50	3	serum	serum	NOUN
iajs-2645	50	4	levels	level	NOUN
iajs-2645	50	5	of	of	ADP
iajs-2645	50	6	anti	anti	ADJ
iajs-2645	50	7	-	-	ADJ
iajs-2645	50	8	gliadin	gliadin	ADJ
iajs-2645	50	9	and	and	CCONJ
iajs-2645	50	10	anti	anti	ADJ
iajs-2645	50	11	-	-	ADJ
iajs-2645	50	12	tissue	tissue	ADJ
iajs-2645	50	13	transglutaminase	transglutaminase	NOUN
iajs-2645	50	14	test	test	NOUN
iajs-2645	50	15	(	(	PUNCT
iajs-2645	50	16	anti	anti	ADJ
iajs-2645	50	17	-	-	ADJ
iajs-2645	50	18	ttg	ttg	ADJ
iajs-2645	50	19	)	)	PUNCT
iajs-2645	50	20	antibodies	antibodie	VERB
iajs-2645	50	21	and	and	CCONJ
iajs-2645	50	22	il1β	il1β	PROPN
iajs-2645	50	23	were	be	AUX
iajs-2645	50	24	measured	measure	VERB
iajs-2645	50	25	using	use	VERB
iajs-2645	50	26	elisa	elisa	PROPN
iajs-2645	50	27	kits	kit	NOUN
iajs-2645	50	28	(	(	PUNCT
iajs-2645	50	29	aeskulisa	aeskulisa	NOUN
iajs-2645	50	30	and	and	CCONJ
iajs-2645	50	31	demeditec	demeditec	NOUN
iajs-2645	50	32	,	,	PUNCT
iajs-2645	50	33	respectively	respectively	ADV
iajs-2645	50	34	;	;	PUNCT
iajs-2645	50	35	germany	germany	PROPN
iajs-2645	50	36	)	)	PUNCT
iajs-2645	50	37	and	and	CCONJ
iajs-2645	50	38	instructions	instruction	NOUN
iajs-2645	50	39	of	of	ADP
iajs-2645	50	40	the	the	DET
iajs-2645	50	41	manufacturer	manufacturer	NOUN
iajs-2645	50	42	were	be	AUX
iajs-2645	50	43	followed	follow	VERB
iajs-2645	50	44	.	.	PUNCT
iajs-2645	51	1	2.3	2.3	NUM
iajs-2645	51	2	.	.	PUNCT
iajs-2645	51	3	gene	gene	NOUN
iajs-2645	51	4	expression	expression	NOUN
iajs-2645	51	5	of	of	ADP
iajs-2645	51	6	nlrp3	nlrp3	NOUN
iajs-2645	51	7	inflammasome	inflammasome	NOUN
iajs-2645	51	8	gene	gene	NOUN
iajs-2645	51	9	expression	expression	NOUN
iajs-2645	51	10	of	of	ADP
iajs-2645	51	11	nlrp3	nlrp3	ADJ
iajs-2645	51	12	inflammasome	inflammasome	NOUN
iajs-2645	51	13	was	be	AUX
iajs-2645	51	14	determined	determine	VERB
iajs-2645	51	15	by	by	ADP
iajs-2645	51	16	the	the	DET
iajs-2645	51	17	reverse	reverse	ADJ
iajs-2645	51	18	transcriptionhttp://ihicps.com/	transcriptionhttp://ihicps.com/	PROPN
iajs-2645	51	19	special	special	ADJ
iajs-2645	51	20	issue	issue	NOUN
iajs-2645	51	21	1ihicpas	1ihicpas	NUM
iajs-2645	51	22	202	202	NUM
iajs-2645	51	23	ibn	ibn	PROPN
iajs-2645	51	24	al	al	PROPN
iajs-2645	51	25	-	-	PUNCT
iajs-2645	51	26	haitham	haitham	PROPN
iajs-2645	51	27	journal	journal	PROPN
iajs-2645	51	28	for	for	ADP
iajs-2645	51	29	pure	pure	ADJ
iajs-2645	51	30	and	and	CCONJ
iajs-2645	51	31	applied	apply	VERB
iajs-2645	51	32	science	science	NOUN
iajs-2645	51	33	https://doi.org/10.30526/2021.ihicpas.2645	https://doi.org/10.30526/2021.ihicpas.2645	PROPN
iajs-2645	51	34	for	for	ADP
iajs-2645	51	35	more	more	ADJ
iajs-2645	51	36	information	information	NOUN
iajs-2645	51	37	about	about	ADP
iajs-2645	51	38	the	the	DET
iajs-2645	51	39	conference	conference	NOUN
iajs-2645	51	40	please	please	INTJ
iajs-2645	51	41	visit	visit	VERB
iajs-2645	51	42	the	the	DET
iajs-2645	51	43	websites	website	NOUN
iajs-2645	51	44	:	:	PUNCT
iajs-2645	52	1	http://ihicps.com/	http://ihicps.com/	NOUN
iajs-2645	52	2	b	b	NOUN
iajs-2645	53	1	i	i	NOUN
iajs-2645	53	2	o	o	NOUN
iajs-2645	54	1	l	l	NOUN
iajs-2645	54	2	o	o	X
iajs-2645	54	3	g	g	NOUN
iajs-2645	54	4	y	y	PROPN
iajs-2645	55	1	|	|	ADV
iajs-2645	55	2	17	17	NUM
iajs-2645	55	3	quantitative	quantitative	ADJ
iajs-2645	55	4	polymerase	polymerase	NOUN
iajs-2645	55	5	chain	chain	NOUN
iajs-2645	55	6	reaction	reaction	NOUN
iajs-2645	55	7	(	(	PUNCT
iajs-2645	55	8	rt	rt	NOUN
iajs-2645	55	9	-	-	PUNCT
iajs-2645	55	10	qpcr	qpcr	ADJ
iajs-2645	55	11	)	)	PUNCT
iajs-2645	55	12	method	method	NOUN
iajs-2645	55	13	.	.	PUNCT
iajs-2645	56	1	total	total	ADJ
iajs-2645	56	2	rna	rna	PROPN
iajs-2645	56	3	was	be	AUX
iajs-2645	56	4	isolated	isolate	VERB
iajs-2645	56	5	from	from	ADP
iajs-2645	56	6	peripheral	peripheral	ADJ
iajs-2645	56	7	using	use	VERB
iajs-2645	56	8	ready	ready	ADJ
iajs-2645	56	9	-	-	PUNCT
iajs-2645	56	10	to	to	PART
iajs-2645	56	11	-	-	PUNCT
iajs-2645	56	12	use	use	VERB
iajs-2645	56	13	reagent	reagent	NOUN
iajs-2645	56	14	(	(	PUNCT
iajs-2645	56	15	trizoltmls	trizoltmls	NOUN
iajs-2645	56	16	reagent	reagent	NOUN
iajs-2645	56	17	;	;	PUNCT
iajs-2645	56	18	thermo	thermo	NOUN
iajs-2645	56	19	fischer	fischer	PROPN
iajs-2645	56	20	scientific	scientific	PROPN
iajs-2645	56	21	;	;	PUNCT
iajs-2645	56	22	usa	usa	PROPN
iajs-2645	56	23	)	)	PUNCT
iajs-2645	56	24	.	.	PUNCT
iajs-2645	57	1	the	the	DET
iajs-2645	57	2	isolated	isolated	ADJ
iajs-2645	57	3	rna	rna	NOUN
iajs-2645	57	4	was	be	AUX
iajs-2645	57	5	reverse	reverse	NOUN
iajs-2645	57	6	-	-	PUNCT
iajs-2645	57	7	transcribed	transcribe	VERB
iajs-2645	57	8	and	and	CCONJ
iajs-2645	57	9	the	the	DET
iajs-2645	57	10	gene	gene	NOUN
iajs-2645	57	11	expression	expression	NOUN
iajs-2645	57	12	of	of	ADP
iajs-2645	57	13	nlrp3	nlrp3	ADJ
iajs-2645	57	14	inflammasome	inflammasome	NOUN
iajs-2645	57	15	was	be	AUX
iajs-2645	57	16	assessed	assess	VERB
iajs-2645	57	17	using	use	VERB
iajs-2645	57	18	gotaq	gotaq	PROPN
iajs-2645	57	19	®	®	NOUN
iajs-2645	57	20	1	1	NUM
iajs-2645	57	21	-	-	PUNCT
iajs-2645	57	22	step	step	NOUN
iajs-2645	57	23	rt	rt	NOUN
iajs-2645	57	24	-	-	PUNCT
iajs-2645	57	25	qpcr	qpcr	ADV
iajs-2645	57	26	system	system	NOUN
iajs-2645	57	27	kit	kit	NOUN
iajs-2645	57	28	(	(	PUNCT
iajs-2645	57	29	promega	promega	PROPN
iajs-2645	57	30	,	,	PUNCT
iajs-2645	57	31	usa	usa	PROPN
iajs-2645	57	32	)	)	PUNCT
iajs-2645	57	33	,	,	PUNCT
iajs-2645	57	34	and	and	CCONJ
iajs-2645	57	35	instructions	instruction	NOUN
iajs-2645	57	36	of	of	ADP
iajs-2645	57	37	the	the	DET
iajs-2645	57	38	manufacturer	manufacturer	NOUN
iajs-2645	57	39	were	be	AUX
iajs-2645	57	40	followed	follow	VERB
iajs-2645	57	41	.	.	PUNCT
iajs-2645	58	1	forward	forward	ADV
iajs-2645	58	2	and	and	CCONJ
iajs-2645	58	3	reverse	reverse	VERB
iajs-2645	58	4	primers	primer	NOUN
iajs-2645	58	5	for	for	ADP
iajs-2645	58	6	nlrp3	nlrp3	ADJ
iajs-2645	58	7	inflammasome	inflammasome	NOUN
iajs-2645	58	8	(	(	PUNCT
iajs-2645	58	9	5’aacagcagatggagagtggc-3	5’aacagcagatggagagtggc-3	NUM
iajs-2645	58	10	’	'	PUNCT
iajs-2645	58	11	and	and	CCONJ
iajs-2645	58	12	5’-ggtcggactcctcaaacagg-3	5’-ggtcggactcctcaaacagg-3	NUM
iajs-2645	58	13	’	'	PUNCT
iajs-2645	58	14	,	,	PUNCT
iajs-2645	58	15	respectively	respectively	ADV
iajs-2645	58	16	)	)	PUNCT
iajs-2645	58	17	and	and	CCONJ
iajs-2645	58	18	the	the	DET
iajs-2645	58	19	housekeeping	housekeeping	NOUN
iajs-2645	58	20	gene	gene	NOUN
iajs-2645	58	21	gapdh	gapdh	NOUN
iajs-2645	58	22	(	(	PUNCT
iajs-2645	58	23	5’-agaaggctggggctcatttg-3	5’-agaaggctggggctcatttg-3	NUM
iajs-2645	58	24	’	'	PUNCT
iajs-2645	58	25	and	and	CCONJ
iajs-2645	58	26	5’aggggccatccacagtcttc-3	5’aggggccatccacagtcttc-3	PROPN
iajs-2645	58	27	’	'	PUNCT
iajs-2645	58	28	,	,	PUNCT
iajs-2645	58	29	respectively	respectively	ADV
iajs-2645	58	30	)	)	PUNCT
iajs-2645	58	31	were	be	AUX
iajs-2645	58	32	according	accord	VERB
iajs-2645	58	33	to	to	ADP
iajs-2645	58	34	published	publish	VERB
iajs-2645	58	35	sequences	sequence	NOUN
iajs-2645	58	36	.	.	PUNCT
iajs-2645	59	1	the	the	DET
iajs-2645	59	2	primers	primer	NOUN
iajs-2645	59	3	were	be	AUX
iajs-2645	59	4	designed	design	VERB
iajs-2645	59	5	using	use	VERB
iajs-2645	59	6	primer	primer	NOUN
iajs-2645	59	7	design	design	NOUN
iajs-2645	59	8	web	web	NOUN
iajs-2645	59	9	-	-	PUNCT
iajs-2645	59	10	based	base	VERB
iajs-2645	59	11	service	service	NOUN
iajs-2645	59	12	and	and	CCONJ
iajs-2645	59	13	validated	validate	VERB
iajs-2645	59	14	using	use	VERB
iajs-2645	59	15	the	the	DET
iajs-2645	59	16	primer	primer	NOUN
iajs-2645	59	17	-	-	PUNCT
iajs-2645	59	18	blast	blast	NOUN
iajs-2645	59	19	-	-	PUNCT
iajs-2645	59	20	ncbi	ncbi	NOUN
iajs-2645	59	21	database	database	NOUN
iajs-2645	59	22	.	.	PUNCT
iajs-2645	60	1	to	to	PART
iajs-2645	60	2	determine	determine	VERB
iajs-2645	60	3	gene	gene	NOUN
iajs-2645	60	4	expression	expression	NOUN
iajs-2645	60	5	of	of	ADP
iajs-2645	60	6	nlrp3	nlrp3	ADJ
iajs-2645	60	7	inflammasome	inflammasome	NOUN
iajs-2645	60	8	(	(	PUNCT
iajs-2645	60	9	expression	expression	NOUN
iajs-2645	60	10	fold	fold	NOUN
iajs-2645	60	11	change	change	NOUN
iajs-2645	60	12	)	)	PUNCT
iajs-2645	60	13	,	,	PUNCT
iajs-2645	60	14	the	the	DET
iajs-2645	60	15	2	2	NUM
iajs-2645	60	16	-	-	PUNCT
iajs-2645	60	17	δδct	δδct	NOUN
iajs-2645	60	18	was	be	AUX
iajs-2645	60	19	calculated	calculate	VERB
iajs-2645	60	20	(	(	PUNCT
iajs-2645	60	21	relative	relative	ADJ
iajs-2645	60	22	fold	fold	ADJ
iajs-2645	60	23	change	change	NOUN
iajs-2645	60	24	)	)	PUNCT
iajs-2645	60	25	.	.	PUNCT
iajs-2645	61	1	thus	thus	ADV
iajs-2645	61	2	,	,	PUNCT
iajs-2645	61	3	the	the	DET
iajs-2645	61	4	expression	expression	NOUN
iajs-2645	61	5	was	be	AUX
iajs-2645	61	6	expressed	express	VERB
iajs-2645	61	7	as	as	ADP
iajs-2645	61	8	a	a	DET
iajs-2645	61	9	fold	fold	ADJ
iajs-2645	61	10	change	change	NOUN
iajs-2645	61	11	in	in	ADP
iajs-2645	61	12	the	the	DET
iajs-2645	61	13	level	level	NOUN
iajs-2645	61	14	of	of	ADP
iajs-2645	61	15	the	the	DET
iajs-2645	61	16	target	target	NOUN
iajs-2645	61	17	gene	gene	NOUN
iajs-2645	61	18	expression	expression	NOUN
iajs-2645	61	19	,	,	PUNCT
iajs-2645	61	20	which	which	PRON
iajs-2645	61	21	was	be	AUX
iajs-2645	61	22	normalized	normalize	VERB
iajs-2645	61	23	to	to	ADP
iajs-2645	61	24	the	the	DET
iajs-2645	61	25	expression	expression	NOUN
iajs-2645	61	26	level	level	NOUN
iajs-2645	61	27	of	of	ADP
iajs-2645	61	28	the	the	DET
iajs-2645	61	29	housekeeping	housekeeping	NOUN
iajs-2645	61	30	gene	gene	NOUN
iajs-2645	61	31	gapdh	gapdh	NOUN
iajs-2645	61	32	(	(	PUNCT
iajs-2645	61	33	endogenous	endogenous	ADJ
iajs-2645	61	34	control	control	NOUN
iajs-2645	61	35	)	)	PUNCT
iajs-2645	61	36	and	and	CCONJ
iajs-2645	61	37	relative	relative	ADJ
iajs-2645	61	38	to	to	ADP
iajs-2645	61	39	the	the	DET
iajs-2645	61	40	target	target	NOUN
iajs-2645	61	41	gene	gene	NOUN
iajs-2645	61	42	in	in	ADP
iajs-2645	61	43	control	control	NOUN
iajs-2645	61	44	subjects	subject	NOUN
iajs-2645	61	45	(	(	PUNCT
iajs-2645	61	46	calibrator	calibrator	NOUN
iajs-2645	61	47	)	)	PUNCT
iajs-2645	62	1	[	[	X
iajs-2645	62	2	12	12	NUM
iajs-2645	62	3	]	]	PUNCT
iajs-2645	62	4	.	.	PUNCT
iajs-2645	63	1	2.4	2.4	NUM
iajs-2645	63	2	.	.	PUNCT
iajs-2645	64	1	statistical	statistical	ADJ
iajs-2645	64	2	analysis	analysis	NOUN
iajs-2645	64	3	the	the	DET
iajs-2645	64	4	data	datum	NOUN
iajs-2645	64	5	was	be	AUX
iajs-2645	64	6	statistically	statistically	ADV
iajs-2645	64	7	analyzed	analyze	VERB
iajs-2645	64	8	using	use	VERB
iajs-2645	64	9	the	the	DET
iajs-2645	64	10	statistical	statistical	ADJ
iajs-2645	64	11	package	package	NOUN
iajs-2645	64	12	for	for	ADP
iajs-2645	64	13	social	social	ADJ
iajs-2645	64	14	sciences	science	NOUN
iajs-2645	64	15	(	(	PUNCT
iajs-2645	64	16	spss	spss	PROPN
iajs-2645	64	17	version	version	NOUN
iajs-2645	64	18	19.0	19.0	NUM
iajs-2645	64	19	)	)	PUNCT
iajs-2645	64	20	.	.	PUNCT
iajs-2645	65	1	pearson	pearson	PROPN
iajs-2645	65	2	chi	chi	PROPN
iajs-2645	65	3	-	-	PUNCT
iajs-2645	65	4	square	square	NOUN
iajs-2645	65	5	test	test	NOUN
iajs-2645	65	6	or	or	CCONJ
iajs-2645	65	7	two	two	NUM
iajs-2645	65	8	-	-	PUNCT
iajs-2645	65	9	tailed	tail	VERB
iajs-2645	65	10	fisher	fisher	PROPN
iajs-2645	65	11	exact	exact	ADJ
iajs-2645	65	12	test	test	NOUN
iajs-2645	65	13	was	be	AUX
iajs-2645	65	14	used	use	VERB
iajs-2645	65	15	to	to	ADP
iajs-2645	65	16	analyzing	analyze	VERB
iajs-2645	65	17	categorical	categorical	ADJ
iajs-2645	65	18	variables	variable	NOUN
iajs-2645	65	19	.	.	PUNCT
iajs-2645	66	1	for	for	ADP
iajs-2645	66	2	continuous	continuous	ADJ
iajs-2645	66	3	variables	variable	NOUN
iajs-2645	66	4	and	and	CCONJ
iajs-2645	66	5	depending	depend	VERB
iajs-2645	66	6	on	on	ADP
iajs-2645	66	7	the	the	DET
iajs-2645	66	8	distribution	distribution	NOUN
iajs-2645	66	9	of	of	ADP
iajs-2645	66	10	data	datum	NOUN
iajs-2645	66	11	,	,	PUNCT
iajs-2645	66	12	parametric	parametric	ADJ
iajs-2645	66	13	variables	variable	NOUN
iajs-2645	66	14	were	be	AUX
iajs-2645	66	15	given	give	VERB
iajs-2645	66	16	as	as	ADP
iajs-2645	66	17	mean	mean	PROPN
iajs-2645	66	18	±	±	NUM
iajs-2645	66	19	standard	standard	ADJ
iajs-2645	66	20	deviation	deviation	NOUN
iajs-2645	66	21	(	(	PUNCT
iajs-2645	66	22	sd	sd	NOUN
iajs-2645	66	23	)	)	PUNCT
iajs-2645	66	24	,	,	PUNCT
iajs-2645	66	25	and	and	CCONJ
iajs-2645	66	26	significant	significant	ADJ
iajs-2645	66	27	differences	difference	NOUN
iajs-2645	66	28	between	between	ADP
iajs-2645	66	29	means	mean	NOUN
iajs-2645	66	30	were	be	AUX
iajs-2645	66	31	assessed	assess	VERB
iajs-2645	66	32	using	use	VERB
iajs-2645	66	33	the	the	DET
iajs-2645	66	34	student	student	NOUN
iajs-2645	66	35	t	t	PROPN
iajs-2645	66	36	-	-	PUNCT
iajs-2645	66	37	test	test	NOUN
iajs-2645	66	38	.	.	PUNCT
iajs-2645	67	1	for	for	ADP
iajs-2645	67	2	non	non	ADJ
iajs-2645	67	3	-	-	ADJ
iajs-2645	67	4	parametric	parametric	ADJ
iajs-2645	67	5	variables	variable	NOUN
iajs-2645	67	6	,	,	PUNCT
iajs-2645	67	7	median	median	ADJ
iajs-2645	67	8	and	and	CCONJ
iajs-2645	67	9	interquartile	interquartile	ADJ
iajs-2645	67	10	range	range	NOUN
iajs-2645	67	11	(	(	PUNCT
iajs-2645	67	12	iqr	iqr	NOUN
iajs-2645	67	13	:	:	PUNCT
iajs-2645	67	14	25	25	NUM
iajs-2645	67	15	-	-	SYM
iajs-2645	67	16	75	75	NUM
iajs-2645	67	17	%	%	NOUN
iajs-2645	67	18	)	)	PUNCT
iajs-2645	67	19	were	be	AUX
iajs-2645	67	20	given	give	VERB
iajs-2645	67	21	and	and	CCONJ
iajs-2645	67	22	a	a	DET
iajs-2645	67	23	significant	significant	ADJ
iajs-2645	67	24	difference	difference	NOUN
iajs-2645	67	25	between	between	ADP
iajs-2645	67	26	medians	median	NOUN
iajs-2645	67	27	was	be	AUX
iajs-2645	67	28	assessed	assess	VERB
iajs-2645	67	29	using	use	VERB
iajs-2645	67	30	either	either	CCONJ
iajs-2645	67	31	mann	mann	PROPN
iajs-2645	67	32	–	–	PUNCT
iajs-2645	67	33	whitney	whitney	PROPN
iajs-2645	67	34	u	u	PROPN
iajs-2645	67	35	test	test	NOUN
iajs-2645	67	36	(	(	PUNCT
iajs-2645	67	37	to	to	PART
iajs-2645	67	38	compare	compare	VERB
iajs-2645	67	39	to	to	ADP
iajs-2645	67	40	groups	group	NOUN
iajs-2645	67	41	)	)	PUNCT
iajs-2645	67	42	or	or	CCONJ
iajs-2645	67	43	kruskal	kruskal	NOUN
iajs-2645	67	44	–	–	PUNCT
iajs-2645	67	45	wallis	wallis	PROPN
iajs-2645	67	46	test	test	NOUN
iajs-2645	67	47	(	(	PUNCT
iajs-2645	67	48	to	to	PART
iajs-2645	67	49	compare	compare	VERB
iajs-2645	67	50	more	more	ADJ
iajs-2645	67	51	than	than	ADP
iajs-2645	67	52	two	two	NUM
iajs-2645	67	53	groups	group	NOUN
iajs-2645	67	54	)	)	PUNCT
iajs-2645	67	55	.	.	PUNCT
iajs-2645	68	1	receiver	receiver	ADJ
iajs-2645	68	2	operating	operate	VERB
iajs-2645	68	3	characteristic	characteristic	NOUN
iajs-2645	68	4	(	(	PUNCT
iajs-2645	68	5	roc	roc	PROPN
iajs-2645	68	6	)	)	PUNCT
iajs-2645	68	7	analysis	analysis	NOUN
iajs-2645	68	8	was	be	AUX
iajs-2645	68	9	employed	employ	VERB
iajs-2645	68	10	to	to	PART
iajs-2645	68	11	estimate	estimate	VERB
iajs-2645	68	12	the	the	DET
iajs-2645	68	13	area	area	NOUN
iajs-2645	68	14	under	under	ADP
iajs-2645	68	15	the	the	DET
iajs-2645	68	16	curve	curve	NOUN
iajs-2645	68	17	(	(	PUNCT
iajs-2645	68	18	auc	auc	NOUN
iajs-2645	68	19	)	)	PUNCT
iajs-2645	68	20	and	and	CCONJ
iajs-2645	68	21	optimum	optimum	ADJ
iajs-2645	68	22	cut	cut	NOUN
iajs-2645	68	23	-	-	PUNCT
iajs-2645	68	24	off	off	ADP
iajs-2645	68	25	point	point	NOUN
iajs-2645	68	26	that	that	PRON
iajs-2645	68	27	predicts	predict	VERB
iajs-2645	68	28	cd	cd	PROPN
iajs-2645	68	29	.	.	PUNCT
iajs-2645	69	1	a	a	DET
iajs-2645	69	2	probability	probability	NOUN
iajs-2645	69	3	(	(	PUNCT
iajs-2645	69	4	p	p	NOUN
iajs-2645	69	5	)	)	PUNCT
iajs-2645	69	6	value	value	NOUN
iajs-2645	69	7	≤	≤	NOUN
iajs-2645	69	8	0.05	0.05	NUM
iajs-2645	69	9	was	be	AUX
iajs-2645	69	10	considered	consider	VERB
iajs-2645	69	11	statistically	statistically	ADV
iajs-2645	69	12	significant	significant	ADJ
iajs-2645	69	13	.	.	PUNCT
iajs-2645	70	1	3	3	X
iajs-2645	70	2	.	.	NOUN
iajs-2645	70	3	results	result	NOUN
iajs-2645	70	4	and	and	CCONJ
iajs-2645	70	5	discussion	discussion	NOUN
iajs-2645	70	6	as	as	SCONJ
iajs-2645	70	7	shown	show	VERB
iajs-2645	70	8	in	in	ADP
iajs-2645	70	9	table	table	NOUN
iajs-2645	70	10	(	(	PUNCT
iajs-2645	70	11	1	1	NUM
iajs-2645	70	12	)	)	PUNCT
iajs-2645	70	13	,	,	PUNCT
iajs-2645	70	14	the	the	DET
iajs-2645	70	15	highest	high	ADJ
iajs-2645	70	16	incidence	incidence	NOUN
iajs-2645	70	17	of	of	ADP
iajs-2645	70	18	cd	cd	PROPN
iajs-2645	70	19	was	be	AUX
iajs-2645	70	20	noticed	notice	VERB
iajs-2645	70	21	in	in	ADP
iajs-2645	70	22	children	child	NOUN
iajs-2645	70	23	aged	age	VERB
iajs-2645	70	24	8	8	NUM
iajs-2645	70	25	-	-	SYM
iajs-2645	70	26	12	12	NUM
iajs-2645	70	27	years	year	NOUN
iajs-2645	70	28	(	(	PUNCT
iajs-2645	70	29	56.7	56.7	NUM
iajs-2645	70	30	%	%	NOUN
iajs-2645	70	31	)	)	PUNCT
iajs-2645	70	32	.	.	PUNCT
iajs-2645	71	1	this	this	PRON
iajs-2645	71	2	may	may	AUX
iajs-2645	71	3	indicate	indicate	VERB
iajs-2645	71	4	that	that	SCONJ
iajs-2645	71	5	the	the	DET
iajs-2645	71	6	disease	disease	NOUN
iajs-2645	71	7	is	be	AUX
iajs-2645	71	8	more	more	ADV
iajs-2645	71	9	common	common	ADJ
iajs-2645	71	10	in	in	ADP
iajs-2645	71	11	this	this	DET
iajs-2645	71	12	age	age	NOUN
iajs-2645	71	13	range	range	NOUN
iajs-2645	71	14	.	.	PUNCT
iajs-2645	72	1	there	there	PRON
iajs-2645	72	2	is	be	VERB
iajs-2645	72	3	no	no	DET
iajs-2645	72	4	specific	specific	ADJ
iajs-2645	72	5	explanation	explanation	NOUN
iajs-2645	72	6	for	for	ADP
iajs-2645	72	7	such	such	ADJ
iajs-2645	72	8	age	age	NOUN
iajs-2645	72	9	-	-	PUNCT
iajs-2645	72	10	dependency	dependency	NOUN
iajs-2645	72	11	,	,	PUNCT
iajs-2645	72	12	but	but	CCONJ
iajs-2645	72	13	delayed	delay	VERB
iajs-2645	72	14	diagnosis	diagnosis	NOUN
iajs-2645	72	15	and	and	CCONJ
iajs-2645	72	16	lack	lack	NOUN
iajs-2645	72	17	of	of	ADP
iajs-2645	72	18	awareness	awareness	NOUN
iajs-2645	72	19	of	of	ADP
iajs-2645	72	20	disease	disease	NOUN
iajs-2645	72	21	due	due	ADP
iajs-2645	72	22	to	to	ADP
iajs-2645	72	23	the	the	DET
iajs-2645	72	24	absence	absence	NOUN
iajs-2645	72	25	of	of	ADP
iajs-2645	72	26	any	any	DET
iajs-2645	72	27	symptoms	symptom	NOUN
iajs-2645	72	28	may	may	AUX
iajs-2645	72	29	account	account	VERB
iajs-2645	72	30	for	for	ADP
iajs-2645	72	31	underestimation	underestimation	NOUN
iajs-2645	72	32	of	of	ADP
iajs-2645	72	33	disease	disease	NOUN
iajs-2645	72	34	prevalence	prevalence	NOUN
iajs-2645	72	35	at	at	ADP
iajs-2645	72	36	a	a	DET
iajs-2645	72	37	younger	young	ADJ
iajs-2645	72	38	age	age	NOUN
iajs-2645	73	1	[	[	X
iajs-2645	73	2	13	13	NUM
iajs-2645	73	3	]	]	PUNCT
iajs-2645	73	4	.	.	PUNCT
iajs-2645	74	1	delayed	delay	VERB
iajs-2645	74	2	onset	onset	NOUN
iajs-2645	74	3	of	of	ADP
iajs-2645	74	4	cd	cd	PROPN
iajs-2645	74	5	may	may	AUX
iajs-2645	74	6	also	also	ADV
iajs-2645	74	7	account	account	VERB
iajs-2645	74	8	for	for	ADP
iajs-2645	74	9	the	the	DET
iajs-2645	74	10	development	development	NOUN
iajs-2645	74	11	of	of	ADP
iajs-2645	74	12	disease	disease	NOUN
iajs-2645	74	13	later	later	ADV
iajs-2645	74	14	in	in	ADP
iajs-2645	74	15	life	life	NOUN
iajs-2645	74	16	[	[	X
iajs-2645	74	17	14	14	NUM
iajs-2645	74	18	]	]	PUNCT
iajs-2645	74	19	.	.	PUNCT
iajs-2645	75	1	thus	thus	ADV
iajs-2645	75	2	,	,	PUNCT
iajs-2645	75	3	the	the	DET
iajs-2645	75	4	majority	majority	NOUN
iajs-2645	75	5	of	of	ADP
iajs-2645	75	6	cd	cd	PROPN
iajs-2645	75	7	patients	patient	NOUN
iajs-2645	75	8	are	be	AUX
iajs-2645	75	9	diagnosed	diagnose	VERB
iajs-2645	75	10	during	during	ADP
iajs-2645	75	11	adulthood	adulthood	NOUN
iajs-2645	75	12	[	[	X
iajs-2645	75	13	15	15	NUM
iajs-2645	75	14	]	]	PUNCT
iajs-2645	75	15	.	.	PUNCT
iajs-2645	76	1	the	the	DET
iajs-2645	76	2	results	result	NOUN
iajs-2645	76	3	revealed	reveal	VERB
iajs-2645	76	4	that	that	SCONJ
iajs-2645	76	5	female	female	ADJ
iajs-2645	76	6	patients	patient	NOUN
iajs-2645	76	7	outnumbered	outnumber	VERB
iajs-2645	76	8	male	male	ADJ
iajs-2645	76	9	patients	patient	NOUN
iajs-2645	76	10	(	(	PUNCT
iajs-2645	76	11	60	60	NUM
iajs-2645	76	12	vs.	vs.	ADP
iajs-2645	76	13	40	40	NUM
iajs-2645	76	14	%	%	NOUN
iajs-2645	76	15	)	)	PUNCT
iajs-2645	76	16	but	but	CCONJ
iajs-2645	76	17	the	the	DET
iajs-2645	76	18	difference	difference	NOUN
iajs-2645	76	19	was	be	AUX
iajs-2645	76	20	not	not	PART
iajs-2645	76	21	significant	significant	ADJ
iajs-2645	76	22	compared	compare	VERB
iajs-2645	76	23	to	to	ADP
iajs-2645	76	24	controls	control	NOUN
iajs-2645	76	25	(	(	PUNCT
iajs-2645	76	26	p	p	NOUN
iajs-2645	76	27	=	=	NOUN
iajs-2645	76	28	0.248	0.248	NUM
iajs-2645	76	29	)	)	PUNCT
iajs-2645	76	30	table	table	NOUN
iajs-2645	76	31	(	(	PUNCT
iajs-2645	76	32	1	1	NUM
iajs-2645	76	33	)	)	PUNCT
iajs-2645	76	34	.	.	PUNCT
iajs-2645	77	1	it	it	PRON
iajs-2645	77	2	is	be	AUX
iajs-2645	77	3	generally	generally	ADV
iajs-2645	77	4	agreed	agree	VERB
iajs-2645	77	5	that	that	SCONJ
iajs-2645	77	6	cd	cd	PROPN
iajs-2645	77	7	is	be	AUX
iajs-2645	77	8	a	a	DET
iajs-2645	77	9	female	female	ADJ
iajs-2645	77	10	-	-	PUNCT
iajs-2645	77	11	predominant	predominant	ADJ
iajs-2645	77	12	disease	disease	NOUN
iajs-2645	77	13	,	,	PUNCT
iajs-2645	77	14	but	but	CCONJ
iajs-2645	77	15	males	male	NOUN
iajs-2645	77	16	had	have	VERB
iajs-2645	77	17	a	a	DET
iajs-2645	77	18	shorter	short	ADJ
iajs-2645	77	19	duration	duration	NOUN
iajs-2645	77	20	of	of	ADP
iajs-2645	77	21	illness	illness	NOUN
iajs-2645	77	22	before	before	ADP
iajs-2645	77	23	diagnosis	diagnosis	NOUN
iajs-2645	77	24	and	and	CCONJ
iajs-2645	77	25	more	more	ADV
iajs-2645	77	26	severe	severe	ADJ
iajs-2645	77	27	manifestations	manifestation	NOUN
iajs-2645	77	28	of	of	ADP
iajs-2645	77	29	malabsorption	malabsorption	NOUN
iajs-2645	77	30	[	[	X
iajs-2645	77	31	16	16	NUM
iajs-2645	77	32	]	]	PUNCT
iajs-2645	77	33	.	.	PUNCT
iajs-2645	78	1	the	the	DET
iajs-2645	78	2	higher	high	ADJ
iajs-2645	78	3	prevalence	prevalence	NOUN
iajs-2645	78	4	of	of	ADP
iajs-2645	78	5	cd	cd	PROPN
iajs-2645	78	6	among	among	ADP
iajs-2645	78	7	females	female	NOUN
iajs-2645	78	8	could	could	AUX
iajs-2645	78	9	be	be	AUX
iajs-2645	78	10	explained	explain	VERB
iajs-2645	78	11	by	by	ADP
iajs-2645	78	12	multiple	multiple	ADJ
iajs-2645	78	13	factors	factor	NOUN
iajs-2645	78	14	such	such	ADJ
iajs-2645	78	15	as	as	ADP
iajs-2645	78	16	hormones	hormone	NOUN
iajs-2645	78	17	and	and	CCONJ
iajs-2645	78	18	genetics	genetic	NOUN
iajs-2645	78	19	,	,	PUNCT
iajs-2645	78	20	the	the	DET
iajs-2645	78	21	male	male	NOUN
iajs-2645	78	22	y	y	PROPN
iajs-2645	78	23	chromosome	chromosome	NOUN
iajs-2645	78	24	might	might	AUX
iajs-2645	78	25	have	have	VERB
iajs-2645	78	26	a	a	DET
iajs-2645	78	27	protective	protective	ADJ
iajs-2645	78	28	role	role	NOUN
iajs-2645	78	29	[	[	X
iajs-2645	78	30	17	17	NUM
iajs-2645	78	31	]	]	PUNCT
iajs-2645	78	32	.	.	PUNCT
iajs-2645	79	1	reasons	reason	NOUN
iajs-2645	79	2	for	for	ADP
iajs-2645	79	3	female	female	ADJ
iajs-2645	79	4	predominance	predominance	NOUN
iajs-2645	79	5	have	have	AUX
iajs-2645	79	6	not	not	PART
iajs-2645	79	7	been	be	AUX
iajs-2645	79	8	well	well	ADV
iajs-2645	79	9	defined	define	VERB
iajs-2645	79	10	,	,	PUNCT
iajs-2645	79	11	but	but	CCONJ
iajs-2645	79	12	it	it	PRON
iajs-2645	79	13	has	have	AUX
iajs-2645	79	14	been	be	AUX
iajs-2645	79	15	proposed	propose	VERB
iajs-2645	79	16	that	that	SCONJ
iajs-2645	79	17	females	female	NOUN
iajs-2645	79	18	are	be	AUX
iajs-2645	79	19	at	at	ADP
iajs-2645	79	20	greater	great	ADJ
iajs-2645	79	21	risk	risk	NOUN
iajs-2645	79	22	to	to	PART
iajs-2645	79	23	develop	develop	VERB
iajs-2645	79	24	immune	immune	NOUN
iajs-2645	79	25	-	-	PUNCT
iajs-2645	79	26	mediated	mediate	VERB
iajs-2645	79	27	diseases	disease	NOUN
iajs-2645	80	1	[	[	X
iajs-2645	80	2	18	18	NUM
iajs-2645	80	3	]	]	PUNCT
iajs-2645	80	4	.	.	PUNCT
iajs-2645	81	1	regarding	regard	VERB
iajs-2645	81	2	growth	growth	NOUN
iajs-2645	81	3	criteria	criterion	NOUN
iajs-2645	81	4	,	,	PUNCT
iajs-2645	81	5	most	most	ADJ
iajs-2645	81	6	of	of	ADP
iajs-2645	81	7	cd	cd	PROPN
iajs-2645	81	8	patients	patient	NOUN
iajs-2645	81	9	were	be	AUX
iajs-2645	81	10	of	of	ADP
iajs-2645	81	11	normal	normal	ADJ
iajs-2645	81	12	weight	weight	NOUN
iajs-2645	81	13	(	(	PUNCT
iajs-2645	81	14	5th	5th	ADJ
iajs-2645	81	15	to	to	ADP
iajs-2645	81	16	˂85th	˂85th	NUM
iajs-2645	81	17	;	;	PUNCT
iajs-2645	81	18	63.3	63.3	NUM
iajs-2645	81	19	%	%	NOUN
iajs-2645	81	20	)	)	PUNCT
iajs-2645	81	21	as	as	SCONJ
iajs-2645	81	22	shown	show	VERB
iajs-2645	81	23	in	in	ADP
iajs-2645	81	24	table	table	NOUN
iajs-2645	81	25	(	(	PUNCT
iajs-2645	81	26	1	1	NUM
iajs-2645	81	27	)	)	PUNCT
iajs-2645	81	28	.	.	PUNCT
iajs-2645	82	1	a	a	DET
iajs-2645	82	2	study	study	NOUN
iajs-2645	82	3	in	in	ADP
iajs-2645	82	4	indian	indian	ADJ
iajs-2645	82	5	patients	patient	NOUN
iajs-2645	82	6	indicated	indicate	VERB
iajs-2645	82	7	that	that	SCONJ
iajs-2645	82	8	the	the	DET
iajs-2645	82	9	bmi	bmi	NOUN
iajs-2645	82	10	was	be	AUX
iajs-2645	82	11	significantly	significantly	ADV
iajs-2645	82	12	lower	low	ADJ
iajs-2645	82	13	in	in	ADP
iajs-2645	82	14	cd	cd	NOUN
iajs-2645	82	15	patients	patient	NOUN
iajs-2645	82	16	compared	compare	VERB
iajs-2645	82	17	to	to	ADP
iajs-2645	82	18	healthy	healthy	ADJ
iajs-2645	82	19	children	child	NOUN
iajs-2645	82	20	(	(	PUNCT
iajs-2645	82	21	17.18	17.18	NUM
iajs-2645	82	22	vs.	vs.	ADP
iajs-2645	82	23	21.2	21.2	NUM
iajs-2645	82	24	kg	kg	NOUN
iajs-2645	82	25	/	/	SYM
iajs-2645	82	26	cm2	cm2	NOUN
iajs-2645	82	27	;	;	PUNCT
iajs-2645	82	28	p	p	X
iajs-2645	82	29	<	<	NOUN
iajs-2645	82	30	0.001	0.001	NUM
iajs-2645	82	31	)	)	PUNCT
iajs-2645	82	32	,	,	PUNCT
iajs-2645	82	33	and	and	CCONJ
iajs-2645	82	34	there	there	PRON
iajs-2645	82	35	was	be	VERB
iajs-2645	82	36	no	no	DET
iajs-2645	82	37	significant	significant	ADJ
iajs-2645	82	38	difference	difference	NOUN
iajs-2645	82	39	between	between	ADP
iajs-2645	82	40	http://ihicps.com/	http://ihicps.com/	ADJ
iajs-2645	82	41	special	special	ADJ
iajs-2645	82	42	issue	issue	NOUN
iajs-2645	82	43	1ihicpas	1ihicpas	NUM
iajs-2645	82	44	202	202	NUM
iajs-2645	82	45	ibn	ibn	PROPN
iajs-2645	82	46	al	al	PROPN
iajs-2645	82	47	-	-	PUNCT
iajs-2645	82	48	haitham	haitham	PROPN
iajs-2645	82	49	journal	journal	PROPN
iajs-2645	82	50	for	for	ADP
iajs-2645	82	51	pure	pure	ADJ
iajs-2645	82	52	and	and	CCONJ
iajs-2645	82	53	applied	apply	VERB
iajs-2645	82	54	science	science	NOUN
iajs-2645	82	55	https://doi.org/10.30526/2021.ihicpas.2645	https://doi.org/10.30526/2021.ihicpas.2645	PROPN
iajs-2645	82	56	for	for	ADP
iajs-2645	82	57	more	more	ADJ
iajs-2645	82	58	information	information	NOUN
iajs-2645	82	59	about	about	ADP
iajs-2645	82	60	the	the	DET
iajs-2645	82	61	conference	conference	NOUN
iajs-2645	82	62	please	please	INTJ
iajs-2645	82	63	visit	visit	VERB
iajs-2645	82	64	the	the	DET
iajs-2645	82	65	websites	website	NOUN
iajs-2645	82	66	:	:	PUNCT
iajs-2645	82	67	http://ihicps.com/	http://ihicps.com/	NOUN
iajs-2645	82	68	b	b	NOUN
iajs-2645	83	1	i	i	NOUN
iajs-2645	83	2	o	o	NOUN
iajs-2645	84	1	l	l	NOUN
iajs-2645	84	2	o	o	X
iajs-2645	84	3	g	g	NOUN
iajs-2645	84	4	y	y	PROPN
iajs-2645	84	5	|	|	ADV
iajs-2645	84	6	18	18	NUM
iajs-2645	84	7	boys	boy	NOUN
iajs-2645	84	8	and	and	CCONJ
iajs-2645	84	9	girls	girl	NOUN
iajs-2645	84	10	with	with	ADP
iajs-2645	84	11	cd	cd	PROPN
iajs-2645	84	12	[	[	X
iajs-2645	84	13	19	19	NUM
iajs-2645	84	14	]	]	PUNCT
iajs-2645	84	15	.	.	PUNCT
iajs-2645	85	1	it	it	PRON
iajs-2645	85	2	has	have	AUX
iajs-2645	85	3	been	be	AUX
iajs-2645	85	4	found	find	VERB
iajs-2645	85	5	that	that	SCONJ
iajs-2645	85	6	bmi	bmi	NOUN
iajs-2645	85	7	can	can	AUX
iajs-2645	85	8	be	be	AUX
iajs-2645	85	9	increased	increase	VERB
iajs-2645	85	10	significantly	significantly	ADV
iajs-2645	85	11	after	after	ADP
iajs-2645	85	12	a	a	DET
iajs-2645	85	13	gluten	gluten	NOUN
iajs-2645	85	14	-	-	PUNCT
iajs-2645	85	15	free	free	ADJ
iajs-2645	85	16	diet	diet	NOUN
iajs-2645	86	1	[	[	X
iajs-2645	86	2	20	20	NUM
iajs-2645	86	3	]	]	PUNCT
iajs-2645	86	4	.	.	PUNCT
iajs-2645	87	1	generally	generally	ADV
iajs-2645	87	2	,	,	PUNCT
iajs-2645	87	3	withdrawal	withdrawal	NOUN
iajs-2645	87	4	of	of	ADP
iajs-2645	87	5	gluten	gluten	PROPN
iajs-2645	87	6	from	from	ADP
iajs-2645	87	7	the	the	DET
iajs-2645	87	8	diet	diet	NOUN
iajs-2645	87	9	leads	lead	VERB
iajs-2645	87	10	to	to	ADP
iajs-2645	87	11	rapid	rapid	ADJ
iajs-2645	87	12	catch	catch	NOUN
iajs-2645	87	13	-	-	PUNCT
iajs-2645	87	14	up	up	ADP
iajs-2645	87	15	growth	growth	NOUN
iajs-2645	87	16	of	of	ADP
iajs-2645	87	17	body	body	NOUN
iajs-2645	87	18	weight	weight	NOUN
iajs-2645	87	19	within	within	ADP
iajs-2645	87	20	6	6	NUM
iajs-2645	87	21	-	-	SYM
iajs-2645	87	22	12	12	NUM
iajs-2645	87	23	months	month	NOUN
iajs-2645	87	24	,	,	PUNCT
iajs-2645	87	25	whereas	whereas	SCONJ
iajs-2645	87	26	the	the	DET
iajs-2645	87	27	height	height	NOUN
iajs-2645	87	28	catches	catch	VERB
iajs-2645	87	29	up	up	ADP
iajs-2645	87	30	is	be	AUX
iajs-2645	87	31	more	more	ADV
iajs-2645	87	32	gradually	gradually	ADV
iajs-2645	87	33	[	[	X
iajs-2645	87	34	21	21	NUM
iajs-2645	87	35	]	]	PUNCT
iajs-2645	87	36	.	.	PUNCT
iajs-2645	88	1	a	a	DET
iajs-2645	88	2	swedish	swedish	ADJ
iajs-2645	88	3	study	study	NOUN
iajs-2645	88	4	showed	show	VERB
iajs-2645	88	5	that	that	SCONJ
iajs-2645	88	6	the	the	DET
iajs-2645	88	7	bmi	bmi	NOUN
iajs-2645	88	8	median	median	NOUN
iajs-2645	88	9	was	be	AUX
iajs-2645	88	10	slightly	slightly	ADV
iajs-2645	88	11	lower	low	ADJ
iajs-2645	88	12	among	among	ADP
iajs-2645	88	13	the	the	DET
iajs-2645	88	14	children	child	NOUN
iajs-2645	88	15	with	with	ADP
iajs-2645	88	16	screening	screen	VERB
iajs-2645	88	17	-	-	PUNCT
iajs-2645	88	18	detected	detect	VERB
iajs-2645	88	19	cd	cd	NOUN
iajs-2645	88	20	compared	compare	VERB
iajs-2645	88	21	to	to	ADP
iajs-2645	88	22	their	their	PRON
iajs-2645	88	23	healthy	healthy	ADJ
iajs-2645	88	24	children	child	NOUN
iajs-2645	88	25	,	,	PUNCT
iajs-2645	88	26	but	but	CCONJ
iajs-2645	88	27	most	most	ADJ
iajs-2645	88	28	of	of	ADP
iajs-2645	88	29	the	the	DET
iajs-2645	88	30	cd	cd	PROPN
iajs-2645	88	31	cases	case	NOUN
iajs-2645	88	32	had	have	VERB
iajs-2645	88	33	a	a	DET
iajs-2645	88	34	normal	normal	ADJ
iajs-2645	88	35	bmi	bmi	NOUN
iajs-2645	89	1	[	[	X
iajs-2645	89	2	22	22	NUM
iajs-2645	89	3	]	]	PUNCT
iajs-2645	89	4	.	.	PUNCT
iajs-2645	90	1	in	in	ADP
iajs-2645	90	2	the	the	DET
iajs-2645	90	3	case	case	NOUN
iajs-2645	90	4	of	of	ADP
iajs-2645	90	5	march	march	PROPN
iajs-2645	90	6	classification	classification	NOUN
iajs-2645	90	7	,	,	PUNCT
iajs-2645	90	8	the	the	DET
iajs-2645	90	9	majority	majority	NOUN
iajs-2645	90	10	of	of	ADP
iajs-2645	90	11	patients	patient	NOUN
iajs-2645	90	12	had	have	VERB
iajs-2645	90	13	partial	partial	ADJ
iajs-2645	90	14	villous	villous	ADJ
iajs-2645	90	15	atrophy	atrophy	NOUN
iajs-2645	90	16	(	(	PUNCT
iajs-2645	90	17	marsh	marsh	PROPN
iajs-2645	90	18	шa	шa	NOUN
iajs-2645	90	19	;	;	PUNCT
iajs-2645	90	20	70	70	NUM
iajs-2645	90	21	%	%	NOUN
iajs-2645	90	22	)	)	PUNCT
iajs-2645	90	23	,	,	PUNCT
iajs-2645	90	24	while	while	SCONJ
iajs-2645	90	25	children	child	NOUN
iajs-2645	90	26	with	with	ADP
iajs-2645	90	27	subtotal	subtotal	ADJ
iajs-2645	90	28	and	and	CCONJ
iajs-2645	90	29	total	total	ADJ
iajs-2645	90	30	villous	villous	ADJ
iajs-2645	90	31	atrophy	atrophy	NOUN
iajs-2645	90	32	(	(	PUNCT
iajs-2645	90	33	marsh	marsh	PROPN
iajs-2645	90	34	iii	iii	PROPN
iajs-2645	90	35	b	b	PROPN
iajs-2645	90	36	and	and	CCONJ
iajs-2645	90	37	iii	iii	NUM
iajs-2645	90	38	c	c	X
iajs-2645	90	39	)	)	PUNCT
iajs-2645	90	40	were	be	AUX
iajs-2645	90	41	less	less	ADV
iajs-2645	90	42	frequent	frequent	ADJ
iajs-2645	90	43	(	(	PUNCT
iajs-2645	90	44	30	30	NUM
iajs-2645	90	45	%	%	NOUN
iajs-2645	90	46	)	)	PUNCT
iajs-2645	90	47	table	table	NOUN
iajs-2645	90	48	(	(	PUNCT
iajs-2645	90	49	1	1	NUM
iajs-2645	90	50	)	)	PUNCT
iajs-2645	90	51	.	.	PUNCT
iajs-2645	91	1	in	in	ADP
iajs-2645	91	2	a	a	DET
iajs-2645	91	3	previous	previous	ADJ
iajs-2645	91	4	iraqi	iraqi	ADJ
iajs-2645	91	5	study	study	NOUN
iajs-2645	91	6	,	,	PUNCT
iajs-2645	91	7	different	different	ADJ
iajs-2645	91	8	frequencies	frequency	NOUN
iajs-2645	91	9	were	be	AUX
iajs-2645	91	10	found	find	VERB
iajs-2645	91	11	(	(	PUNCT
iajs-2645	91	12	24	24	NUM
iajs-2645	91	13	%	%	NOUN
iajs-2645	91	14	marsh	marsh	PROPN
iajs-2645	91	15	iiia	iiia	NOUN
iajs-2645	91	16	,	,	PUNCT
iajs-2645	91	17	47.8	47.8	NUM
iajs-2645	91	18	%	%	NOUN
iajs-2645	91	19	marsh	marsh	PROPN
iajs-2645	91	20	iiib	iiib	NOUN
iajs-2645	91	21	,	,	PUNCT
iajs-2645	91	22	and	and	CCONJ
iajs-2645	91	23	28.2	28.2	NUM
iajs-2645	91	24	%	%	NOUN
iajs-2645	91	25	marsh	marsh	PROPN
iajs-2645	91	26	iiic	iiic	PROPN
iajs-2645	91	27	respectively	respectively	ADV
iajs-2645	91	28	)	)	PUNCT
iajs-2645	92	1	[	[	X
iajs-2645	92	2	23	23	NUM
iajs-2645	92	3	]	]	PUNCT
iajs-2645	92	4	.	.	PUNCT
iajs-2645	93	1	the	the	DET
iajs-2645	93	2	reason	reason	NOUN
iajs-2645	93	3	behind	behind	ADP
iajs-2645	93	4	the	the	DET
iajs-2645	93	5	increased	increase	VERB
iajs-2645	93	6	frequency	frequency	NOUN
iajs-2645	93	7	of	of	ADP
iajs-2645	93	8	marsh	marsh	PROPN
iajs-2645	93	9	iii	iii	PROPN
iajs-2645	93	10	a	a	PRON
iajs-2645	93	11	might	might	AUX
iajs-2645	93	12	be	be	AUX
iajs-2645	93	13	related	relate	VERB
iajs-2645	93	14	to	to	ADP
iajs-2645	93	15	an	an	DET
iajs-2645	93	16	early	early	ADJ
iajs-2645	93	17	diagnosis	diagnosis	NOUN
iajs-2645	93	18	of	of	ADP
iajs-2645	93	19	the	the	DET
iajs-2645	93	20	studied	study	VERB
iajs-2645	93	21	samples	sample	NOUN
iajs-2645	93	22	.	.	PUNCT
iajs-2645	94	1	comparable	comparable	ADJ
iajs-2645	94	2	frequencies	frequency	NOUN
iajs-2645	94	3	have	have	AUX
iajs-2645	94	4	also	also	ADV
iajs-2645	94	5	been	be	AUX
iajs-2645	94	6	presented	present	VERB
iajs-2645	94	7	;	;	PUNCT
iajs-2645	94	8	5.3	5.3	NUM
iajs-2645	94	9	%	%	NOUN
iajs-2645	94	10	marsh	marsh	PROPN
iajs-2645	94	11	iii	iii	PROPN
iajs-2645	94	12	c	c	NOUN
iajs-2645	94	13	,	,	PUNCT
iajs-2645	94	14	24.2	24.2	NUM
iajs-2645	94	15	%	%	NOUN
iajs-2645	94	16	,	,	PUNCT
iajs-2645	94	17	55.3	55.3	NUM
iajs-2645	94	18	%	%	NOUN
iajs-2645	94	19	marsh	marsh	PROPN
iajs-2645	94	20	iii	iii	PROPN
iajs-2645	94	21	-	-	PUNCT
iajs-2645	94	22	a	a	NOUN
iajs-2645	94	23	,	,	PUNCT
iajs-2645	94	24	and	and	CCONJ
iajs-2645	94	25	15.1	15.1	NUM
iajs-2645	94	26	%	%	NOUN
iajs-2645	94	27	marsh	marsh	PROPN
iajs-2645	94	28	iii	iii	PROPN
iajs-2645	94	29	b	b	PROPN
iajs-2645	94	30	and	and	CCONJ
iajs-2645	94	31	marsh	marsh	PROPN
iajs-2645	94	32	iii	iii	PROPN
iajs-2645	94	33	c	c	PROPN
iajs-2645	95	1	[	[	X
iajs-2645	95	2	24	24	NUM
iajs-2645	95	3	]	]	PUNCT
iajs-2645	95	4	.	.	PUNCT
iajs-2645	96	1	in	in	ADP
iajs-2645	96	2	this	this	DET
iajs-2645	96	3	study	study	NOUN
iajs-2645	96	4	,	,	PUNCT
iajs-2645	96	5	serum	serum	NOUN
iajs-2645	96	6	concentrations	concentration	NOUN
iajs-2645	96	7	of	of	ADP
iajs-2645	96	8	anti	anti	ADJ
iajs-2645	96	9	-	-	ADJ
iajs-2645	96	10	ttg	ttg	NOUN
iajs-2645	96	11	and	and	CCONJ
iajs-2645	96	12	anti	anti	ADJ
iajs-2645	96	13	-	-	ADJ
iajs-2645	96	14	gliadin	gliadin	ADJ
iajs-2645	96	15	iga	iga	PROPN
iajs-2645	96	16	antibodies	antibody	NOUN
iajs-2645	96	17	were	be	AUX
iajs-2645	96	18	significantly	significantly	ADV
iajs-2645	96	19	elevated	elevate	VERB
iajs-2645	96	20	in	in	ADP
iajs-2645	96	21	cd	cd	NOUN
iajs-2645	96	22	children	child	NOUN
iajs-2645	96	23	compared	compare	VERB
iajs-2645	96	24	to	to	ADP
iajs-2645	96	25	healthy	healthy	ADJ
iajs-2645	96	26	children	child	NOUN
iajs-2645	96	27	(	(	PUNCT
iajs-2645	96	28	73.8	73.8	NUM
iajs-2645	96	29	and	and	CCONJ
iajs-2645	96	30	31.8	31.8	NUM
iajs-2645	96	31	vs.	vs.	ADP
iajs-2645	96	32	0.8	0.8	NUM
iajs-2645	96	33	u//ml	u//ml	NOUN
iajs-2645	96	34	,	,	PUNCT
iajs-2645	96	35	respectively	respectively	ADV
iajs-2645	96	36	;	;	PUNCT
iajs-2645	96	37	p	p	X
iajs-2645	96	38	<	<	X
iajs-2645	96	39	0.001	0.001	NUM
iajs-2645	96	40	)	)	PUNCT
iajs-2645	96	41	table	table	NOUN
iajs-2645	96	42	(	(	PUNCT
iajs-2645	96	43	1	1	NUM
iajs-2645	96	44	)	)	PUNCT
iajs-2645	96	45	.	.	PUNCT
iajs-2645	97	1	consistent	consistent	ADJ
iajs-2645	97	2	with	with	ADP
iajs-2645	97	3	these	these	DET
iajs-2645	97	4	findings	finding	NOUN
iajs-2645	97	5	,	,	PUNCT
iajs-2645	97	6	[	[	X
iajs-2645	97	7	25	25	NUM
iajs-2645	97	8	]	]	PUNCT
iajs-2645	97	9	indicated	indicate	VERB
iajs-2645	97	10	that	that	SCONJ
iajs-2645	97	11	an	an	DET
iajs-2645	97	12	anti	anti	NOUN
iajs-2645	97	13	-	-	NOUN
iajs-2645	97	14	ttg	ttg	NOUN
iajs-2645	97	15	is	be	AUX
iajs-2645	97	16	the	the	DET
iajs-2645	97	17	marker	marker	NOUN
iajs-2645	97	18	of	of	ADP
iajs-2645	97	19	choice	choice	NOUN
iajs-2645	97	20	for	for	ADP
iajs-2645	97	21	cd	cd	PROPN
iajs-2645	97	22	mass	mass	NOUN
iajs-2645	97	23	screening	screening	NOUN
iajs-2645	97	24	and	and	CCONJ
iajs-2645	97	25	helpful	helpful	ADJ
iajs-2645	97	26	in	in	ADP
iajs-2645	97	27	identifying	identify	VERB
iajs-2645	97	28	patients	patient	NOUN
iajs-2645	97	29	who	who	PRON
iajs-2645	97	30	can	can	AUX
iajs-2645	97	31	benefit	benefit	VERB
iajs-2645	97	32	from	from	ADP
iajs-2645	97	33	a	a	DET
iajs-2645	97	34	gluten	gluten	ADJ
iajs-2645	97	35	-	-	PUNCT
iajs-2645	97	36	free	free	ADJ
iajs-2645	97	37	diet	diet	NOUN
iajs-2645	97	38	and	and	CCONJ
iajs-2645	97	39	follow	follow	NOUN
iajs-2645	97	40	-	-	PUNCT
iajs-2645	97	41	up	up	NOUN
iajs-2645	97	42	.	.	PUNCT
iajs-2645	98	1	although	although	SCONJ
iajs-2645	98	2	the	the	DET
iajs-2645	98	3	gold	gold	NOUN
iajs-2645	98	4	standard	standard	NOUN
iajs-2645	98	5	for	for	ADP
iajs-2645	98	6	detecting	detect	VERB
iajs-2645	98	7	cd	cd	PROPN
iajs-2645	98	8	is	be	AUX
iajs-2645	98	9	a	a	DET
iajs-2645	98	10	duodenal	duodenal	ADJ
iajs-2645	98	11	biopsy	biopsy	NOUN
iajs-2645	98	12	,	,	PUNCT
iajs-2645	98	13	it	it	PRON
iajs-2645	98	14	has	have	AUX
iajs-2645	98	15	been	be	AUX
iajs-2645	98	16	shown	show	VERB
iajs-2645	98	17	that	that	SCONJ
iajs-2645	98	18	anti	anti	ADJ
iajs-2645	98	19	-	-	ADJ
iajs-2645	98	20	ttg	ttg	ADJ
iajs-2645	98	21	antibody	antibody	NOUN
iajs-2645	98	22	together	together	ADV
iajs-2645	98	23	with	with	ADP
iajs-2645	98	24	an	an	DET
iajs-2645	98	25	anti	anti	ADJ
iajs-2645	98	26	-	-	ADJ
iajs-2645	98	27	gliadin	gliadin	ADJ
iajs-2645	98	28	antibody	antibody	NOUN
iajs-2645	98	29	is	be	AUX
iajs-2645	98	30	a	a	DET
iajs-2645	98	31	sensitive	sensitive	ADJ
iajs-2645	98	32	marker	marker	NOUN
iajs-2645	98	33	for	for	ADP
iajs-2645	98	34	cd	cd	PROPN
iajs-2645	98	35	[	[	X
iajs-2645	98	36	26	26	NUM
iajs-2645	98	37	,	,	PUNCT
iajs-2645	98	38	27	27	NUM
iajs-2645	98	39	]	]	PUNCT
iajs-2645	98	40	.	.	PUNCT
iajs-2645	99	1	the	the	DET
iajs-2645	99	2	findings	finding	NOUN
iajs-2645	99	3	of	of	ADP
iajs-2645	99	4	this	this	DET
iajs-2645	99	5	study	study	NOUN
iajs-2645	99	6	and	and	CCONJ
iajs-2645	99	7	other	other	ADJ
iajs-2645	99	8	studies	study	NOUN
iajs-2645	99	9	indicate	indicate	VERB
iajs-2645	99	10	the	the	DET
iajs-2645	99	11	diagnostic	diagnostic	ADJ
iajs-2645	99	12	potential	potential	NOUN
iajs-2645	99	13	of	of	ADP
iajs-2645	99	14	both	both	DET
iajs-2645	99	15	antibodies	antibody	NOUN
iajs-2645	99	16	in	in	ADP
iajs-2645	99	17	cd	cd	PROPN
iajs-2645	99	18	when	when	SCONJ
iajs-2645	99	19	conducting	conduct	VERB
iajs-2645	99	20	screening	screen	VERB
iajs-2645	99	21	surveys	survey	NOUN
iajs-2645	99	22	for	for	ADP
iajs-2645	99	23	the	the	DET
iajs-2645	99	24	disease	disease	NOUN
iajs-2645	99	25	in	in	ADP
iajs-2645	99	26	children	child	NOUN
iajs-2645	99	27	and	and	CCONJ
iajs-2645	99	28	adolescents	adolescent	NOUN
iajs-2645	99	29	[	[	X
iajs-2645	99	30	28	28	NUM
iajs-2645	99	31	,	,	PUNCT
iajs-2645	99	32	29	29	NUM
iajs-2645	99	33	]	]	PUNCT
iajs-2645	99	34	.	.	PUNCT
iajs-2645	100	1	in	in	ADP
iajs-2645	100	2	a	a	DET
iajs-2645	100	3	study	study	NOUN
iajs-2645	100	4	of	of	ADP
iajs-2645	100	5	cd	cd	PROPN
iajs-2645	100	6	children	child	NOUN
iajs-2645	100	7	5	5	NUM
iajs-2645	100	8	years	year	NOUN
iajs-2645	100	9	old	old	ADJ
iajs-2645	100	10	and	and	CCONJ
iajs-2645	100	11	younger	young	ADJ
iajs-2645	100	12	,	,	PUNCT
iajs-2645	100	13	it	it	PRON
iajs-2645	100	14	has	have	AUX
iajs-2645	100	15	been	be	AUX
iajs-2645	100	16	reached	reach	VERB
iajs-2645	100	17	that	that	SCONJ
iajs-2645	100	18	anti	anti	ADJ
iajs-2645	100	19	-	-	ADJ
iajs-2645	100	20	gliadin	gliadin	ADJ
iajs-2645	100	21	iga	iga	PROPN
iajs-2645	100	22	is	be	AUX
iajs-2645	100	23	suitable	suitable	ADJ
iajs-2645	100	24	to	to	PART
iajs-2645	100	25	test	test	VERB
iajs-2645	100	26	for	for	ADP
iajs-2645	100	27	diagnosing	diagnose	VERB
iajs-2645	100	28	the	the	DET
iajs-2645	100	29	disease	disease	NOUN
iajs-2645	100	30	,	,	PUNCT
iajs-2645	100	31	because	because	SCONJ
iajs-2645	100	32	anti	anti	ADJ
iajs-2645	100	33	-	-	ADJ
iajs-2645	100	34	ttg	ttg	ADJ
iajs-2645	100	35	antibodies	antibody	NOUN
iajs-2645	100	36	may	may	AUX
iajs-2645	100	37	only	only	ADV
iajs-2645	100	38	appear	appear	VERB
iajs-2645	100	39	in	in	ADP
iajs-2645	100	40	the	the	DET
iajs-2645	100	41	elderly	elderly	ADJ
iajs-2645	100	42	[	[	X
iajs-2645	100	43	30	30	NUM
iajs-2645	100	44	]	]	PUNCT
iajs-2645	100	45	.	.	PUNCT
iajs-2645	101	1	the	the	DET
iajs-2645	101	2	study	study	NOUN
iajs-2645	101	3	also	also	ADV
iajs-2645	101	4	pointed	point	VERB
iajs-2645	101	5	to	to	ADP
iajs-2645	101	6	the	the	DET
iajs-2645	101	7	role	role	NOUN
iajs-2645	101	8	of	of	ADP
iajs-2645	101	9	il-1β	il-1β	PROPN
iajs-2645	101	10	in	in	ADP
iajs-2645	101	11	the	the	DET
iajs-2645	101	12	pathogenesis	pathogenesis	NOUN
iajs-2645	101	13	of	of	ADP
iajs-2645	101	14	cd	cd	PROPN
iajs-2645	101	15	.	.	PUNCT
iajs-2645	102	1	the	the	DET
iajs-2645	102	2	serum	serum	NOUN
iajs-2645	102	3	level	level	NOUN
iajs-2645	102	4	of	of	ADP
iajs-2645	102	5	this	this	DET
iajs-2645	102	6	cytokine	cytokine	NOUN
iajs-2645	102	7	was	be	AUX
iajs-2645	102	8	decreased	decrease	VERB
iajs-2645	102	9	in	in	ADP
iajs-2645	102	10	cd	cd	NOUN
iajs-2645	102	11	children	child	NOUN
iajs-2645	102	12	compared	compare	VERB
iajs-2645	102	13	to	to	ADP
iajs-2645	102	14	healthy	healthy	ADJ
iajs-2645	102	15	children	child	NOUN
iajs-2645	102	16	(	(	PUNCT
iajs-2645	102	17	35.5	35.5	NUM
iajs-2645	102	18	vs.	vs.	ADP
iajs-2645	102	19	53.4	53.4	NUM
iajs-2645	102	20	pg	pg	NOUN
iajs-2645	102	21	/	/	SYM
iajs-2645	102	22	ml	ml	X
iajs-2645	102	23	respectively	respectively	ADV
iajs-2645	102	24	)	)	PUNCT
iajs-2645	102	25	;	;	PUNCT
iajs-2645	102	26	however	however	ADV
iajs-2645	102	27	,	,	PUNCT
iajs-2645	102	28	the	the	DET
iajs-2645	102	29	difference	difference	NOUN
iajs-2645	102	30	did	do	AUX
iajs-2645	102	31	not	not	PART
iajs-2645	102	32	attend	attend	VERB
iajs-2645	102	33	a	a	DET
iajs-2645	102	34	statistical	statistical	ADJ
iajs-2645	102	35	significance	significance	NOUN
iajs-2645	102	36	(	(	PUNCT
iajs-2645	102	37	p	p	NOUN
iajs-2645	102	38	=	=	NOUN
iajs-2645	102	39	0.285	0.285	NUM
iajs-2645	102	40	)	)	PUNCT
iajs-2645	102	41	table	table	NOUN
iajs-2645	102	42	(	(	PUNCT
iajs-2645	102	43	1	1	NUM
iajs-2645	102	44	)	)	PUNCT
iajs-2645	102	45	.	.	PUNCT
iajs-2645	103	1	consistent	consistent	ADJ
iajs-2645	103	2	with	with	ADP
iajs-2645	103	3	these	these	DET
iajs-2645	103	4	findings	finding	NOUN
iajs-2645	103	5	,	,	PUNCT
iajs-2645	103	6	it	it	PRON
iajs-2645	103	7	has	have	AUX
iajs-2645	103	8	been	be	AUX
iajs-2645	103	9	demonstrated	demonstrate	VERB
iajs-2645	103	10	that	that	SCONJ
iajs-2645	103	11	serum	serum	NOUN
iajs-2645	103	12	levels	level	NOUN
iajs-2645	103	13	of	of	ADP
iajs-2645	103	14	il-1β	il-1β	PROPN
iajs-2645	103	15	and	and	CCONJ
iajs-2645	103	16	other	other	ADJ
iajs-2645	103	17	cytokines	cytokine	NOUN
iajs-2645	103	18	(	(	PUNCT
iajs-2645	103	19	tnf	tnf	PROPN
iajs-2645	103	20	-	-	PUNCT
iajs-2645	103	21	α	α	PROPN
iajs-2645	103	22	,	,	PUNCT
iajs-2645	103	23	il-2	il-2	PROPN
iajs-2645	103	24	,	,	PUNCT
iajs-2645	103	25	il-4	il-4	PRON
iajs-2645	103	26	,	,	PUNCT
iajs-2645	103	27	and	and	CCONJ
iajs-2645	103	28	il-8	il-8	NUM
iajs-2645	103	29	)	)	PUNCT
iajs-2645	103	30	showed	show	VERB
iajs-2645	103	31	no	no	DET
iajs-2645	103	32	significant	significant	ADJ
iajs-2645	103	33	differences	difference	NOUN
iajs-2645	103	34	between	between	ADP
iajs-2645	103	35	3	3	NUM
iajs-2645	103	36	years	year	NOUN
iajs-2645	103	37	old	old	ADJ
iajs-2645	103	38	cd	cd	NOUN
iajs-2645	103	39	children	child	NOUN
iajs-2645	103	40	and	and	CCONJ
iajs-2645	103	41	matched	match	VERB
iajs-2645	103	42	children	child	NOUN
iajs-2645	103	43	.	.	PUNCT
iajs-2645	104	1	the	the	DET
iajs-2645	104	2	authors	author	NOUN
iajs-2645	104	3	also	also	ADV
iajs-2645	104	4	concluded	conclude	VERB
iajs-2645	104	5	that	that	SCONJ
iajs-2645	104	6	a	a	DET
iajs-2645	104	7	gluten	gluten	VERB
iajs-2645	104	8	-	-	PUNCT
iajs-2645	104	9	free	free	ADJ
iajs-2645	104	10	diet	diet	NOUN
iajs-2645	104	11	may	may	AUX
iajs-2645	104	12	also	also	ADV
iajs-2645	104	13	influence	influence	VERB
iajs-2645	104	14	the	the	DET
iajs-2645	104	15	serum	serum	NOUN
iajs-2645	104	16	level	level	NOUN
iajs-2645	104	17	of	of	ADP
iajs-2645	104	18	some	some	DET
iajs-2645	104	19	cytokines	cytokine	NOUN
iajs-2645	104	20	[	[	X
iajs-2645	104	21	31	31	NUM
iajs-2645	104	22	]	]	PUNCT
iajs-2645	104	23	.	.	PUNCT
iajs-2645	105	1	in	in	ADP
iajs-2645	105	2	table	table	NOUN
iajs-2645	105	3	(	(	PUNCT
iajs-2645	105	4	1	1	NUM
iajs-2645	105	5	)	)	PUNCT
iajs-2645	105	6	,	,	PUNCT
iajs-2645	105	7	the	the	DET
iajs-2645	105	8	gene	gene	NOUN
iajs-2645	105	9	expression	expression	NOUN
iajs-2645	105	10	of	of	ADP
iajs-2645	105	11	nlrp3	nlrp3	ADJ
iajs-2645	105	12	inflammasome	inflammasome	NOUN
iajs-2645	105	13	was	be	AUX
iajs-2645	105	14	also	also	ADV
iajs-2645	105	15	given	give	VERB
iajs-2645	105	16	as	as	ADP
iajs-2645	105	17	a	a	DET
iajs-2645	105	18	relative	relative	ADJ
iajs-2645	105	19	fold	fold	NOUN
iajs-2645	105	20	changing	change	VERB
iajs-2645	105	21	(	(	PUNCT
iajs-2645	105	22	2	2	NUM
iajs-2645	105	23	-	-	PUNCT
iajs-2645	105	24	δδct	δδct	NOUN
iajs-2645	105	25	)	)	PUNCT
iajs-2645	105	26	.	.	PUNCT
iajs-2645	106	1	the	the	DET
iajs-2645	106	2	expression	expression	NOUN
iajs-2645	106	3	was	be	AUX
iajs-2645	106	4	down	down	ADV
iajs-2645	106	5	-	-	PUNCT
iajs-2645	106	6	regulated	regulate	VERB
iajs-2645	106	7	by	by	ADP
iajs-2645	106	8	0.594	0.594	NUM
iajs-2645	106	9	in	in	ADP
iajs-2645	106	10	cd	cd	NOUN
iajs-2645	106	11	children	child	NOUN
iajs-2645	106	12	and	and	CCONJ
iajs-2645	106	13	this	this	PRON
iajs-2645	106	14	may	may	AUX
iajs-2645	106	15	suggest	suggest	VERB
iajs-2645	106	16	a	a	DET
iajs-2645	106	17	role	role	NOUN
iajs-2645	106	18	for	for	ADP
iajs-2645	106	19	the	the	DET
iajs-2645	106	20	nlrp3	nlrp3	ADJ
iajs-2645	106	21	inflammasome	inflammasome	NOUN
iajs-2645	106	22	in	in	ADP
iajs-2645	106	23	the	the	DET
iajs-2645	106	24	immunopathogenesis	immunopathogenesis	NOUN
iajs-2645	106	25	of	of	ADP
iajs-2645	106	26	cd	cd	PROPN
iajs-2645	106	27	.	.	PUNCT
iajs-2645	107	1	to	to	ADP
iajs-2645	107	2	the	the	DET
iajs-2645	107	3	best	good	ADJ
iajs-2645	107	4	knowledge	knowledge	NOUN
iajs-2645	107	5	of	of	ADP
iajs-2645	107	6	investigators	investigator	NOUN
iajs-2645	107	7	,	,	PUNCT
iajs-2645	107	8	this	this	DET
iajs-2645	107	9	study	study	NOUN
iajs-2645	107	10	was	be	AUX
iajs-2645	107	11	the	the	DET
iajs-2645	107	12	first	first	ADJ
iajs-2645	107	13	in	in	ADP
iajs-2645	107	14	iraqi	iraqi	ADJ
iajs-2645	107	15	cd	cd	NOUN
iajs-2645	107	16	patients	patient	NOUN
iajs-2645	107	17	.	.	PUNCT
iajs-2645	108	1	it	it	PRON
iajs-2645	108	2	has	have	AUX
iajs-2645	108	3	been	be	AUX
iajs-2645	108	4	demonstrated	demonstrate	VERB
iajs-2645	108	5	that	that	SCONJ
iajs-2645	108	6	inflammasomes	inflammasome	NOUN
iajs-2645	108	7	play	play	VERB
iajs-2645	108	8	a	a	DET
iajs-2645	108	9	significant	significant	ADJ
iajs-2645	108	10	role	role	NOUN
iajs-2645	108	11	in	in	ADP
iajs-2645	108	12	the	the	DET
iajs-2645	108	13	pathogenesis	pathogenesis	NOUN
iajs-2645	108	14	of	of	ADP
iajs-2645	108	15	autoimmune	autoimmune	ADJ
iajs-2645	108	16	diseases	disease	NOUN
iajs-2645	108	17	including	include	VERB
iajs-2645	108	18	cd	cd	PROPN
iajs-2645	108	19	[	[	X
iajs-2645	108	20	8	8	NUM
iajs-2645	108	21	]	]	PUNCT
iajs-2645	108	22	.	.	PUNCT
iajs-2645	109	1	table	table	NOUN
iajs-2645	109	2	1	1	NUM
iajs-2645	109	3	.	.	NOUN
iajs-2645	109	4	anthropometric	anthropometric	ADJ
iajs-2645	109	5	and	and	CCONJ
iajs-2645	109	6	laboratory	laboratory	NOUN
iajs-2645	109	7	data	datum	NOUN
iajs-2645	109	8	of	of	ADP
iajs-2645	109	9	celiac	celiac	ADJ
iajs-2645	109	10	disease	disease	NOUN
iajs-2645	109	11	patients	patient	NOUN
iajs-2645	109	12	and	and	CCONJ
iajs-2645	109	13	controls	control	NOUN
iajs-2645	109	14	.	.	PUNCT
iajs-2645	110	1	characteristic	characteristic	ADJ
iajs-2645	110	2	*	*	PUNCT
iajs-2645	110	3	cd	cd	NOUN
iajs-2645	110	4	patients	patient	NOUN
iajs-2645	110	5	(	(	PUNCT
iajs-2645	110	6	n	n	NOUN
iajs-2645	110	7	=	=	SYM
iajs-2645	110	8	30	30	NUM
iajs-2645	110	9	)	)	PUNCT
iajs-2645	110	10	control	control	NOUN
iajs-2645	110	11	(	(	PUNCT
iajs-2645	110	12	n	n	NOUN
iajs-2645	110	13	=	=	SYM
iajs-2645	110	14	20	20	NUM
iajs-2645	110	15	)	)	PUNCT
iajs-2645	110	16	p	p	NOUN
iajs-2645	110	17	http://ihicps.com/	http://ihicps.com/	ADJ
iajs-2645	110	18	special	special	ADJ
iajs-2645	110	19	issue	issue	NOUN
iajs-2645	110	20	1ihicpas	1ihicpas	NUM
iajs-2645	110	21	202	202	NUM
iajs-2645	110	22	ibn	ibn	PROPN
iajs-2645	110	23	al	al	PROPN
iajs-2645	110	24	-	-	PUNCT
iajs-2645	110	25	haitham	haitham	PROPN
iajs-2645	110	26	journal	journal	PROPN
iajs-2645	110	27	for	for	ADP
iajs-2645	110	28	pure	pure	ADJ
iajs-2645	110	29	and	and	CCONJ
iajs-2645	110	30	applied	apply	VERB
iajs-2645	110	31	science	science	NOUN
iajs-2645	110	32	https://doi.org/10.30526/2021.ihicpas.2645	https://doi.org/10.30526/2021.ihicpas.2645	PROPN
iajs-2645	110	33	for	for	ADP
iajs-2645	110	34	more	more	ADJ
iajs-2645	110	35	information	information	NOUN
iajs-2645	110	36	about	about	ADP
iajs-2645	110	37	the	the	DET
iajs-2645	110	38	conference	conference	NOUN
iajs-2645	110	39	please	please	INTJ
iajs-2645	110	40	visit	visit	VERB
iajs-2645	110	41	the	the	DET
iajs-2645	110	42	websites	website	NOUN
iajs-2645	110	43	:	:	PUNCT
iajs-2645	110	44	http://ihicps.com/	http://ihicps.com/	NOUN
iajs-2645	110	45	b	b	NOUN
iajs-2645	111	1	i	i	NOUN
iajs-2645	111	2	o	o	NOUN
iajs-2645	112	1	l	l	NOUN
iajs-2645	112	2	o	o	X
iajs-2645	113	1	g	g	NOUN
iajs-2645	114	1	y	y	PROPN
iajs-2645	115	1	|	|	ADV
iajs-2645	115	2	19	19	NUM
iajs-2645	115	3	age	age	NOUN
iajs-2645	115	4	(	(	PUNCT
iajs-2645	115	5	year	year	NOUN
iajs-2645	115	6	)	)	PUNCT
iajs-2645	115	7	9.6	9.6	NUM
iajs-2645	115	8	±	±	NUM
iajs-2645	115	9	3.0	3.0	NUM
iajs-2645	115	10	10.0	10.0	NUM
iajs-2645	115	11	±	±	NUM
iajs-2645	115	12	3.4	3.4	NUM
iajs-2645	115	13	0.666	0.666	NUM
iajs-2645	115	14	age	age	NOUN
iajs-2645	115	15	groups	group	NOUN
iajs-2645	115	16	(	(	PUNCT
iajs-2645	115	17	year	year	NOUN
iajs-2645	115	18	)	)	PUNCT
iajs-2645	115	19	<	<	X
iajs-2645	115	20	8	8	NUM
iajs-2645	115	21	8	8	NUM
iajs-2645	115	22	(	(	PUNCT
iajs-2645	115	23	26.7	26.7	NUM
iajs-2645	115	24	)	)	SYM
iajs-2645	115	25	5	5	NUM
iajs-2645	115	26	(	(	PUNCT
iajs-2645	115	27	25.0	25.0	NUM
iajs-2645	115	28	)	)	PUNCT
iajs-2645	115	29	0.768	0.768	NUM
iajs-2645	115	30	8	8	NUM
iajs-2645	115	31	–	–	PUNCT
iajs-2645	115	32	12	12	NUM
iajs-2645	115	33	17	17	NUM
iajs-2645	115	34	(	(	PUNCT
iajs-2645	115	35	56.7	56.7	NUM
iajs-2645	115	36	)	)	PUNCT
iajs-2645	115	37	10	10	NUM
iajs-2645	115	38	(	(	PUNCT
iajs-2645	115	39	50.0	50.0	NUM
iajs-2645	115	40	)	)	PUNCT
iajs-2645	115	41	13	13	NUM
iajs-2645	115	42	15	15	NUM
iajs-2645	115	43	5	5	NUM
iajs-2645	115	44	(	(	PUNCT
iajs-2645	115	45	16.7	16.7	NUM
iajs-2645	115	46	)	)	SYM
iajs-2645	115	47	5	5	NUM
iajs-2645	115	48	(	(	PUNCT
iajs-2645	115	49	25.0	25.0	NUM
iajs-2645	115	50	)	)	PUNCT
iajs-2645	115	51	gender	gender	NOUN
iajs-2645	115	52	male	male	NOUN
iajs-2645	115	53	12	12	NUM
iajs-2645	115	54	(	(	PUNCT
iajs-2645	115	55	40.0	40.0	NUM
iajs-2645	115	56	)	)	PUNCT
iajs-2645	115	57	12	12	NUM
iajs-2645	115	58	(	(	PUNCT
iajs-2645	115	59	60.0	60.0	NUM
iajs-2645	115	60	)	)	PUNCT
iajs-2645	115	61	0.248	0.248	NUM
iajs-2645	115	62	female	female	ADJ
iajs-2645	115	63	18	18	NUM
iajs-2645	115	64	(	(	PUNCT
iajs-2645	115	65	60.0	60.0	NUM
iajs-2645	115	66	)	)	PUNCT
iajs-2645	115	67	8	8	NUM
iajs-2645	115	68	(	(	PUNCT
iajs-2645	115	69	40.0	40.0	NUM
iajs-2645	115	70	)	)	PUNCT
iajs-2645	115	71	bmi	bmi	NOUN
iajs-2645	115	72	percentiles	percentile	NOUN
iajs-2645	115	73	<	<	X
iajs-2645	115	74	5th	5th	ADJ
iajs-2645	115	75	(	(	PUNCT
iajs-2645	115	76	underweight	underweight	NOUN
iajs-2645	115	77	)	)	PUNCT
iajs-2645	115	78	8	8	NUM
iajs-2645	115	79	(	(	PUNCT
iajs-2645	115	80	26.7	26.7	NUM
iajs-2645	115	81	)	)	SYM
iajs-2645	115	82	1	1	NUM
iajs-2645	115	83	(	(	PUNCT
iajs-2645	115	84	5.0	5.0	NUM
iajs-2645	115	85	)	)	PUNCT
iajs-2645	115	86	0.121	0.121	NUM
iajs-2645	115	87	5th	5th	NOUN
iajs-2645	115	88	to	to	ADP
iajs-2645	115	89	<	<	X
iajs-2645	115	90	85th	85th	ADJ
iajs-2645	115	91	(	(	PUNCT
iajs-2645	115	92	normal	normal	ADJ
iajs-2645	115	93	weight	weight	NOUN
iajs-2645	115	94	)	)	PUNCT
iajs-2645	115	95	19	19	NUM
iajs-2645	115	96	(	(	PUNCT
iajs-2645	115	97	63.3	63.3	NUM
iajs-2645	115	98	)	)	PUNCT
iajs-2645	115	99	15	15	NUM
iajs-2645	115	100	(	(	PUNCT
iajs-2645	115	101	75.0	75.0	NUM
iajs-2645	115	102	)	)	PUNCT
iajs-2645	115	103	≥	≥	NOUN
iajs-2645	115	104	85th	85th	ADJ
iajs-2645	115	105	(	(	PUNCT
iajs-2645	115	106	overweight	overweight	ADJ
iajs-2645	115	107	/	/	SYM
iajs-2645	115	108	obese	obese	NOUN
iajs-2645	115	109	)	)	PUNCT
iajs-2645	115	110	3	3	NUM
iajs-2645	115	111	(	(	PUNCT
iajs-2645	115	112	10.0	10.0	NUM
iajs-2645	115	113	)	)	PUNCT
iajs-2645	115	114	4	4	NUM
iajs-2645	115	115	(	(	PUNCT
iajs-2645	115	116	20.0	20.0	NUM
iajs-2645	115	117	)	)	PUNCT
iajs-2645	115	118	marsh	marsh	PROPN
iajs-2645	115	119	classification	classification	PROPN
iajs-2645	115	120	marsh	marsh	PROPN
iajs-2645	115	121	iii	iii	PROPN
iajs-2645	115	122	:	:	PUNCT
iajs-2645	115	123	3a	3a	NUM
iajs-2645	115	124	21	21	NUM
iajs-2645	115	125	(	(	PUNCT
iajs-2645	115	126	70.0	70.0	NUM
iajs-2645	115	127	)	)	PUNCT
iajs-2645	115	128	na	na	ADP
iajs-2645	115	129	marsh	marsh	PROPN
iajs-2645	115	130	iii	iii	PROPN
iajs-2645	115	131	:	:	PUNCT
iajs-2645	115	132	3b/3c	3b/3c	NUM
iajs-2645	115	133	9	9	NUM
iajs-2645	115	134	(	(	PUNCT
iajs-2645	115	135	30.0	30.0	NUM
iajs-2645	115	136	)	)	PUNCT
iajs-2645	115	137	na	na	ADP
iajs-2645	115	138	iga	iga	PROPN
iajs-2645	115	139	anti	anti	ADJ
iajs-2645	115	140	-	-	ADJ
iajs-2645	115	141	ttg	ttg	ADJ
iajs-2645	115	142	antibody	antibody	NOUN
iajs-2645	115	143	(	(	PUNCT
iajs-2645	115	144	u	u	NOUN
iajs-2645	115	145	/	/	SYM
iajs-2645	115	146	ml	ml	VERB
iajs-2645	115	147	)	)	PUNCT
iajs-2645	115	148	73.8	73.8	NUM
iajs-2645	115	149	(	(	PUNCT
iajs-2645	115	150	26.7	26.7	NUM
iajs-2645	115	151	-	-	SYM
iajs-2645	115	152	526.1	526.1	NUM
iajs-2645	115	153	)	)	PUNCT
iajs-2645	115	154	0.8	0.8	NUM
iajs-2645	115	155	(	(	PUNCT
iajs-2645	115	156	0.5	0.5	NUM
iajs-2645	115	157	-	-	SYM
iajs-2645	115	158	1.5	1.5	NUM
iajs-2645	115	159	)	)	PUNCT
iajs-2645	115	160	<	<	X
iajs-2645	115	161	0.001	0.001	NUM
iajs-2645	115	162	iga	iga	PROPN
iajs-2645	115	163	and	and	CCONJ
iajs-2645	115	164	anti	anti	ADJ
iajs-2645	115	165	-	-	ADJ
iajs-2645	115	166	gliadin	gliadin	ADJ
iajs-2645	115	167	antibody	antibody	NOUN
iajs-2645	115	168	(	(	PUNCT
iajs-2645	115	169	u	u	NOUN
iajs-2645	115	170	/	/	SYM
iajs-2645	115	171	ml	ml	VERB
iajs-2645	115	172	)	)	PUNCT
iajs-2645	115	173	31.8	31.8	NUM
iajs-2645	115	174	(	(	PUNCT
iajs-2645	115	175	18.0	18.0	NUM
iajs-2645	115	176	-	-	SYM
iajs-2645	115	177	94.6	94.6	NUM
iajs-2645	115	178	)	)	PUNCT
iajs-2645	115	179	0.8	0.8	NUM
iajs-2645	115	180	(	(	PUNCT
iajs-2645	115	181	0.5	0.5	NUM
iajs-2645	115	182	-	-	SYM
iajs-2645	115	183	1.2	1.2	NUM
iajs-2645	115	184	)	)	PUNCT
iajs-2645	115	185	<	<	X
iajs-2645	115	186	0.001	0.001	NUM
iajs-2645	115	187	il-1β	il-1β	PROPN
iajs-2645	115	188	(	(	PUNCT
iajs-2645	115	189	pg	pg	NOUN
iajs-2645	115	190	/	/	SYM
iajs-2645	115	191	ml	ml	VERB
iajs-2645	115	192	)	)	PUNCT
iajs-2645	115	193	35.5	35.5	NUM
iajs-2645	115	194	(	(	PUNCT
iajs-2645	115	195	28	28	NUM
iajs-2645	115	196	-47.7	-47.7	NUM
iajs-2645	115	197	)	)	PUNCT
iajs-2645	115	198	53.4	53.4	NUM
iajs-2645	115	199	(	(	PUNCT
iajs-2645	115	200	25.7	25.7	NUM
iajs-2645	115	201	-	-	SYM
iajs-2645	115	202	132	132	NUM
iajs-2645	115	203	)	)	PUNCT
iajs-2645	115	204	0.285	0.285	NUM
iajs-2645	116	1	nlrp3	nlrp3	NOUN
iajs-2645	116	2	gene	gene	NOUN
iajs-2645	116	3	expression	expression	NOUN
iajs-2645	116	4	(	(	PUNCT
iajs-2645	116	5	2-∆∆ct	2-∆∆ct	PROPN
iajs-2645	116	6	)	)	PUNCT
iajs-2645	116	7	0.594	0.594	NUM
iajs-2645	116	8	(	(	PUNCT
iajs-2645	116	9	0.120	0.120	NUM
iajs-2645	116	10	-	-	SYM
iajs-2645	116	11	2.018	2.018	NUM
iajs-2645	116	12	)	)	PUNCT
iajs-2645	116	13	na	na	NOUN
iajs-2645	116	14	*	*	NOUN
iajs-2645	116	15	values	value	NOUN
iajs-2645	116	16	are	be	AUX
iajs-2645	116	17	mean	mean	ADJ
iajs-2645	116	18	±	±	NUM
iajs-2645	116	19	sd	sd	NOUN
iajs-2645	116	20	(	(	PUNCT
iajs-2645	116	21	standard	standard	ADJ
iajs-2645	116	22	deviation	deviation	NOUN
iajs-2645	116	23	)	)	PUNCT
iajs-2645	116	24	,	,	PUNCT
iajs-2645	116	25	number	number	NOUN
iajs-2645	116	26	followed	follow	VERB
iajs-2645	116	27	by	by	ADP
iajs-2645	116	28	percentage	percentage	NOUN
iajs-2645	116	29	in	in	ADP
iajs-2645	116	30	parentheses	parenthesis	NOUN
iajs-2645	116	31	or	or	CCONJ
iajs-2645	116	32	median	median	NOUN
iajs-2645	116	33	with	with	ADP
iajs-2645	116	34	the	the	DET
iajs-2645	116	35	interquartile	interquartile	NOUN
iajs-2645	116	36	(	(	PUNCT
iajs-2645	116	37	iqr	iqr	NOUN
iajs-2645	116	38	)	)	PUNCT
iajs-2645	116	39	range	range	NOUN
iajs-2645	116	40	(	(	PUNCT
iajs-2645	116	41	25	25	NUM
iajs-2645	116	42	%	%	NOUN
iajs-2645	116	43	75	75	NUM
iajs-2645	116	44	%	%	NOUN
iajs-2645	116	45	)	)	PUNCT
iajs-2645	116	46	;	;	PUNCT
iajs-2645	116	47	cd	cd	PROPN
iajs-2645	116	48	:	:	PUNCT
iajs-2645	116	49	celiac	celiac	ADJ
iajs-2645	116	50	disease	disease	NOUN
iajs-2645	116	51	;	;	PUNCT
iajs-2645	116	52	bmi	bmi	PROPN
iajs-2645	116	53	:	:	PUNCT
iajs-2645	116	54	body	body	NOUN
iajs-2645	116	55	mass	mass	PROPN
iajs-2645	116	56	index	index	NOUN
iajs-2645	116	57	;	;	PUNCT
iajs-2645	116	58	ttg	ttg	NOUN
iajs-2645	116	59	:	:	PUNCT
iajs-2645	116	60	tissue	tissue	NOUN
iajs-2645	116	61	transglutaminase	transglutaminase	NOUN
iajs-2645	116	62	;	;	PUNCT
iajs-2645	116	63	nlrp3	nlrp3	ADJ
iajs-2645	116	64	:	:	PUNCT
iajs-2645	116	65	nucleotide	nucleotide	NOUN
iajs-2645	116	66	-	-	PUNCT
iajs-2645	116	67	binding	bind	VERB
iajs-2645	116	68	oligomerization	oligomerization	NOUN
iajs-2645	116	69	domain	domain	NOUN
iajs-2645	116	70	leucine	leucine	NOUN
iajs-2645	116	71	-	-	PUNCT
iajs-2645	116	72	rich	rich	ADJ
iajs-2645	116	73	repeat	repeat	NOUN
iajs-2645	116	74	and	and	CCONJ
iajs-2645	116	75	pyrin	pyrin	NOUN
iajs-2645	116	76	domain	domain	NOUN
iajs-2645	116	77	-	-	PUNCT
iajs-2645	116	78	containing	contain	VERB
iajs-2645	116	79	protein	protein	NOUN
iajs-2645	116	80	3	3	NUM
iajs-2645	116	81	;	;	PUNCT
iajs-2645	116	82	na	na	PART
iajs-2645	116	83	:	:	PUNCT
iajs-2645	116	84	not	not	PART
iajs-2645	116	85	applicable	applicable	ADJ
iajs-2645	116	86	;	;	PUNCT
iajs-2645	116	87	p	p	X
iajs-2645	116	88	:	:	PUNCT
iajs-2645	116	89	probability	probability	NOUN
iajs-2645	116	90	;	;	PUNCT
iajs-2645	116	91	significant	significant	ADJ
iajs-2645	116	92	p	p	NOUN
iajs-2645	116	93	is	be	AUX
iajs-2645	116	94	bold	bold	ADV
iajs-2645	116	95	-	-	PUNCT
iajs-2645	116	96	marked	mark	VERB
iajs-2645	116	97	.	.	PUNCT
iajs-2645	117	1	to	to	PART
iajs-2645	117	2	make	make	VERB
iajs-2645	117	3	a	a	DET
iajs-2645	117	4	further	further	ADJ
iajs-2645	117	5	understanding	understanding	NOUN
iajs-2645	117	6	of	of	ADP
iajs-2645	117	7	the	the	DET
iajs-2645	117	8	investigated	investigate	VERB
iajs-2645	117	9	immunological	immunological	ADJ
iajs-2645	117	10	and	and	CCONJ
iajs-2645	117	11	molecular	molecular	ADJ
iajs-2645	117	12	parameters	parameter	NOUN
iajs-2645	117	13	in	in	ADP
iajs-2645	117	14	the	the	DET
iajs-2645	117	15	pathogenesis	pathogenesis	NOUN
iajs-2645	117	16	of	of	ADP
iajs-2645	117	17	cd	cd	PROPN
iajs-2645	117	18	,	,	PUNCT
iajs-2645	117	19	the	the	DET
iajs-2645	117	20	patients	patient	NOUN
iajs-2645	117	21	were	be	AUX
iajs-2645	117	22	distributed	distribute	VERB
iajs-2645	117	23	into	into	ADP
iajs-2645	117	24	subgroups	subgroup	NOUN
iajs-2645	117	25	according	accord	VERB
iajs-2645	117	26	to	to	ADP
iajs-2645	117	27	some	some	DET
iajs-2645	117	28	anthropometric	anthropometric	ADJ
iajs-2645	117	29	and	and	CCONJ
iajs-2645	117	30	clinical	clinical	ADJ
iajs-2645	117	31	characteristics	characteristic	NOUN
iajs-2645	117	32	table	table	NOUN
iajs-2645	117	33	(	(	PUNCT
iajs-2645	117	34	2	2	NUM
iajs-2645	117	35	)	)	PUNCT
iajs-2645	117	36	.	.	PUNCT
iajs-2645	118	1	no	no	DET
iajs-2645	118	2	significant	significant	ADJ
iajs-2645	118	3	variations	variation	NOUN
iajs-2645	118	4	between	between	ADP
iajs-2645	118	5	the	the	DET
iajs-2645	118	6	medians	median	NOUN
iajs-2645	118	7	of	of	ADP
iajs-2645	118	8	anti	anti	ADJ
iajs-2645	118	9	-	-	ADJ
iajs-2645	118	10	ttg	ttg	NOUN
iajs-2645	118	11	and	and	CCONJ
iajs-2645	118	12	anti	anti	ADJ
iajs-2645	118	13	-	-	ADJ
iajs-2645	118	14	gliadin	gliadin	ADJ
iajs-2645	118	15	iga	iga	PROPN
iajs-2645	118	16	antibodies	antibodie	VERB
iajs-2645	118	17	,	,	PUNCT
iajs-2645	118	18	il-1β	il-1β	PROPN
iajs-2645	118	19	,	,	PUNCT
iajs-2645	118	20	and	and	CCONJ
iajs-2645	118	21	nlrp3	nlrp3	ADJ
iajs-2645	118	22	gene	gene	NOUN
iajs-2645	118	23	expression	expression	NOUN
iajs-2645	118	24	between	between	ADP
iajs-2645	118	25	subgroups	subgroup	NOUN
iajs-2645	118	26	of	of	ADP
iajs-2645	118	27	cd	cd	PROPN
iajs-2645	118	28	children	child	NOUN
iajs-2645	118	29	were	be	AUX
iajs-2645	118	30	distributed	distribute	VERB
iajs-2645	118	31	according	accord	VERB
iajs-2645	118	32	to	to	ADP
iajs-2645	118	33	age	age	NOUN
iajs-2645	118	34	,	,	PUNCT
iajs-2645	118	35	gender	gender	NOUN
iajs-2645	118	36	,	,	PUNCT
iajs-2645	118	37	bmi	bmi	NOUN
iajs-2645	118	38	,	,	PUNCT
iajs-2645	118	39	and	and	CCONJ
iajs-2645	118	40	march	march	PROPN
iajs-2645	118	41	classification	classification	NOUN
iajs-2645	118	42	.	.	PUNCT
iajs-2645	119	1	two	two	NUM
iajs-2645	119	2	exceptions	exception	NOUN
iajs-2645	119	3	were	be	AUX
iajs-2645	119	4	encountered	encounter	VERB
iajs-2645	119	5	.	.	PUNCT
iajs-2645	120	1	in	in	ADP
iajs-2645	120	2	the	the	DET
iajs-2645	120	3	first	first	ADJ
iajs-2645	120	4	,	,	PUNCT
iajs-2645	120	5	the	the	DET
iajs-2645	120	6	decreased	decrease	VERB
iajs-2645	120	7	level	level	NOUN
iajs-2645	120	8	of	of	ADP
iajs-2645	120	9	il1β	il1β	PROPN
iajs-2645	120	10	was	be	AUX
iajs-2645	120	11	more	more	ADV
iajs-2645	120	12	pronounced	pronounce	VERB
iajs-2645	120	13	in	in	ADP
iajs-2645	120	14	male	male	ADJ
iajs-2645	120	15	patients	patient	NOUN
iajs-2645	120	16	compared	compare	VERB
iajs-2645	120	17	to	to	ADP
iajs-2645	120	18	female	female	ADJ
iajs-2645	120	19	patients	patient	NOUN
iajs-2645	120	20	and	and	CCONJ
iajs-2645	120	21	the	the	DET
iajs-2645	120	22	difference	difference	NOUN
iajs-2645	120	23	was	be	AUX
iajs-2645	120	24	significant	significant	ADJ
iajs-2645	120	25	(	(	PUNCT
iajs-2645	120	26	24.7	24.7	NUM
iajs-2645	120	27	vs.	vs.	ADP
iajs-2645	120	28	37.6	37.6	NUM
iajs-2645	120	29	pg	pg	NOUN
iajs-2645	120	30	/	/	SYM
iajs-2645	120	31	ml	ml	NOUN
iajs-2645	120	32	;	;	PUNCT
iajs-2645	120	33	p	p	X
iajs-2645	120	34	=	=	NOUN
iajs-2645	120	35	0.050	0.050	NUM
iajs-2645	120	36	)	)	PUNCT
iajs-2645	120	37	.	.	PUNCT
iajs-2645	121	1	although	although	SCONJ
iajs-2645	121	2	cd	cd	PROPN
iajs-2645	121	3	patients	patient	NOUN
iajs-2645	121	4	were	be	AUX
iajs-2645	121	5	children	child	NOUN
iajs-2645	121	6	,	,	PUNCT
iajs-2645	121	7	sex	sex	NOUN
iajs-2645	121	8	hormones	hormone	NOUN
iajs-2645	121	9	might	might	AUX
iajs-2645	121	10	have	have	VERB
iajs-2645	121	11	a	a	DET
iajs-2645	121	12	role	role	NOUN
iajs-2645	121	13	in	in	ADP
iajs-2645	121	14	deviating	deviate	VERB
iajs-2645	121	15	serum	serum	NOUN
iajs-2645	121	16	levels	level	NOUN
iajs-2645	121	17	of	of	ADP
iajs-2645	121	18	il-1β	il-1β	PROPN
iajs-2645	121	19	in	in	ADP
iajs-2645	121	20	males	male	NOUN
iajs-2645	121	21	and	and	CCONJ
iajs-2645	121	22	females	female	NOUN
iajs-2645	121	23	[	[	X
iajs-2645	121	24	32	32	NUM
iajs-2645	121	25	]	]	PUNCT
iajs-2645	121	26	.	.	PUNCT
iajs-2645	122	1	the	the	DET
iajs-2645	122	2	second	second	ADJ
iajs-2645	122	3	exception	exception	NOUN
iajs-2645	122	4	involved	involve	VERB
iajs-2645	122	5	a	a	DET
iajs-2645	122	6	significantly	significantly	ADV
iajs-2645	122	7	increased	increase	VERB
iajs-2645	122	8	concentration	concentration	NOUN
iajs-2645	122	9	of	of	ADP
iajs-2645	122	10	anti	anti	ADJ
iajs-2645	122	11	-	-	ADJ
iajs-2645	122	12	ttg	ttg	ADJ
iajs-2645	122	13	iga	iga	PROPN
iajs-2645	122	14	antibody	antibody	NOUN
iajs-2645	122	15	in	in	ADP
iajs-2645	122	16	cd	cd	PROPN
iajs-2645	122	17	children	child	NOUN
iajs-2645	122	18	with	with	ADP
iajs-2645	122	19	marsh	marsh	PROPN
iajs-2645	122	20	iii	iii	PROPN
iajs-2645	122	21	:	:	PUNCT
iajs-2645	122	22	3b/3c	3b/3c	NUM
iajs-2645	122	23	classification	classification	NOUN
iajs-2645	122	24	compared	compare	VERB
iajs-2645	122	25	to	to	ADP
iajs-2645	122	26	marsh	marsh	PROPN
iajs-2645	122	27	iii	iii	PROPN
iajs-2645	122	28	:	:	PUNCT
iajs-2645	122	29	3a	3a	NUM
iajs-2645	122	30	children	child	NOUN
iajs-2645	122	31	(	(	PUNCT
iajs-2645	122	32	501.6	501.6	NUM
iajs-2645	122	33	vs.	vs.	ADP
iajs-2645	122	34	36.8	36.8	NUM
iajs-2645	122	35	iu	iu	NOUN
iajs-2645	122	36	;	;	PUNCT
iajs-2645	122	37	p	p	X
iajs-2645	122	38	=	=	NOUN
iajs-2645	122	39	0.022	0.022	NUM
iajs-2645	122	40	)	)	PUNCT
iajs-2645	122	41	.	.	PUNCT
iajs-2645	123	1	this	this	PRON
iajs-2645	123	2	may	may	AUX
iajs-2645	123	3	suggest	suggest	VERB
iajs-2645	123	4	a	a	DET
iajs-2645	123	5	correlation	correlation	NOUN
iajs-2645	123	6	between	between	ADP
iajs-2645	123	7	anti	anti	ADJ
iajs-2645	123	8	-	-	ADJ
iajs-2645	123	9	ttg	ttg	ADJ
iajs-2645	123	10	iga	iga	PROPN
iajs-2645	123	11	antibody	antibody	NOUN
iajs-2645	123	12	and	and	CCONJ
iajs-2645	123	13	marsh	marsh	PROPN
iajs-2645	123	14	classification	classification	NOUN
iajs-2645	123	15	;	;	PUNCT
iajs-2645	123	16	however	however	ADV
iajs-2645	123	17	,	,	PUNCT
iajs-2645	123	18	the	the	DET
iajs-2645	123	19	low	low	ADJ
iajs-2645	123	20	sample	sample	NOUN
iajs-2645	123	21	size	size	NOUN
iajs-2645	123	22	of	of	ADP
iajs-2645	123	23	patients	patient	NOUN
iajs-2645	123	24	may	may	AUX
iajs-2645	123	25	limit	limit	VERB
iajs-2645	123	26	such	such	ADJ
iajs-2645	123	27	suggestion	suggestion	NOUN
iajs-2645	123	28	.	.	PUNCT
iajs-2645	124	1	table	table	NOUN
iajs-2645	124	2	2	2	NUM
iajs-2645	124	3	.	.	PUNCT
iajs-2645	125	1	iga	iga	PROPN
iajs-2645	125	2	anti	anti	PROPN
iajs-2645	125	3	-	-	ADJ
iajs-2645	125	4	ttg	ttg	ADJ
iajs-2645	125	5	antibody	antibody	NOUN
iajs-2645	125	6	,	,	PUNCT
iajs-2645	125	7	anti	anti	ADJ
iajs-2645	125	8	-	-	ADJ
iajs-2645	125	9	gliadin	gliadin	ADJ
iajs-2645	125	10	antibody	antibody	NOUN
iajs-2645	125	11	,	,	PUNCT
iajs-2645	125	12	il-1β	il-1β	PROPN
iajs-2645	125	13	,	,	PUNCT
iajs-2645	125	14	and	and	CCONJ
iajs-2645	125	15	nlrp3	nlrp3	ADJ
iajs-2645	125	16	gene	gene	NOUN
iajs-2645	125	17	expression	expression	NOUN
iajs-2645	125	18	(	(	PUNCT
iajs-2645	125	19	2-∆∆ct	2-∆∆ct	PROPN
iajs-2645	125	20	)	)	PUNCT
iajs-2645	125	21	distributed	distribute	VERB
iajs-2645	125	22	according	accord	VERB
iajs-2645	125	23	to	to	ADP
iajs-2645	125	24	anthropometric	anthropometric	ADJ
iajs-2645	125	25	and	and	CCONJ
iajs-2645	125	26	clinical	clinical	ADJ
iajs-2645	125	27	characteristics	characteristic	NOUN
iajs-2645	125	28	of	of	ADP
iajs-2645	125	29	celiac	celiac	ADJ
iajs-2645	125	30	disease	disease	NOUN
iajs-2645	125	31	patients	patient	NOUN
iajs-2645	125	32	.	.	PUNCT
iajs-2645	126	1	http://ihicps.com/	http://ihicps.com/	ADJ
iajs-2645	126	2	special	special	ADJ
iajs-2645	126	3	issue	issue	NOUN
iajs-2645	126	4	1ihicpas	1ihicpas	NUM
iajs-2645	126	5	202	202	NUM
iajs-2645	126	6	ibn	ibn	PROPN
iajs-2645	126	7	al	al	PROPN
iajs-2645	126	8	-	-	PUNCT
iajs-2645	126	9	haitham	haitham	PROPN
iajs-2645	126	10	journal	journal	PROPN
iajs-2645	126	11	for	for	ADP
iajs-2645	126	12	pure	pure	ADJ
iajs-2645	126	13	and	and	CCONJ
iajs-2645	126	14	applied	apply	VERB
iajs-2645	126	15	science	science	NOUN
iajs-2645	126	16	https://doi.org/10.30526/2021.ihicpas.2645	https://doi.org/10.30526/2021.ihicpas.2645	PROPN
iajs-2645	126	17	for	for	ADP
iajs-2645	126	18	more	more	ADJ
iajs-2645	126	19	information	information	NOUN
iajs-2645	126	20	about	about	ADP
iajs-2645	126	21	the	the	DET
iajs-2645	126	22	conference	conference	NOUN
iajs-2645	126	23	please	please	INTJ
iajs-2645	126	24	visit	visit	VERB
iajs-2645	126	25	the	the	DET
iajs-2645	126	26	websites	website	NOUN
iajs-2645	126	27	:	:	PUNCT
iajs-2645	126	28	http://ihicps.com/	http://ihicps.com/	NOUN
iajs-2645	126	29	b	b	NOUN
iajs-2645	127	1	i	i	NOUN
iajs-2645	127	2	o	o	NOUN
iajs-2645	128	1	l	l	NOUN
iajs-2645	128	2	o	o	X
iajs-2645	128	3	g	g	NOUN
iajs-2645	128	4	y	y	PROPN
iajs-2645	129	1	|	|	ADV
iajs-2645	129	2	20	20	NUM
iajs-2645	129	3	characteristic	characteristic	ADJ
iajs-2645	129	4	median	median	NOUN
iajs-2645	129	5	with	with	ADP
iajs-2645	129	6	the	the	DET
iajs-2645	129	7	interquartile	interquartile	NOUN
iajs-2645	129	8	(	(	PUNCT
iajs-2645	129	9	iqr	iqr	NOUN
iajs-2645	129	10	)	)	PUNCT
iajs-2645	129	11	range	range	NOUN
iajs-2645	129	12	(	(	PUNCT
iajs-2645	129	13	25	25	NUM
iajs-2645	129	14	%	%	NOUN
iajs-2645	129	15	75	75	NUM
iajs-2645	129	16	%	%	NOUN
iajs-2645	129	17	)	)	PUNCT
iajs-2645	129	18	iga	iga	PROPN
iajs-2645	129	19	anti	anti	ADJ
iajs-2645	129	20	-	-	ADJ
iajs-2645	129	21	ttg	ttg	ADJ
iajs-2645	129	22	antibody	antibody	NOUN
iajs-2645	129	23	(	(	PUNCT
iajs-2645	129	24	u	u	NOUN
iajs-2645	129	25	/	/	SYM
iajs-2645	129	26	ml	ml	NOUN
iajs-2645	129	27	)	)	PUNCT
iajs-2645	129	28	iga	iga	PROPN
iajs-2645	129	29	and	and	CCONJ
iajs-2645	129	30	anti	anti	ADJ
iajs-2645	129	31	-	-	ADJ
iajs-2645	129	32	gliadin	gliadin	ADJ
iajs-2645	129	33	antibody	antibody	NOUN
iajs-2645	129	34	(	(	PUNCT
iajs-2645	129	35	u	u	NOUN
iajs-2645	129	36	/	/	SYM
iajs-2645	129	37	ml	ml	NOUN
iajs-2645	129	38	)	)	PUNCT
iajs-2645	129	39	il-1β	il-1β	PROPN
iajs-2645	129	40	(	(	PUNCT
iajs-2645	129	41	pg	pg	NOUN
iajs-2645	129	42	/	/	SYM
iajs-2645	129	43	ml	ml	NOUN
iajs-2645	129	44	)	)	PUNCT
iajs-2645	129	45	nlrp3	nlrp3	NOUN
iajs-2645	129	46	gene	gene	NOUN
iajs-2645	129	47	expression	expression	NOUN
iajs-2645	129	48	(	(	PUNCT
iajs-2645	129	49	2-∆∆ct	2-∆∆ct	PROPN
iajs-2645	129	50	)	)	PUNCT
iajs-2645	129	51	age	age	NOUN
iajs-2645	129	52	groups	group	NOUN
iajs-2645	129	53	(	(	PUNCT
iajs-2645	129	54	year	year	NOUN
iajs-2645	129	55	)	)	PUNCT
iajs-2645	129	56	<	<	X
iajs-2645	129	57	8	8	NUM
iajs-2645	129	58	7.0	7.0	NUM
iajs-2645	129	59	(	(	PUNCT
iajs-2645	129	60	35.4	35.4	NUM
iajs-2645	129	61	70.8	70.8	NUM
iajs-2645	129	62	)	)	PUNCT
iajs-2645	129	63	35.4	35.4	NUM
iajs-2645	129	64	(	(	PUNCT
iajs-2645	129	65	7.0	7.0	NUM
iajs-2645	129	66	70.8	70.8	NUM
iajs-2645	129	67	)	)	PUNCT
iajs-2645	129	68	36.9	36.9	NUM
iajs-2645	129	69	(	(	PUNCT
iajs-2645	129	70	31.4	31.4	NUM
iajs-2645	129	71	49.6	49.6	NUM
iajs-2645	129	72	)	)	PUNCT
iajs-2645	129	73	1.214	1.214	NUM
iajs-2645	129	74	(	(	PUNCT
iajs-2645	129	75	0.305	0.305	NUM
iajs-2645	129	76	3.807	3.807	NUM
iajs-2645	129	77	)	)	PUNCT
iajs-2645	129	78	8	8	NUM
iajs-2645	129	79	–	–	PUNCT
iajs-2645	129	80	12	12	NUM
iajs-2645	129	81	29.0	29.0	NUM
iajs-2645	129	82	(	(	PUNCT
iajs-2645	129	83	56.0	56.0	NUM
iajs-2645	129	84	147.4	147.4	NUM
iajs-2645	129	85	)	)	PUNCT
iajs-2645	129	86	56.0	56.0	NUM
iajs-2645	129	87	(	(	PUNCT
iajs-2645	129	88	29.0	29.0	NUM
iajs-2645	129	89	147.4	147.4	NUM
iajs-2645	129	90	)	)	PUNCT
iajs-2645	129	91	36.2	36.2	NUM
iajs-2645	129	92	(	(	PUNCT
iajs-2645	129	93	31.3	31.3	NUM
iajs-2645	129	94	40.9	40.9	NUM
iajs-2645	129	95	)	)	PUNCT
iajs-2645	129	96	0.300	0.300	NUM
iajs-2645	129	97	(	(	PUNCT
iajs-2645	129	98	0.182	0.182	NUM
iajs-2645	129	99	1.774	1.774	NUM
iajs-2645	129	100	)	)	PUNCT
iajs-2645	129	101	13	13	NUM
iajs-2645	129	102	15	15	NUM
iajs-2645	129	103	17.2	17.2	NUM
iajs-2645	129	104	(	(	PUNCT
iajs-2645	129	105	19.4	19.4	NUM
iajs-2645	129	106	22.4	22.4	NUM
iajs-2645	129	107	)	)	PUNCT
iajs-2645	129	108	19.4	19.4	NUM
iajs-2645	129	109	(	(	PUNCT
iajs-2645	129	110	17.2	17.2	NUM
iajs-2645	129	111	22.4	22.4	NUM
iajs-2645	129	112	)	)	PUNCT
iajs-2645	129	113	24.4	24.4	NUM
iajs-2645	129	114	(	(	PUNCT
iajs-2645	129	115	15.1	15.1	NUM
iajs-2645	129	116	25.0	25.0	NUM
iajs-2645	129	117	)	)	PUNCT
iajs-2645	129	118	0.051	0.051	NUM
iajs-2645	129	119	(	(	PUNCT
iajs-2645	129	120	0.029	0.029	NUM
iajs-2645	129	121	2.954	2.954	NUM
iajs-2645	129	122	)	)	PUNCT
iajs-2645	129	123	p	p	NOUN
iajs-2645	129	124	-	-	PUNCT
iajs-2645	129	125	value	value	NOUN
iajs-2645	129	126	0.537	0.537	NUM
iajs-2645	129	127	0.088	0.088	NUM
iajs-2645	129	128	0.155	0.155	NUM
iajs-2645	129	129	0.353	0.353	NUM
iajs-2645	129	130	gender	gender	NOUN
iajs-2645	129	131	male	male	NOUN
iajs-2645	129	132	39.2	39.2	NUM
iajs-2645	129	133	(	(	PUNCT
iajs-2645	129	134	24.5	24.5	NUM
iajs-2645	129	135	73.4	73.4	NUM
iajs-2645	129	136	)	)	PUNCT
iajs-2645	129	137	22.4	22.4	NUM
iajs-2645	129	138	(	(	PUNCT
iajs-2645	129	139	14.3	14.3	NUM
iajs-2645	129	140	38.8	38.8	NUM
iajs-2645	129	141	)	)	PUNCT
iajs-2645	129	142	24.7	24.7	NUM
iajs-2645	129	143	(	(	PUNCT
iajs-2645	129	144	19.5	19.5	NUM
iajs-2645	129	145	36.3	36.3	NUM
iajs-2645	129	146	)	)	PUNCT
iajs-2645	129	147	0.191	0.191	NUM
iajs-2645	129	148	(	(	PUNCT
iajs-2645	129	149	0.058	0.058	NUM
iajs-2645	129	150	3.043	3.043	NUM
iajs-2645	129	151	)	)	PUNCT
iajs-2645	129	152	female	female	NOUN
iajs-2645	129	153	220.6	220.6	NUM
iajs-2645	129	154	(	(	PUNCT
iajs-2645	129	155	29.9	29.9	NUM
iajs-2645	129	156	529.2	529.2	NUM
iajs-2645	129	157	)	)	PUNCT
iajs-2645	129	158	51.8	51.8	NUM
iajs-2645	129	159	(	(	PUNCT
iajs-2645	129	160	25.9	25.9	NUM
iajs-2645	129	161	123.7	123.7	NUM
iajs-2645	129	162	)	)	PUNCT
iajs-2645	129	163	37.6	37.6	NUM
iajs-2645	129	164	(	(	PUNCT
iajs-2645	129	165	31.4	31.4	NUM
iajs-2645	129	166	49.6	49.6	NUM
iajs-2645	129	167	)	)	PUNCT
iajs-2645	129	168	0.725	0.725	NUM
iajs-2645	129	169	(	(	PUNCT
iajs-2645	129	170	0.246	0.246	NUM
iajs-2645	129	171	1.657	1.657	NUM
iajs-2645	129	172	)	)	PUNCT
iajs-2645	129	173	p	p	NOUN
iajs-2645	129	174	-	-	PUNCT
iajs-2645	129	175	value	value	NOUN
iajs-2645	129	176	0.204	0.204	NUM
iajs-2645	129	177	0.086	0.086	NUM
iajs-2645	129	178	0.050	0.050	NUM
iajs-2645	129	179	0.703	0.703	NUM
iajs-2645	129	180	bmi	bmi	NOUN
iajs-2645	129	181	percentiles	percentile	NOUN
iajs-2645	129	182	<	<	X
iajs-2645	129	183	5th	5th	ADJ
iajs-2645	129	184	(	(	PUNCT
iajs-2645	129	185	underweight	underweight	NOUN
iajs-2645	129	186	)	)	PUNCT
iajs-2645	129	187	28.3	28.3	NUM
iajs-2645	129	188	(	(	PUNCT
iajs-2645	129	189	1.5	1.5	NUM
iajs-2645	129	190	377.9	377.9	NUM
iajs-2645	129	191	)	)	PUNCT
iajs-2645	129	192	29.6	29.6	NUM
iajs-2645	129	193	(	(	PUNCT
iajs-2645	129	194	22.4	22.4	NUM
iajs-2645	129	195	244.5	244.5	NUM
iajs-2645	129	196	)	)	PUNCT
iajs-2645	129	197	37.6	37.6	NUM
iajs-2645	129	198	(	(	PUNCT
iajs-2645	129	199	28.7	28.7	NUM
iajs-2645	129	200	40.9	40.9	NUM
iajs-2645	129	201	)	)	PUNCT
iajs-2645	129	202	0.422	0.422	NUM
iajs-2645	129	203	(	(	PUNCT
iajs-2645	129	204	0.246	0.246	NUM
iajs-2645	129	205	1.207	1.207	NUM
iajs-2645	129	206	)	)	PUNCT
iajs-2645	129	207	5th	5th	NOUN
iajs-2645	129	208	to	to	ADP
iajs-2645	129	209	<	<	X
iajs-2645	129	210	85th	85th	ADJ
iajs-2645	129	211	(	(	PUNCT
iajs-2645	129	212	normal	normal	ADJ
iajs-2645	129	213	weight	weight	NOUN
iajs-2645	129	214	)	)	PUNCT
iajs-2645	129	215	183.7	183.7	NUM
iajs-2645	129	216	(	(	PUNCT
iajs-2645	129	217	41.5	41.5	NUM
iajs-2645	129	218	801.8	801.8	NUM
iajs-2645	129	219	)	)	PUNCT
iajs-2645	129	220	31.0	31.0	NUM
iajs-2645	129	221	(	(	PUNCT
iajs-2645	129	222	15.0	15.0	NUM
iajs-2645	129	223	93.0	93.0	NUM
iajs-2645	129	224	)	)	PUNCT
iajs-2645	129	225	32.6	32.6	NUM
iajs-2645	129	226	(	(	PUNCT
iajs-2645	129	227	24.1	24.1	NUM
iajs-2645	129	228	37.4	37.4	NUM
iajs-2645	129	229	)	)	PUNCT
iajs-2645	129	230	0.508	0.508	NUM
iajs-2645	129	231	(	(	PUNCT
iajs-2645	129	232	0.065	0.065	NUM
iajs-2645	129	233	3.132	3.132	NUM
iajs-2645	129	234	)	)	PUNCT
iajs-2645	129	235	≥	≥	NOUN
iajs-2645	129	236	85th	85th	ADJ
iajs-2645	129	237	(	(	PUNCT
iajs-2645	129	238	overweight	overweight	ADJ
iajs-2645	129	239	/	/	SYM
iajs-2645	129	240	obese	obese	NOUN
iajs-2645	129	241	)	)	PUNCT
iajs-2645	129	242	15.5	15.5	NUM
iajs-2645	129	243	(	(	PUNCT
iajs-2645	129	244	14.5	14.5	NUM
iajs-2645	129	245	16.4	16.4	NUM
iajs-2645	129	246	)	)	PUNCT
iajs-2645	129	247	73.8	73.8	NUM
iajs-2645	129	248	(	(	PUNCT
iajs-2645	129	249	47.5	47.5	NUM
iajs-2645	129	250	100.0	100.0	NUM
iajs-2645	129	251	)	)	PUNCT
iajs-2645	129	252	38.4	38.4	NUM
iajs-2645	129	253	(	(	PUNCT
iajs-2645	129	254	29.0	29.0	NUM
iajs-2645	129	255	47.8	47.8	NUM
iajs-2645	129	256	)	)	PUNCT
iajs-2645	129	257	1.214	1.214	NUM
iajs-2645	129	258	(	(	PUNCT
iajs-2645	129	259	0.887	0.887	NUM
iajs-2645	129	260	1.540	1.540	NUM
iajs-2645	129	261	)	)	PUNCT
iajs-2645	130	1	p	p	NOUN
iajs-2645	130	2	-	-	PUNCT
iajs-2645	130	3	value	value	NOUN
iajs-2645	130	4	0.061	0.061	NUM
iajs-2645	130	5	0.562	0.562	NUM
iajs-2645	130	6	0.591	0.591	NUM
iajs-2645	130	7	0.562	0.562	NUM
iajs-2645	130	8	marsh	marsh	ADJ
iajs-2645	130	9	classification	classification	PROPN
iajs-2645	130	10	marsh	marsh	PROPN
iajs-2645	130	11	iii	iii	PROPN
iajs-2645	130	12	:	:	PUNCT
iajs-2645	130	13	3a	3a	NUM
iajs-2645	130	14	36.8	36.8	NUM
iajs-2645	130	15	(	(	PUNCT
iajs-2645	130	16	18.1	18.1	NUM
iajs-2645	130	17	226.5	226.5	NUM
iajs-2645	130	18	)	)	PUNCT
iajs-2645	130	19	28.8	28.8	NUM
iajs-2645	130	20	(	(	PUNCT
iajs-2645	130	21	15.0	15.0	NUM
iajs-2645	130	22	48.6	48.6	NUM
iajs-2645	130	23	)	)	PUNCT
iajs-2645	130	24	36.3	36.3	NUM
iajs-2645	130	25	(	(	PUNCT
iajs-2645	130	26	29.0	29.0	NUM
iajs-2645	130	27	40.9	40.9	NUM
iajs-2645	130	28	)	)	PUNCT
iajs-2645	130	29	0.592	0.592	NUM
iajs-2645	130	30	(	(	PUNCT
iajs-2645	130	31	0.176	0.176	NUM
iajs-2645	130	32	2.010	2.010	NUM
iajs-2645	130	33	)	)	PUNCT
iajs-2645	130	34	marsh	marsh	PROPN
iajs-2645	130	35	iii	iii	PROPN
iajs-2645	130	36	:	:	PUNCT
iajs-2645	130	37	3b/3c	3b/3c	NUM
iajs-2645	130	38	501.6	501.6	NUM
iajs-2645	130	39	(	(	PUNCT
iajs-2645	130	40	152.8	152.8	NUM
iajs-2645	130	41	992.0	992.0	NUM
iajs-2645	130	42	)	)	PUNCT
iajs-2645	130	43	93.4	93.4	NUM
iajs-2645	130	44	(	(	PUNCT
iajs-2645	130	45	56.0	56.0	NUM
iajs-2645	130	46	95.5	95.5	NUM
iajs-2645	130	47	)	)	PUNCT
iajs-2645	130	48	33.1	33.1	NUM
iajs-2645	130	49	(	(	PUNCT
iajs-2645	130	50	24.1	24.1	NUM
iajs-2645	130	51	40.9	40.9	NUM
iajs-2645	130	52	)	)	PUNCT
iajs-2645	130	53	0.775	0.775	NUM
iajs-2645	130	54	(	(	PUNCT
iajs-2645	130	55	0.120	0.120	NUM
iajs-2645	130	56	1.774	1.774	NUM
iajs-2645	130	57	)	)	PUNCT
iajs-2645	130	58	p	p	NOUN
iajs-2645	130	59	-	-	PUNCT
iajs-2645	130	60	value	value	NOUN
iajs-2645	130	61	0.022	0.022	NUM
iajs-2645	130	62	0.110	0.110	NUM
iajs-2645	130	63	0.635	0.635	NUM
iajs-2645	130	64	0.839	0.839	NUM
iajs-2645	130	65	cd	cd	PROPN
iajs-2645	130	66	:	:	PUNCT
iajs-2645	130	67	celiac	celiac	ADJ
iajs-2645	130	68	disease	disease	NOUN
iajs-2645	130	69	;	;	PUNCT
iajs-2645	130	70	bmi	bmi	PROPN
iajs-2645	130	71	:	:	PUNCT
iajs-2645	130	72	body	body	NOUN
iajs-2645	130	73	mass	mass	PROPN
iajs-2645	130	74	index	index	NOUN
iajs-2645	130	75	;	;	PUNCT
iajs-2645	130	76	ttg	ttg	NOUN
iajs-2645	130	77	:	:	PUNCT
iajs-2645	130	78	tissue	tissue	NOUN
iajs-2645	130	79	transglutaminase	transglutaminase	NOUN
iajs-2645	130	80	;	;	PUNCT
iajs-2645	130	81	nlrp3	nlrp3	ADJ
iajs-2645	130	82	:	:	PUNCT
iajs-2645	130	83	nucleotide	nucleotide	NOUN
iajs-2645	130	84	-	-	PUNCT
iajs-2645	130	85	binding	bind	VERB
iajs-2645	130	86	oligomerization	oligomerization	NOUN
iajs-2645	130	87	domain	domain	NOUN
iajs-2645	130	88	leucine	leucine	NOUN
iajs-2645	130	89	rich	rich	ADJ
iajs-2645	130	90	repeat	repeat	NOUN
iajs-2645	130	91	and	and	CCONJ
iajs-2645	130	92	pyrin	pyrin	NOUN
iajs-2645	130	93	domain	domain	NOUN
iajs-2645	130	94	-	-	PUNCT
iajs-2645	130	95	containing	contain	VERB
iajs-2645	130	96	protein	protein	NOUN
iajs-2645	130	97	3	3	NUM
iajs-2645	130	98	;	;	PUNCT
iajs-2645	130	99	p	p	X
iajs-2645	130	100	:	:	PUNCT
iajs-2645	130	101	probability	probability	NOUN
iajs-2645	130	102	;	;	PUNCT
iajs-2645	130	103	significant	significant	ADJ
iajs-2645	130	104	p	p	NOUN
iajs-2645	130	105	is	be	AUX
iajs-2645	130	106	bold	bold	ADV
iajs-2645	130	107	-	-	PUNCT
iajs-2645	130	108	marked	mark	VERB
iajs-2645	130	109	.	.	PUNCT
iajs-2645	131	1	receiver	receiver	ADJ
iajs-2645	131	2	operating	operate	VERB
iajs-2645	131	3	characteristic	characteristic	NOUN
iajs-2645	131	4	(	(	PUNCT
iajs-2645	131	5	roc	roc	PROPN
iajs-2645	131	6	)	)	PUNCT
iajs-2645	131	7	curve	curve	NOUN
iajs-2645	131	8	analysis	analysis	NOUN
iajs-2645	131	9	was	be	AUX
iajs-2645	131	10	performed	perform	VERB
iajs-2645	131	11	to	to	PART
iajs-2645	131	12	determine	determine	VERB
iajs-2645	131	13	whether	whether	SCONJ
iajs-2645	131	14	there	there	PRON
iajs-2645	131	15	was	be	VERB
iajs-2645	131	16	an	an	DET
iajs-2645	131	17	additional	additional	ADJ
iajs-2645	131	18	advantage	advantage	NOUN
iajs-2645	131	19	of	of	ADP
iajs-2645	131	20	using	use	VERB
iajs-2645	131	21	the	the	DET
iajs-2645	131	22	study	study	NOUN
iajs-2645	131	23	parameters	parameter	NOUN
iajs-2645	131	24	for	for	ADP
iajs-2645	131	25	predicting	predict	VERB
iajs-2645	131	26	cd	cd	PROPN
iajs-2645	131	27	.	.	PUNCT
iajs-2645	132	1	both	both	DET
iajs-2645	132	2	antibodies	antibodie	VERB
iajs-2645	132	3	(	(	PUNCT
iajs-2645	132	4	anti	anti	ADJ
iajs-2645	132	5	-	-	ADJ
iajs-2645	132	6	gliadin	gliadin	ADJ
iajs-2645	132	7	and	and	CCONJ
iajs-2645	132	8	anti	anti	ADJ
iajs-2645	132	9	-	-	ADJ
iajs-2645	132	10	ttg	ttg	ADJ
iajs-2645	132	11	iga	iga	PROPN
iajs-2645	132	12	antibodies	antibodie	VERB
iajs-2645	132	13	)	)	PUNCT
iajs-2645	132	14	occupied	occupy	VERB
iajs-2645	132	15	a	a	DET
iajs-2645	132	16	significant	significant	ADJ
iajs-2645	132	17	area	area	NOUN
iajs-2645	132	18	under	under	ADP
iajs-2645	132	19	the	the	DET
iajs-2645	132	20	curve	curve	NOUN
iajs-2645	132	21	(	(	PUNCT
iajs-2645	132	22	auc	auc	NOUN
iajs-2645	132	23	)	)	PUNCT
iajs-2645	132	24	.	.	PUNCT
iajs-2645	133	1	it	it	PRON
iajs-2645	133	2	was	be	AUX
iajs-2645	133	3	0.999	0.999	NUM
iajs-2645	133	4	for	for	ADP
iajs-2645	133	5	the	the	DET
iajs-2645	133	6	former	former	ADJ
iajs-2645	133	7	antibody	antibody	NOUN
iajs-2645	133	8	,	,	PUNCT
iajs-2645	133	9	while	while	SCONJ
iajs-2645	133	10	it	it	PRON
iajs-2645	133	11	was	be	AUX
iajs-2645	133	12	lower	low	ADJ
iajs-2645	133	13	in	in	ADP
iajs-2645	133	14	the	the	DET
iajs-2645	133	15	latter	latter	ADJ
iajs-2645	133	16	antibody	antibody	NOUN
iajs-2645	133	17	(	(	PUNCT
iajs-2645	133	18	auc	auc	NOUN
iajs-2645	133	19	=	=	SYM
iajs-2645	133	20	0.956	0.956	NUM
iajs-2645	133	21	)	)	PUNCT
iajs-2645	133	22	with	with	ADP
iajs-2645	133	23	sensitivity	sensitivity	NOUN
iajs-2645	133	24	and	and	CCONJ
iajs-2645	133	25	specificity	specificity	NOUN
iajs-2645	133	26	of	of	ADP
iajs-2645	133	27	100	100	NUM
iajs-2645	133	28	and	and	CCONJ
iajs-2645	133	29	95	95	NUM
iajs-2645	133	30	%	%	NOUN
iajs-2645	133	31	and	and	CCONJ
iajs-2645	133	32	91.7	91.7	NUM
iajs-2645	133	33	and	and	CCONJ
iajs-2645	133	34	90	90	NUM
iajs-2645	133	35	%	%	NOUN
iajs-2645	133	36	,	,	PUNCT
iajs-2645	133	37	respectively	respectively	ADV
iajs-2645	133	38	.	.	PUNCT
iajs-2645	134	1	whereas	whereas	SCONJ
iajs-2645	134	2	,	,	PUNCT
iajs-2645	134	3	il-1β	il-1β	PROPN
iajs-2645	134	4	and	and	CCONJ
iajs-2645	134	5	nlrp3	nlrp3	ADJ
iajs-2645	134	6	gene	gene	NOUN
iajs-2645	134	7	expression	expression	NOUN
iajs-2645	134	8	did	do	AUX
iajs-2645	134	9	not	not	PART
iajs-2645	134	10	occupy	occupy	VERB
iajs-2645	134	11	a	a	DET
iajs-2645	134	12	significant	significant	ADJ
iajs-2645	134	13	auc	auc	NOUN
iajs-2645	134	14	(	(	PUNCT
iajs-2645	134	15	0.398	0.398	NUM
iajs-2645	134	16	and	and	CCONJ
iajs-2645	134	17	0.627	0.627	NUM
iajs-2645	134	18	,	,	PUNCT
iajs-2645	134	19	respectively	respectively	ADV
iajs-2645	134	20	)	)	PUNCT
iajs-2645	134	21	;	;	PUNCT
iajs-2645	134	22	therefore	therefore	ADV
iajs-2645	134	23	,	,	PUNCT
iajs-2645	134	24	their	their	PRON
iajs-2645	134	25	diagnostic	diagnostic	ADJ
iajs-2645	134	26	performance	performance	NOUN
iajs-2645	134	27	in	in	ADP
iajs-2645	134	28	cd	cd	PROPN
iajs-2645	134	29	was	be	AUX
iajs-2645	134	30	limited	limited	ADJ
iajs-2645	134	31	table	table	NOUN
iajs-2645	134	32	(	(	PUNCT
iajs-2645	134	33	3	3	NUM
iajs-2645	134	34	)	)	PUNCT
iajs-2645	134	35	and	and	CCONJ
iajs-2645	134	36	figure	figure	NOUN
iajs-2645	134	37	(	(	PUNCT
iajs-2645	134	38	1	1	NUM
iajs-2645	134	39	)	)	PUNCT
iajs-2645	134	40	.	.	PUNCT
iajs-2645	135	1	table	table	NOUN
iajs-2645	135	2	3	3	NUM
iajs-2645	135	3	.	.	PUNCT
iajs-2645	136	1	roc	roc	PROPN
iajs-2645	136	2	curve	curve	NOUN
iajs-2645	136	3	analysis	analysis	NOUN
iajs-2645	136	4	of	of	ADP
iajs-2645	136	5	iga	iga	PROPN
iajs-2645	136	6	anti	anti	PROPN
iajs-2645	136	7	-	-	PROPN
iajs-2645	136	8	ttg	ttg	ADJ
iajs-2645	136	9	,	,	PUNCT
iajs-2645	136	10	iga	iga	PROPN
iajs-2645	136	11	antibody	antibody	NOUN
iajs-2645	136	12	,	,	PUNCT
iajs-2645	136	13	anti	anti	ADJ
iajs-2645	136	14	-	-	ADJ
iajs-2645	136	15	gliadin	gliadin	ADJ
iajs-2645	136	16	antibody	antibody	NOUN
iajs-2645	136	17	,	,	PUNCT
iajs-2645	136	18	il-1β	il-1β	PROPN
iajs-2645	136	19	and	and	CCONJ
iajs-2645	136	20	nlrp3	nlrp3	ADJ
iajs-2645	136	21	gene	gene	NOUN
iajs-2645	136	22	expression	expression	NOUN
iajs-2645	136	23	in	in	ADP
iajs-2645	136	24	celiac	celiac	ADJ
iajs-2645	136	25	disease	disease	NOUN
iajs-2645	136	26	patients	patient	NOUN
iajs-2645	136	27	.	.	PUNCT
iajs-2645	137	1	variable	variable	ADJ
iajs-2645	137	2	auc	auc	VERB
iajs-2645	137	3	95	95	NUM
iajs-2645	137	4	%	%	NOUN
iajs-2645	137	5	ci	ci	NOUN
iajs-2645	137	6	p	p	ADJ
iajs-2645	137	7	-	-	PUNCT
iajs-2645	137	8	value	value	NOUN
iajs-2645	137	9	sensitivity	sensitivity	NOUN
iajs-2645	137	10	(	(	PUNCT
iajs-2645	137	11	%	%	INTJ
iajs-2645	137	12	)	)	PUNCT
iajs-2645	137	13	specificity	specificity	NOUN
iajs-2645	137	14	(	(	PUNCT
iajs-2645	137	15	%	%	INTJ
iajs-2645	137	16	)	)	PUNCT
iajs-2645	137	17	cut	cut	NOUN
iajs-2645	137	18	-	-	PUNCT
iajs-2645	137	19	off	off	ADP
iajs-2645	137	20	value	value	NOUN
iajs-2645	137	21	iga	iga	PROPN
iajs-2645	137	22	and	and	CCONJ
iajs-2645	137	23	anti	anti	ADJ
iajs-2645	137	24	-	-	ADJ
iajs-2645	137	25	gliadin	gliadin	ADJ
iajs-2645	137	26	antibody	antibody	NOUN
iajs-2645	137	27	(	(	PUNCT
iajs-2645	137	28	u	u	NOUN
iajs-2645	137	29	/	/	SYM
iajs-2645	137	30	ml	ml	VERB
iajs-2645	137	31	)	)	PUNCT
iajs-2645	137	32	0.999	0.999	NUM
iajs-2645	137	33	0.995	0.995	NUM
iajs-2645	137	34	-	-	SYM
iajs-2645	137	35	1.000	1.000	NUM
iajs-2645	137	36	<	<	NOUN
iajs-2645	137	37	0.001	0.001	NUM
iajs-2645	137	38	100.0	100.0	NUM
iajs-2645	137	39	95.0	95.0	NUM
iajs-2645	137	40	1.7	1.7	NUM
iajs-2645	137	41	iga	iga	PROPN
iajs-2645	137	42	anti	anti	ADJ
iajs-2645	137	43	-	-	ADJ
iajs-2645	137	44	ttg	ttg	ADJ
iajs-2645	137	45	antibody	antibody	NOUN
iajs-2645	137	46	(	(	PUNCT
iajs-2645	137	47	u	u	NOUN
iajs-2645	137	48	/	/	SYM
iajs-2645	137	49	ml	ml	VERB
iajs-2645	137	50	)	)	PUNCT
iajs-2645	137	51	0.956	0.956	NUM
iajs-2645	137	52	0.896	0.896	NUM
iajs-2645	137	53	-	-	SYM
iajs-2645	137	54	1.000	1.000	NUM
iajs-2645	137	55	<	<	NOUN
iajs-2645	137	56	0.001	0.001	NUM
iajs-2645	137	57	91.7	91.7	NUM
iajs-2645	137	58	90.0	90.0	NUM
iajs-2645	137	59	1.8	1.8	NUM
iajs-2645	137	60	il-1β	il-1β	PROPN
iajs-2645	137	61	(	(	PUNCT
iajs-2645	137	62	pg	pg	NOUN
iajs-2645	137	63	/	/	SYM
iajs-2645	137	64	ml	ml	NOUN
iajs-2645	137	65	)	)	PUNCT
iajs-2645	137	66	0.398	0.398	NUM
iajs-2645	137	67	0.219	0.219	NUM
iajs-2645	137	68	-	-	PUNCT
iajs-2645	137	69	0.576	0.576	NUM
iajs-2645	137	70	0.248	0.248	NUM
iajs-2645	137	71	55.0	55.0	NUM
iajs-2645	137	72	50.0	50.0	NUM
iajs-2645	137	73	56.4	56.4	NUM
iajs-2645	137	74	nlrp3	nlrp3	NOUN
iajs-2645	137	75	gene	gene	NOUN
iajs-2645	137	76	expression	expression	NOUN
iajs-2645	137	77	(	(	PUNCT
iajs-2645	137	78	dct	dct	PROPN
iajs-2645	137	79	)	)	PUNCT
iajs-2645	137	80	0.627	0.627	NUM
iajs-2645	137	81	0.461	0.461	NUM
iajs-2645	137	82	-	-	SYM
iajs-2645	137	83	0.793	0.793	NUM
iajs-2645	137	84	0.150	0.150	NUM
iajs-2645	137	85	65.0	65.0	NUM
iajs-2645	137	86	58.0	58.0	NUM
iajs-2645	137	87	0.800	0.800	NUM
iajs-2645	137	88	http://ihicps.com/	http://ihicps.com/	ADJ
iajs-2645	137	89	special	special	ADJ
iajs-2645	137	90	issue	issue	NOUN
iajs-2645	137	91	1ihicpas	1ihicpas	NUM
iajs-2645	137	92	202	202	NUM
iajs-2645	137	93	ibn	ibn	PROPN
iajs-2645	137	94	al	al	PROPN
iajs-2645	137	95	-	-	PUNCT
iajs-2645	137	96	haitham	haitham	PROPN
iajs-2645	137	97	journal	journal	PROPN
iajs-2645	137	98	for	for	ADP
iajs-2645	137	99	pure	pure	ADJ
iajs-2645	137	100	and	and	CCONJ
iajs-2645	137	101	applied	apply	VERB
iajs-2645	137	102	science	science	NOUN
iajs-2645	137	103	https://doi.org/10.30526/2021.ihicpas.2645	https://doi.org/10.30526/2021.ihicpas.2645	PROPN
iajs-2645	137	104	for	for	ADP
iajs-2645	137	105	more	more	ADJ
iajs-2645	137	106	information	information	NOUN
iajs-2645	137	107	about	about	ADP
iajs-2645	137	108	the	the	DET
iajs-2645	137	109	conference	conference	NOUN
iajs-2645	137	110	please	please	INTJ
iajs-2645	137	111	visit	visit	VERB
iajs-2645	137	112	the	the	DET
iajs-2645	137	113	websites	website	NOUN
iajs-2645	137	114	:	:	PUNCT
iajs-2645	137	115	http://ihicps.com/	http://ihicps.com/	NOUN
iajs-2645	137	116	b	b	NOUN
iajs-2645	138	1	i	i	NOUN
iajs-2645	138	2	o	o	NOUN
iajs-2645	139	1	l	l	NOUN
iajs-2645	139	2	o	o	X
iajs-2645	140	1	g	g	NOUN
iajs-2645	140	2	y	y	PROPN
iajs-2645	140	3	|	|	ADV
iajs-2645	140	4	21	21	NUM
iajs-2645	140	5	figure	figure	NOUN
iajs-2645	140	6	2	2	NUM
iajs-2645	140	7	.	.	PUNCT
iajs-2645	141	1	roc	roc	PROPN
iajs-2645	141	2	curve	curve	NOUN
iajs-2645	141	3	analysis	analysis	NOUN
iajs-2645	141	4	of	of	ADP
iajs-2645	141	5	iga	iga	PROPN
iajs-2645	141	6	anti	anti	PROPN
iajs-2645	141	7	-	-	PROPN
iajs-2645	141	8	ttg	ttg	ADJ
iajs-2645	141	9	,	,	PUNCT
iajs-2645	141	10	iga	iga	PROPN
iajs-2645	141	11	antibody	antibody	NOUN
iajs-2645	141	12	,	,	PUNCT
iajs-2645	141	13	anti	anti	ADJ
iajs-2645	141	14	-	-	ADJ
iajs-2645	141	15	gliadin	gliadin	ADJ
iajs-2645	141	16	antibody	antibody	NOUN
iajs-2645	141	17	,	,	PUNCT
iajs-2645	141	18	il-1β	il-1β	PROPN
iajs-2645	141	19	and	and	CCONJ
iajs-2645	141	20	nlrp3	nlrp3	ADJ
iajs-2645	141	21	gene	gene	NOUN
iajs-2645	141	22	expression	expression	NOUN
iajs-2645	141	23	in	in	ADP
iajs-2645	141	24	celiac	celiac	ADJ
iajs-2645	141	25	disease	disease	NOUN
iajs-2645	141	26	patients	patient	NOUN
iajs-2645	141	27	showing	show	VERB
iajs-2645	141	28	area	area	NOUN
iajs-2645	141	29	under	under	ADP
iajs-2645	141	30	the	the	DET
iajs-2645	141	31	curve	curve	NOUN
iajs-2645	141	32	.	.	PUNCT
iajs-2645	142	1	4	4	X
iajs-2645	142	2	.	.	X
iajs-2645	142	3	conclusion	conclusion	NOUN
iajs-2645	142	4	in	in	ADP
iajs-2645	142	5	conclusion	conclusion	NOUN
iajs-2645	142	6	,	,	PUNCT
iajs-2645	142	7	the	the	DET
iajs-2645	142	8	nlrp3	nlrp3	NOUN
iajs-2645	142	9	inflammasome	inflammasome	NOUN
iajs-2645	142	10	was	be	AUX
iajs-2645	142	11	down	down	ADV
iajs-2645	142	12	-	-	PUNCT
iajs-2645	142	13	regulated	regulate	VERB
iajs-2645	142	14	in	in	ADP
iajs-2645	142	15	the	the	DET
iajs-2645	142	16	present	present	ADJ
iajs-2645	142	17	sample	sample	NOUN
iajs-2645	142	18	of	of	ADP
iajs-2645	142	19	cd	cd	PROPN
iajs-2645	142	20	children	child	NOUN
iajs-2645	142	21	,	,	PUNCT
iajs-2645	142	22	and	and	CCONJ
iajs-2645	142	23	it	it	PRON
iajs-2645	142	24	was	be	AUX
iajs-2645	142	25	accompanied	accompany	VERB
iajs-2645	142	26	by	by	ADP
iajs-2645	142	27	a	a	DET
iajs-2645	142	28	decreased	decrease	VERB
iajs-2645	142	29	serum	serum	NOUN
iajs-2645	142	30	level	level	NOUN
iajs-2645	142	31	of	of	ADP
iajs-2645	142	32	il-1β	il-1β	PROPN
iajs-2645	142	33	.	.	PUNCT
iajs-2645	143	1	the	the	DET
iajs-2645	143	2	diagnostic	diagnostic	ADJ
iajs-2645	143	3	significance	significance	NOUN
iajs-2645	143	4	of	of	ADP
iajs-2645	143	5	anti	anti	ADJ
iajs-2645	143	6	-	-	ADJ
iajs-2645	143	7	ttg	ttg	NOUN
iajs-2645	143	8	and	and	CCONJ
iajs-2645	143	9	anti	anti	ADJ
iajs-2645	143	10	-	-	ADJ
iajs-2645	143	11	gliadin	gliadin	ADJ
iajs-2645	143	12	iga	iga	PROPN
iajs-2645	143	13	antibodies	antibody	NOUN
iajs-2645	143	14	was	be	AUX
iajs-2645	143	15	reinforced	reinforce	VERB
iajs-2645	143	16	by	by	ADP
iajs-2645	143	17	the	the	DET
iajs-2645	143	18	present	present	ADJ
iajs-2645	143	19	study	study	NOUN
iajs-2645	143	20	.	.	PUNCT
iajs-2645	144	1	references	reference	NOUN
iajs-2645	144	2	1	1	NUM
iajs-2645	144	3	.	.	PUNCT
iajs-2645	144	4	lebwohl	lebwohl	PROPN
iajs-2645	144	5	,	,	PUNCT
iajs-2645	144	6	b.	b.	PROPN
iajs-2645	144	7	;	;	PUNCT
iajs-2645	144	8	sanders	sanders	PROPN
iajs-2645	144	9	,	,	PUNCT
iajs-2645	144	10	d.s	d.s	PROPN
iajs-2645	144	11	.	.	PROPN
iajs-2645	144	12	;	;	PUNCT
iajs-2645	144	13	green	green	PROPN
iajs-2645	144	14	,	,	PUNCT
iajs-2645	144	15	p.h	p.h	PROPN
iajs-2645	144	16	.	.	PROPN
iajs-2645	144	17	coeliac	coeliac	PROPN
iajs-2645	144	18	disease	disease	PROPN
iajs-2645	144	19	.	.	PUNCT
iajs-2645	145	1	lancet	lancet	PROPN
iajs-2645	145	2	2018	2018	NUM
iajs-2645	145	3	,	,	PUNCT
iajs-2645	145	4	391	391	NUM
iajs-2645	145	5	,	,	PUNCT
iajs-2645	145	6	70	70	NUM
iajs-2645	145	7	.	.	NOUN
iajs-2645	145	8	2	2	X
iajs-2645	145	9	.	.	X
iajs-2645	145	10	mearin	mearin	PROPN
iajs-2645	145	11	,	,	PUNCT
iajs-2645	145	12	m.l	m.l	PROPN
iajs-2645	145	13	.	.	PROPN
iajs-2645	145	14	;	;	PUNCT
iajs-2645	145	15	montoro	montoro	PROPN
iajs-2645	145	16	-	-	PUNCT
iajs-2645	145	17	huguet	huguet	NOUN
iajs-2645	145	18	,	,	PUNCT
iajs-2645	145	19	m.	m.	NOUN
iajs-2645	145	20	;	;	PUNCT
iajs-2645	145	21	polanco	polanco	PROPN
iajs-2645	145	22	,	,	PUNCT
iajs-2645	145	23	i.	i.	PROPN
iajs-2645	145	24	;	;	PUNCT
iajs-2645	145	25	ribes	ribe	NOUN
iajs-2645	145	26	-	-	PUNCT
iajs-2645	145	27	köninckx	köninckx	NOUN
iajs-2645	145	28	,	,	PUNCT
iajs-2645	145	29	c.	c.	PROPN
iajs-2645	145	30	;	;	PUNCT
iajs-2645	145	31	santolaria	santolaria	PROPN
iajs-2645	145	32	,	,	PUNCT
iajs-2645	145	33	s.	s.	PROPN
iajs-2645	145	34	clinical	clinical	ADJ
iajs-2645	145	35	manifestations	manifestation	NOUN
iajs-2645	145	36	of	of	ADP
iajs-2645	145	37	celiac	celiac	ADJ
iajs-2645	145	38	disease	disease	NOUN
iajs-2645	145	39	and	and	CCONJ
iajs-2645	145	40	diagnostic	diagnostic	ADJ
iajs-2645	145	41	criteria	criterion	NOUN
iajs-2645	145	42	:	:	PUNCT
iajs-2645	145	43	differences	difference	NOUN
iajs-2645	145	44	among	among	ADP
iajs-2645	145	45	children	child	NOUN
iajs-2645	145	46	,	,	PUNCT
iajs-2645	145	47	adolescents	adolescent	NOUN
iajs-2645	145	48	and	and	CCONJ
iajs-2645	145	49	adults	adult	NOUN
iajs-2645	145	50	in	in	ADP
iajs-2645	145	51	:	:	PUNCT
iajs-2645	145	52	arranz	arranz	PROPN
iajs-2645	145	53	.	.	PUNCT
iajs-2645	146	1	e.	e.	PROPN
iajs-2645	146	2	;	;	PUNCT
iajs-2645	146	3	fernández	fernández	NOUN
iajs-2645	146	4	-	-	PUNCT
iajs-2645	146	5	bañares	bañare	NOUN
iajs-2645	146	6	.	.	PUNCT
iajs-2645	147	1	f.	f.	PROPN
iajs-2645	147	2	;	;	PUNCT
iajs-2645	147	3	rosell	rosell	VERB
iajs-2645	147	4	.	.	PUNCT
iajs-2645	148	1	c.m	c.m	PROPN
iajs-2645	148	2	.	.	PROPN
iajs-2645	148	3	;	;	PUNCT
iajs-2645	148	4	rodrig	rodrig	PROPN
iajs-2645	148	5	,	,	PUNCT
iajs-2645	148	6	l.	l.	PROPN
iajs-2645	148	7	;	;	PUNCT
iajs-2645	148	8	peña	peña	PROPN
iajs-2645	148	9	,	,	PUNCT
iajs-2645	148	10	a.s	a.s	PROPN
iajs-2645	148	11	.	.	PROPN
iajs-2645	148	12	(	(	PUNCT
iajs-2645	148	13	eds	ed	NOUN
iajs-2645	148	14	.	.	PUNCT
iajs-2645	148	15	)	)	PUNCT
iajs-2645	148	16	.	.	PUNCT
iajs-2645	149	1	advances	advance	NOUN
iajs-2645	149	2	in	in	ADP
iajs-2645	149	3	the	the	DET
iajs-2645	149	4	understanding	understanding	NOUN
iajs-2645	149	5	of	of	ADP
iajs-2645	149	6	gluten	gluten	ADJ
iajs-2645	149	7	related	relate	VERB
iajs-2645	149	8	pathology	pathology	NOUN
iajs-2645	149	9	and	and	CCONJ
iajs-2645	149	10	the	the	DET
iajs-2645	149	11	evolution	evolution	NOUN
iajs-2645	149	12	of	of	ADP
iajs-2645	149	13	gluten	gluten	NOUN
iajs-2645	149	14	-	-	PUNCT
iajs-2645	149	15	free	free	ADJ
iajs-2645	149	16	foods	food	NOUN
iajs-2645	149	17	.	.	PUNCT
iajs-2645	150	1	omnia	omnia	PROPN
iajs-2645	150	2	science.barcelona	science.barcelona	PROPN
iajs-2645	150	3	,	,	PUNCT
iajs-2645	150	4	spain	spain	PROPN
iajs-2645	150	5	.	.	PUNCT
iajs-2645	150	6	2015	2015	NUM
iajs-2645	150	7	,	,	PUNCT
iajs-2645	150	8	291	291	NUM
iajs-2645	150	9	.	.	PUNCT
iajs-2645	151	1	3	3	X
iajs-2645	151	2	.	.	X
iajs-2645	151	3	singh	singh	PROPN
iajs-2645	151	4	,	,	PUNCT
iajs-2645	151	5	p.	p.	PROPN
iajs-2645	151	6	;	;	PUNCT
iajs-2645	151	7	arora	arora	PROPN
iajs-2645	151	8	,	,	PUNCT
iajs-2645	151	9	a.	a.	NOUN
iajs-2645	151	10	;	;	PUNCT
iajs-2645	151	11	strand	strand	PROPN
iajs-2645	151	12	,	,	PUNCT
iajs-2645	151	13	t.a	t.a	PROPN
iajs-2645	151	14	.	.	PROPN
iajs-2645	151	15	;	;	PUNCT
iajs-2645	151	16	leffler	leffler	NOUN
iajs-2645	151	17	,	,	PUNCT
iajs-2645	151	18	d.a	d.a	PROPN
iajs-2645	151	19	.	.	PROPN
iajs-2645	151	20	;	;	PUNCT
iajs-2645	151	21	catassi	catassi	PROPN
iajs-2645	151	22	,	,	PUNCT
iajs-2645	151	23	c.	c.	PROPN
iajs-2645	151	24	;	;	PUNCT
iajs-2645	151	25	green	green	PROPN
iajs-2645	151	26	,	,	PUNCT
iajs-2645	151	27	p.h	p.h	PROPN
iajs-2645	151	28	.	.	PROPN
iajs-2645	151	29	;	;	PUNCT
iajs-2645	151	30	kelly	kelly	PROPN
iajs-2645	151	31	,	,	PUNCT
iajs-2645	151	32	c.p	c.p	PROPN
iajs-2645	151	33	.	.	PROPN
iajs-2645	151	34	;	;	PUNCT
iajs-2645	152	1	ahuja	ahuja	PROPN
iajs-2645	152	2	.	.	PUNCT
iajs-2645	153	1	v.	v.	PROPN
iajs-2645	153	2	;	;	PUNCT
iajs-2645	153	3	makharia	makharia	PROPN
iajs-2645	153	4	.	.	PUNCT
iajs-2645	154	1	g.k	g.k	PROPN
iajs-2645	154	2	.	.	PROPN
iajs-2645	154	3	global	global	ADJ
iajs-2645	154	4	prevalence	prevalence	NOUN
iajs-2645	154	5	of	of	ADP
iajs-2645	154	6	celiac	celiac	ADJ
iajs-2645	154	7	disease	disease	NOUN
iajs-2645	154	8	:	:	PUNCT
iajs-2645	154	9	systematic	systematic	ADJ
iajs-2645	154	10	review	review	NOUN
iajs-2645	154	11	and	and	CCONJ
iajs-2645	154	12	meta	meta	ADJ
iajs-2645	154	13	-	-	PUNCT
iajs-2645	154	14	analysis	analysis	NOUN
iajs-2645	154	15	.	.	PUNCT
iajs-2645	155	1	clin	clin	PROPN
iajs-2645	155	2	.	.	PUNCT
iajs-2645	155	3	gastroenterol	gastroenterol	PROPN
iajs-2645	155	4	.	.	PUNCT
iajs-2645	156	1	hepatol	hepatol	ADJ
iajs-2645	156	2	.	.	PUNCT
iajs-2645	157	1	2018	2018	NUM
iajs-2645	157	2	,	,	PUNCT
iajs-2645	157	3	16	16	NUM
iajs-2645	157	4	,	,	PUNCT
iajs-2645	157	5	823	823	NUM
iajs-2645	157	6	.	.	NOUN
iajs-2645	157	7	4	4	NUM
iajs-2645	157	8	.	.	X
iajs-2645	158	1	toma	toma	PROPN
iajs-2645	158	2	,	,	PUNCT
iajs-2645	158	3	m.	m.	NOUN
iajs-2645	158	4	;	;	PUNCT
iajs-2645	158	5	fayadh	fayadh	PROPN
iajs-2645	158	6	,	,	PUNCT
iajs-2645	158	7	m.h	m.h	PROPN
iajs-2645	158	8	.	.	PROPN
iajs-2645	158	9	;	;	PUNCT
iajs-2645	158	10	al	al	PROPN
iajs-2645	158	11	-	-	PUNCT
iajs-2645	158	12	nasseri	nasseri	PROPN
iajs-2645	158	13	,	,	PUNCT
iajs-2645	158	14	s.	s.	PROPN
iajs-2645	158	15	broad	broad	PROPN
iajs-2645	158	16	look	look	VERB
iajs-2645	158	17	on	on	ADP
iajs-2645	158	18	celiac	celiac	ADJ
iajs-2645	158	19	disease	disease	NOUN
iajs-2645	158	20	in	in	ADP
iajs-2645	158	21	iraq	iraq	PROPN
iajs-2645	158	22	.	.	PUNCT
iajs-2645	159	1	m.sc	m.sc	PROPN
iajs-2645	159	2	.	.	PUNCT
iajs-2645	160	1	thesis	thesis	NOUN
iajs-2645	160	2	submitted	submit	VERB
iajs-2645	160	3	to	to	ADP
iajs-2645	160	4	college	college	NOUN
iajs-2645	160	5	of	of	ADP
iajs-2645	160	6	medicine	medicine	PROPN
iajs-2645	160	7	baghdad	baghdad	PROPN
iajs-2645	160	8	university	university	PROPN
iajs-2645	160	9	,	,	PUNCT
iajs-2645	160	10	2004	2004	NUM
iajs-2645	160	11	.	.	PUNCT
iajs-2645	161	1	5	5	NUM
iajs-2645	161	2	.	.	X
iajs-2645	161	3	aune	aune	PROPN
iajs-2645	161	4	,	,	PUNCT
iajs-2645	161	5	t.m	t.m	PROPN
iajs-2645	161	6	.	.	PROPN
iajs-2645	161	7	;	;	PUNCT
iajs-2645	161	8	maas	maas	PROPN
iajs-2645	161	9	,	,	PUNCT
iajs-2645	161	10	k.	k.	PROPN
iajs-2645	161	11	;	;	PUNCT
iajs-2645	161	12	parker	parker	PROPN
iajs-2645	161	13	,	,	PUNCT
iajs-2645	161	14	j.	j.	PROPN
iajs-2645	161	15	;	;	PUNCT
iajs-2645	161	16	moore	moore	PROPN
iajs-2645	161	17	,	,	PUNCT
iajs-2645	161	18	j.h	j.h	PROPN
iajs-2645	161	19	.	.	PROPN
iajs-2645	161	20	;	;	PUNCT
iajs-2645	161	21	olsen	olsen	PROPN
iajs-2645	161	22	,	,	PUNCT
iajs-2645	161	23	n.j	n.j	PROPN
iajs-2645	161	24	.	.	PROPN
iajs-2645	161	25	profiles	profile	NOUN
iajs-2645	161	26	of	of	ADP
iajs-2645	161	27	gene	gene	NOUN
iajs-2645	161	28	expression	expression	NOUN
iajs-2645	161	29	in	in	ADP
iajs-2645	161	30	human	human	ADJ
iajs-2645	161	31	autoimmune	autoimmune	ADJ
iajs-2645	161	32	disease	disease	NOUN
iajs-2645	161	33	.	.	PUNCT
iajs-2645	162	1	cell	cell	NOUN
iajs-2645	162	2	biochem	biochem	PROPN
iajs-2645	162	3	.	.	PUNCT
iajs-2645	163	1	biophys	biophy	NOUN
iajs-2645	163	2	.	.	PUNCT
iajs-2645	164	1	2004	2004	NUM
iajs-2645	164	2	,	,	PUNCT
iajs-2645	164	3	40	40	NUM
iajs-2645	164	4	,	,	PUNCT
iajs-2645	164	5	81	81	NUM
iajs-2645	164	6	.	.	NOUN
iajs-2645	164	7	6	6	NUM
iajs-2645	164	8	.	.	X
iajs-2645	164	9	horai	horai	NOUN
iajs-2645	164	10	,	,	PUNCT
iajs-2645	164	11	r.	r.	PROPN
iajs-2645	164	12	;	;	PUNCT
iajs-2645	164	13	saijo	saijo	PROPN
iajs-2645	164	14	.	.	PUNCT
iajs-2645	165	1	s.	s.	PROPN
iajs-2645	165	2	;	;	PUNCT
iajs-2645	165	3	tanioka	tanioka	PROPN
iajs-2645	165	4	,	,	PUNCT
iajs-2645	165	5	h.	h.	PROPN
iajs-2645	165	6	;	;	PUNCT
iajs-2645	165	7	nakae	nakae	ADJ
iajs-2645	165	8	,	,	PUNCT
iajs-2645	165	9	s.	s.	PROPN
iajs-2645	165	10	;	;	PUNCT
iajs-2645	165	11	sudo	sudo	PROPN
iajs-2645	165	12	,	,	PUNCT
iajs-2645	165	13	k.	k.	PROPN
iajs-2645	165	14	;	;	PUNCT
iajs-2645	165	15	okahara	okahara	PROPN
iajs-2645	165	16	,	,	PUNCT
iajs-2645	165	17	a.	a.	NOUN
iajs-2645	165	18	;	;	PUNCT
iajs-2645	165	19	ikuse	ikuse	NOUN
iajs-2645	165	20	,	,	PUNCT
iajs-2645	165	21	t.	t.	PROPN
iajs-2645	165	22	;	;	PUNCT
iajs-2645	165	23	asano	asano	PROPN
iajs-2645	165	24	,	,	PUNCT
iajs-2645	165	25	m.	m.	NOUN
iajs-2645	165	26	;	;	PUNCT
iajs-2645	165	27	iwakura	iwakura	PROPN
iajs-2645	165	28	,	,	PUNCT
iajs-2645	165	29	y.	y.	PROPN
iajs-2645	165	30	development	development	NOUN
iajs-2645	165	31	of	of	ADP
iajs-2645	165	32	chronic	chronic	ADJ
iajs-2645	165	33	inflammatory	inflammatory	ADJ
iajs-2645	165	34	arthropathy	arthropathy	ADJ
iajs-2645	165	35	resembling	resemble	VERB
iajs-2645	165	36	rheumatoid	rheumatoid	NOUN
iajs-2645	165	37	arthritis	arthritis	NOUN
iajs-2645	165	38	in	in	ADP
iajs-2645	165	39	interleukin	interleukin	NOUN
iajs-2645	165	40	1	1	NUM
iajs-2645	165	41	receptor	receptor	NOUN
iajs-2645	165	42	antagonist	antagonist	NOUN
iajs-2645	165	43	-	-	PUNCT
iajs-2645	165	44	deficient	deficient	ADJ
iajs-2645	165	45	mice	mouse	NOUN
iajs-2645	165	46	.	.	PUNCT
iajs-2645	166	1	j.	j.	PROPN
iajs-2645	166	2	exp	exp	PROPN
iajs-2645	166	3	.	.	PROPN
iajs-2645	166	4	med	med	PROPN
iajs-2645	166	5	.	.	PUNCT
iajs-2645	167	1	2000	2000	NUM
iajs-2645	167	2	191	191	NUM
iajs-2645	167	3	,	,	PUNCT
iajs-2645	167	4	313	313	NUM
iajs-2645	167	5	.	.	NOUN
iajs-2645	168	1	7	7	NUM
iajs-2645	168	2	.	.	X
iajs-2645	168	3	yang	yang	PROPN
iajs-2645	168	4	,	,	PUNCT
iajs-2645	168	5	y.	y.	PROPN
iajs-2645	168	6	;	;	PUNCT
iajs-2645	168	7	wang	wang	PROPN
iajs-2645	168	8	,	,	PUNCT
iajs-2645	168	9	h.	h.	PROPN
iajs-2645	168	10	;	;	PUNCT
iajs-2645	168	11	kouadir	kouadir	PROPN
iajs-2645	168	12	,	,	PUNCT
iajs-2645	168	13	m.	m.	NOUN
iajs-2645	168	14	;	;	PUNCT
iajs-2645	168	15	song	song	NOUN
iajs-2645	168	16	,	,	PUNCT
iajs-2645	168	17	h.	h.	PROPN
iajs-2645	168	18	;	;	PUNCT
iajs-2645	168	19	shi	shi	PROPN
iajs-2645	168	20	,	,	PUNCT
iajs-2645	169	1	f.	f.	PROPN
iajs-2645	169	2	recent	recent	ADJ
iajs-2645	169	3	advances	advance	NOUN
iajs-2645	169	4	in	in	ADP
iajs-2645	169	5	the	the	DET
iajs-2645	169	6	mechanisms	mechanism	NOUN
iajs-2645	169	7	of	of	ADP
iajs-2645	169	8	nlrp3	nlrp3	NOUN
iajs-2645	169	9	inflammasome	inflammasome	NOUN
iajs-2645	169	10	activation	activation	NOUN
iajs-2645	169	11	and	and	CCONJ
iajs-2645	169	12	its	its	PRON
iajs-2645	169	13	inhibitors	inhibitor	NOUN
iajs-2645	169	14	.	.	PUNCT
iajs-2645	170	1	cell	cell	NOUN
iajs-2645	170	2	death	death	NOUN
iajs-2645	171	1	dis	dis	PROPN
iajs-2645	171	2	.	.	PUNCT
iajs-2645	172	1	2019	2019	NUM
iajs-2645	172	2	10	10	NUM
iajs-2645	172	3	,	,	PUNCT
iajs-2645	172	4	128	128	NUM
iajs-2645	172	5	.	.	NOUN
iajs-2645	172	6	8	8	NUM
iajs-2645	172	7	.	.	X
iajs-2645	173	1	shaw	shaw	PROPN
iajs-2645	173	2	,	,	PUNCT
iajs-2645	173	3	p.j	p.j	PROPN
iajs-2645	173	4	.	.	PROPN
iajs-2645	173	5	;	;	PUNCT
iajs-2645	173	6	mcdermott	mcdermott	PROPN
iajs-2645	173	7	,	,	PUNCT
iajs-2645	173	8	m.f	m.f	PROPN
iajs-2645	173	9	.	.	PUNCT
iajs-2645	173	10	;	;	PUNCT
iajs-2645	173	11	kanneganti	kanneganti	X
iajs-2645	173	12	,	,	PUNCT
iajs-2645	173	13	t.d	t.d	PROPN
iajs-2645	173	14	.	.	NOUN
iajs-2645	173	15	inflammasomes	inflammasome	NOUN
iajs-2645	173	16	and	and	CCONJ
iajs-2645	173	17	autoimmunity	autoimmunity	NOUN
iajs-2645	173	18	.	.	PUNCT
iajs-2645	174	1	trends	trend	NOUN
iajs-2645	174	2	mol	mol	PROPN
iajs-2645	174	3	.	.	PROPN
iajs-2645	174	4	med	med	PROPN
iajs-2645	174	5	.	.	PROPN
iajs-2645	174	6	2011	2011	NUM
iajs-2645	174	7	,	,	PUNCT
iajs-2645	174	8	17	17	NUM
iajs-2645	174	9	,	,	PUNCT
iajs-2645	174	10	57	57	NUM
iajs-2645	174	11	.	.	NOUN
iajs-2645	174	12	9	9	NUM
iajs-2645	174	13	.	.	X
iajs-2645	175	1	cook	cook	NOUN
iajs-2645	175	2	,	,	PUNCT
iajs-2645	175	3	g.p	g.p	PROPN
iajs-2645	175	4	.	.	PROPN
iajs-2645	175	5	;	;	PUNCT
iajs-2645	175	6	savic	savic	PROPN
iajs-2645	175	7	,	,	PUNCT
iajs-2645	175	8	s.	s.	PROPN
iajs-2645	175	9	;	;	PUNCT
iajs-2645	175	10	wittmann	wittmann	PROPN
iajs-2645	175	11	,	,	PUNCT
iajs-2645	175	12	m.	m.	NOUN
iajs-2645	175	13	;	;	PUNCT
iajs-2645	175	14	mcdermott	mcdermott	PROPN
iajs-2645	175	15	,	,	PUNCT
iajs-2645	175	16	m.f	m.f	PROPN
iajs-2645	175	17	.	.	PUNCT
iajs-2645	176	1	the	the	DET
iajs-2645	176	2	nlrp3	nlrp3	NOUN
iajs-2645	176	3	inflammasome	inflammasome	NOUN
iajs-2645	176	4	,	,	PUNCT
iajs-2645	176	5	a	a	DET
iajs-2645	176	6	target	target	NOUN
iajs-2645	176	7	for	for	ADP
iajs-2645	176	8	therapy	therapy	NOUN
iajs-2645	176	9	in	in	ADP
iajs-2645	176	10	diverse	diverse	ADJ
iajs-2645	176	11	disease	disease	NOUN
iajs-2645	176	12	states	state	NOUN
iajs-2645	176	13	.	.	PUNCT
iajs-2645	177	1	eur	eur	PROPN
iajs-2645	177	2	.	.	PUNCT
iajs-2645	178	1	j.	j.	PROPN
iajs-2645	178	2	immunol	immunol	PROPN
iajs-2645	178	3	.	.	PUNCT
iajs-2645	179	1	2010	2010	NUM
iajs-2645	179	2	,	,	PUNCT
iajs-2645	179	3	40	40	NUM
iajs-2645	179	4	,	,	PUNCT
iajs-2645	179	5	631	631	NUM
iajs-2645	179	6	.	.	PUNCT
iajs-2645	180	1	10	10	NUM
iajs-2645	180	2	.	.	X
iajs-2645	181	1	aslam	aslam	PROPN
iajs-2645	181	2	,	,	PUNCT
iajs-2645	181	3	b.	b.	PROPN
iajs-2645	181	4	;	;	PUNCT
iajs-2645	181	5	basit	basit	PROPN
iajs-2645	181	6	,	,	PUNCT
iajs-2645	181	7	m.	m.	NOUN
iajs-2645	181	8	;	;	PUNCT
iajs-2645	181	9	nisar	nisar	PROPN
iajs-2645	181	10	,	,	PUNCT
iajs-2645	181	11	m.a	m.a	PROPN
iajs-2645	181	12	.	.	PROPN
iajs-2645	181	13	;	;	PUNCT
iajs-2645	181	14	khurshid	khurshid	PROPN
iajs-2645	181	15	,	,	PUNCT
iajs-2645	181	16	m.	m.	NOUN
iajs-2645	181	17	;	;	PUNCT
iajs-2645	181	18	rasool	rasool	PROPN
iajs-2645	181	19	,	,	PUNCT
iajs-2645	181	20	m.h	m.h	PROPN
iajs-2645	181	21	.	.	PROPN
iajs-2645	181	22	proteomics	proteomic	NOUN
iajs-2645	181	23	:	:	PUNCT
iajs-2645	181	24	technologies	technology	NOUN
iajs-2645	181	25	and	and	CCONJ
iajs-2645	181	26	their	their	PRON
iajs-2645	181	27	applications	application	NOUN
iajs-2645	181	28	.	.	PUNCT
iajs-2645	182	1	j.	j.	PROPN
iajs-2645	182	2	chromatogr	chromatogr	PROPN
iajs-2645	182	3	.	.	PUNCT
iajs-2645	183	1	sci	sci	PROPN
iajs-2645	183	2	.	.	PROPN
iajs-2645	183	3	2017	2017	NUM
iajs-2645	183	4	,	,	PUNCT
iajs-2645	183	5	55	55	NUM
iajs-2645	183	6	,	,	PUNCT
iajs-2645	183	7	182	182	NUM
iajs-2645	183	8	.	.	NOUN
iajs-2645	183	9	11	11	NUM
iajs-2645	183	10	.	.	X
iajs-2645	184	1	volta	volta	NOUN
iajs-2645	184	2	,	,	PUNCT
iajs-2645	184	3	u.	u.	PROPN
iajs-2645	184	4	;	;	PUNCT
iajs-2645	184	5	villanacci	villanacci	PROPN
iajs-2645	184	6	,	,	PUNCT
iajs-2645	184	7	v.	v.	ADP
iajs-2645	184	8	celiac	celiac	ADJ
iajs-2645	184	9	disease	disease	NOUN
iajs-2645	184	10	:	:	PUNCT
iajs-2645	184	11	diagnostic	diagnostic	ADJ
iajs-2645	184	12	criteria	criterion	NOUN
iajs-2645	184	13	in	in	ADP
iajs-2645	184	14	progress	progress	NOUN
iajs-2645	184	15	.	.	PUNCT
iajs-2645	185	1	cell	cell	NOUN
iajs-2645	185	2	mol	mol	ADP
iajs-2645	185	3	immunol	immunol	NOUN
iajs-2645	185	4	.	.	PUNCT
iajs-2645	186	1	2011	2011	NUM
iajs-2645	186	2	,	,	PUNCT
iajs-2645	186	3	8	8	NUM
iajs-2645	186	4	,	,	PUNCT
iajs-2645	186	5	96	96	NUM
iajs-2645	186	6	.	.	NOUN
iajs-2645	186	7	12	12	NUM
iajs-2645	186	8	.	.	PUNCT
iajs-2645	187	1	livak	livak	PROPN
iajs-2645	187	2	,	,	PUNCT
iajs-2645	187	3	k.g	k.g	PROPN
iajs-2645	187	4	.	.	PROPN
iajs-2645	187	5	;	;	PUNCT
iajs-2645	187	6	schmittgen	schmittgen	PROPN
iajs-2645	187	7	,	,	PUNCT
iajs-2645	187	8	t.d	t.d	PROPN
iajs-2645	187	9	.	.	NOUN
iajs-2645	187	10	analysis	analysis	NOUN
iajs-2645	187	11	of	of	ADP
iajs-2645	187	12	relative	relative	ADJ
iajs-2645	187	13	gene	gene	NOUN
iajs-2645	187	14	expression	expression	NOUN
iajs-2645	187	15	data	datum	NOUN
iajs-2645	187	16	using	use	VERB
iajs-2645	187	17	real	real	ADJ
iajs-2645	187	18	-	-	PUNCT
iajs-2645	187	19	time	time	NOUN
iajs-2645	187	20	quantitative	quantitative	ADJ
iajs-2645	187	21	pcr	pcr	NOUN
iajs-2645	187	22	and	and	CCONJ
iajs-2645	187	23	the	the	DET
iajs-2645	187	24	2	2	NUM
iajs-2645	187	25	-	-	PUNCT
iajs-2645	187	26	delta	delta	NOUN
iajs-2645	187	27	,	,	PUNCT
iajs-2645	187	28	delta	delta	PROPN
iajs-2645	187	29	c	c	PROPN
iajs-2645	187	30	(	(	PUNCT
iajs-2645	187	31	t	t	PROPN
iajs-2645	187	32	)	)	PUNCT
iajs-2645	187	33	.	.	PUNCT
iajs-2645	188	1	methods	method	NOUN
iajs-2645	188	2	2001	2001	NUM
iajs-2645	188	3	,	,	PUNCT
iajs-2645	188	4	25	25	NUM
iajs-2645	188	5	,	,	PUNCT
iajs-2645	188	6	402	402	NUM
iajs-2645	188	7	.	.	PUNCT
iajs-2645	188	8	http://ihicps.com/	http://ihicps.com/	ADJ
iajs-2645	188	9	special	special	ADJ
iajs-2645	188	10	issue	issue	NOUN
iajs-2645	188	11	1ihicpas	1ihicpas	NUM
iajs-2645	188	12	202	202	NUM
iajs-2645	188	13	ibn	ibn	PROPN
iajs-2645	188	14	al	al	PROPN
iajs-2645	188	15	-	-	PUNCT
iajs-2645	188	16	haitham	haitham	PROPN
iajs-2645	188	17	journal	journal	PROPN
iajs-2645	188	18	for	for	ADP
iajs-2645	188	19	pure	pure	ADJ
iajs-2645	188	20	and	and	CCONJ
iajs-2645	188	21	applied	apply	VERB
iajs-2645	188	22	science	science	NOUN
iajs-2645	188	23	https://doi.org/10.30526/2021.ihicpas.2645	https://doi.org/10.30526/2021.ihicpas.2645	PROPN
iajs-2645	188	24	for	for	ADP
iajs-2645	188	25	more	more	ADJ
iajs-2645	188	26	information	information	NOUN
iajs-2645	188	27	about	about	ADP
iajs-2645	188	28	the	the	DET
iajs-2645	188	29	conference	conference	NOUN
iajs-2645	188	30	please	please	INTJ
iajs-2645	188	31	visit	visit	VERB
iajs-2645	188	32	the	the	DET
iajs-2645	188	33	websites	website	NOUN
iajs-2645	188	34	:	:	PUNCT
iajs-2645	188	35	http://ihicps.com/	http://ihicps.com/	NOUN
iajs-2645	188	36	b	b	NOUN
iajs-2645	189	1	i	i	NOUN
iajs-2645	189	2	o	o	NOUN
iajs-2645	190	1	l	l	NOUN
iajs-2645	190	2	o	o	X
iajs-2645	190	3	g	g	NOUN
iajs-2645	190	4	y	y	PROPN
iajs-2645	191	1	|	|	ADV
iajs-2645	191	2	22	22	NUM
iajs-2645	191	3	13	13	NUM
iajs-2645	191	4	.	.	PUNCT
iajs-2645	192	1	ludvigsson	ludvigsson	PROPN
iajs-2645	192	2	,	,	PUNCT
iajs-2645	192	3	j.f	j.f	PROPN
iajs-2645	192	4	.	.	PROPN
iajs-2645	192	5	;	;	PUNCT
iajs-2645	192	6	montgomery	montgomery	PROPN
iajs-2645	192	7	,	,	PUNCT
iajs-2645	192	8	s.m	s.m	PROPN
iajs-2645	192	9	.	.	PROPN
iajs-2645	192	10	;	;	PUNCT
iajs-2645	192	11	ekbom	ekbom	NOUN
iajs-2645	192	12	,	,	PUNCT
iajs-2645	192	13	a.	a.	NOUN
iajs-2645	192	14	;	;	PUNCT
iajs-2645	192	15	brandt	brandt	PROPN
iajs-2645	192	16	,	,	PUNCT
iajs-2645	192	17	l.	l.	PROPN
iajs-2645	192	18	;	;	PUNCT
iajs-2645	192	19	granath	granath	PROPN
iajs-2645	192	20	,	,	PUNCT
iajs-2645	192	21	f.	f.	PROPN
iajs-2645	192	22	small	small	ADJ
iajs-2645	192	23	-	-	PUNCT
iajs-2645	192	24	intestinal	intestinal	ADJ
iajs-2645	192	25	histopathology	histopathology	NOUN
iajs-2645	192	26	and	and	CCONJ
iajs-2645	192	27	mortality	mortality	NOUN
iajs-2645	192	28	risk	risk	NOUN
iajs-2645	192	29	in	in	ADP
iajs-2645	192	30	celiac	celiac	ADJ
iajs-2645	192	31	disease	disease	NOUN
iajs-2645	192	32	.	.	PUNCT
iajs-2645	193	1	jama	jama	PROPN
iajs-2645	193	2	2009	2009	NUM
iajs-2645	193	3	,	,	PUNCT
iajs-2645	193	4	302	302	NUM
iajs-2645	193	5	,	,	PUNCT
iajs-2645	193	6	1171	1171	NUM
iajs-2645	193	7	.	.	PUNCT
iajs-2645	194	1	14	14	NUM
iajs-2645	194	2	.	.	PUNCT
iajs-2645	195	1	vilppula	vilppula	PROPN
iajs-2645	195	2	,	,	PUNCT
iajs-2645	195	3	a.	a.	NOUN
iajs-2645	195	4	;	;	PUNCT
iajs-2645	195	5	kaukinen	kaukinen	PROPN
iajs-2645	195	6	,	,	PUNCT
iajs-2645	195	7	k.	k.	PROPN
iajs-2645	195	8	;	;	PUNCT
iajs-2645	195	9	luostarinen	luostarinen	PROPN
iajs-2645	195	10	,	,	PUNCT
iajs-2645	195	11	l.	l.	PROPN
iajs-2645	195	12	;	;	PUNCT
iajs-2645	195	13	krekelä	krekelä	PROPN
iajs-2645	195	14	,	,	PUNCT
iajs-2645	195	15	i.	i.	PROPN
iajs-2645	195	16	;	;	PUNCT
iajs-2645	195	17	patrikainen	patrikainen	PROPN
iajs-2645	195	18	,	,	PUNCT
iajs-2645	195	19	h.	h.	PROPN
iajs-2645	195	20	;	;	PUNCT
iajs-2645	195	21	valve	valve	VERB
iajs-2645	195	22	.	.	PUNCT
iajs-2645	196	1	r.	r.	PROPN
iajs-2645	196	2	;	;	PUNCT
iajs-2645	196	3	mäki	mäki	PROPN
iajs-2645	196	4	.	.	PUNCT
iajs-2645	196	5	m.	m.	PROPN
iajs-2645	196	6	;	;	PUNCT
iajs-2645	196	7	collin	collin	PROPN
iajs-2645	196	8	,	,	PUNCT
iajs-2645	196	9	p.	p.	NOUN
iajs-2645	196	10	increasing	increase	VERB
iajs-2645	196	11	prevalence	prevalence	NOUN
iajs-2645	196	12	and	and	CCONJ
iajs-2645	196	13	high	high	ADJ
iajs-2645	196	14	incidence	incidence	NOUN
iajs-2645	196	15	of	of	ADP
iajs-2645	196	16	celiac	celiac	ADJ
iajs-2645	196	17	disease	disease	NOUN
iajs-2645	196	18	in	in	ADP
iajs-2645	196	19	elderly	elderly	ADJ
iajs-2645	196	20	people	people	NOUN
iajs-2645	196	21	:	:	PUNCT
iajs-2645	196	22	a	a	DET
iajs-2645	196	23	population	population	NOUN
iajs-2645	196	24	-	-	PUNCT
iajs-2645	196	25	based	base	VERB
iajs-2645	196	26	study	study	NOUN
iajs-2645	196	27	.	.	PUNCT
iajs-2645	197	1	bmc	bmc	PROPN
iajs-2645	197	2	gastroenterol	gastroenterol	NOUN
iajs-2645	197	3	.	.	PUNCT
iajs-2645	198	1	2009	2009	NUM
iajs-2645	198	2	,	,	PUNCT
iajs-2645	198	3	29	29	NUM
iajs-2645	198	4	,	,	PUNCT
iajs-2645	198	5	49	49	NUM
iajs-2645	198	6	.	.	PUNCT
iajs-2645	199	1	15	15	NUM
iajs-2645	199	2	.	.	PUNCT
iajs-2645	200	1	van	van	NOUN
iajs-2645	200	2	gils	gil	NOUN
iajs-2645	200	3	,	,	PUNCT
iajs-2645	200	4	t.	t.	PROPN
iajs-2645	200	5	;	;	PUNCT
iajs-2645	200	6	nijeboer	nijeboer	PROPN
iajs-2645	200	7	,	,	PUNCT
iajs-2645	200	8	p.	p.	PROPN
iajs-2645	200	9	;	;	PUNCT
iajs-2645	200	10	hein	hein	PROPN
iajs-2645	200	11	,	,	PUNCT
iajs-2645	200	12	g.	g.	PROPN
iajs-2645	200	13	;	;	PUNCT
iajs-2645	200	14	waesberghe	waesberghe	ADJ
iajs-2645	200	15	,	,	PUNCT
iajs-2645	200	16	t.v	t.v	PROPN
iajs-2645	200	17	.	.	PROPN
iajs-2645	200	18	splenic	splenic	PROPN
iajs-2645	200	19	volume	volume	NOUN
iajs-2645	200	20	differentiates	differentiate	NOUN
iajs-2645	200	21	complicated	complicated	ADJ
iajs-2645	200	22	and	and	CCONJ
iajs-2645	200	23	non	non	ADJ
iajs-2645	200	24	-	-	ADJ
iajs-2645	200	25	complicated	complicated	ADJ
iajs-2645	200	26	celiac	celiac	ADJ
iajs-2645	200	27	disease	disease	NOUN
iajs-2645	200	28	2016	2016	NUM
iajs-2645	200	29	https://doi.org/10.1177	https://doi.org/10.1177	ADJ
iajs-2645	200	30	%	%	NOUN
iajs-2645	200	31	2f2050640	2f2050640	NUM
iajs-2645	200	32	616663571	616663571	NUM
iajs-2645	200	33	.	.	PUNCT
iajs-2645	201	1	16	16	NUM
iajs-2645	201	2	.	.	PUNCT
iajs-2645	202	1	bai	bai	PROPN
iajs-2645	202	2	,	,	PUNCT
iajs-2645	202	3	d.	d.	PROPN
iajs-2645	202	4	effect	effect	NOUN
iajs-2645	202	5	of	of	ADP
iajs-2645	202	6	gender	gender	NOUN
iajs-2645	202	7	on	on	ADP
iajs-2645	202	8	the	the	DET
iajs-2645	202	9	manifestations	manifestation	NOUN
iajs-2645	202	10	of	of	ADP
iajs-2645	202	11	celiac	celiac	ADJ
iajs-2645	202	12	disease	disease	NOUN
iajs-2645	202	13	:	:	PUNCT
iajs-2645	202	14	evidence	evidence	NOUN
iajs-2645	202	15	for	for	ADP
iajs-2645	202	16	greater	great	ADJ
iajs-2645	202	17	malabsorption	malabsorption	NOUN
iajs-2645	202	18	in	in	ADP
iajs-2645	202	19	men	man	NOUN
iajs-2645	202	20	scandinavian	scandinavian	NOUN
iajs-2645	202	21	.	.	PUNCT
iajs-2645	203	1	j.	j.	PROPN
iajs-2645	203	2	gastroenterol	gastroenterol	PROPN
iajs-2645	203	3	.	.	PUNCT
iajs-2645	204	1	2005	2005	NUM
iajs-2645	204	2	,	,	PUNCT
iajs-2645	204	3	40	40	NUM
iajs-2645	204	4	,	,	PUNCT
iajs-2645	204	5	183	183	NUM
iajs-2645	204	6	.	.	PUNCT
iajs-2645	205	1	17	17	NUM
iajs-2645	205	2	.	.	PUNCT
iajs-2645	206	1	quintero	quintero	PROPN
iajs-2645	206	2	,	,	PUNCT
iajs-2645	206	3	o.l	o.l	PROPN
iajs-2645	206	4	.	.	PROPN
iajs-2645	206	5	author	author	PROPN
iajs-2645	206	6	's	's	PART
iajs-2645	206	7	personal	personal	ADJ
iajs-2645	206	8	copy	copy	NOUN
iajs-2645	206	9	autoimmune	autoimmune	ADJ
iajs-2645	206	10	disease	disease	NOUN
iajs-2645	206	11	and	and	CCONJ
iajs-2645	206	12	gender	gender	NOUN
iajs-2645	206	13	:	:	PUNCT
iajs-2645	206	14	plausible	plausible	ADJ
iajs-2645	206	15	mechanisms	mechanism	NOUN
iajs-2645	206	16	for	for	ADP
iajs-2645	206	17	the	the	DET
iajs-2645	206	18	female	female	ADJ
iajs-2645	206	19	predominance	predominance	NOUN
iajs-2645	206	20	of	of	ADP
iajs-2645	206	21	autoimmunity	autoimmunity	NOUN
iajs-2645	206	22	.	.	PUNCT
iajs-2645	207	1	j.	j.	PROPN
iajs-2645	207	2	autoimmun	autoimmun	PROPN
iajs-2645	207	3	.	.	PUNCT
iajs-2645	208	1	2012	2012	NUM
iajs-2645	208	2	,	,	PUNCT
iajs-2645	208	3	38	38	NUM
iajs-2645	208	4	,	,	PUNCT
iajs-2645	208	5	j109	j109	NUM
iajs-2645	208	6	.	.	PUNCT
iajs-2645	209	1	18	18	NUM
iajs-2645	209	2	.	.	X
iajs-2645	209	3	tajuddin	tajuddin	NOUN
iajs-2645	209	4	,	,	PUNCT
iajs-2645	209	5	t.	t.	PROPN
iajs-2645	209	6	;	;	PUNCT
iajs-2645	209	7	razif	razif	NOUN
iajs-2645	209	8	,	,	PUNCT
iajs-2645	209	9	s.	s.	PROPN
iajs-2645	209	10	;	;	PUNCT
iajs-2645	209	11	thorne	thorne	PROPN
iajs-2645	209	12	,	,	PUNCT
iajs-2645	209	13	j.	j.	PROPN
iajs-2645	209	14	;	;	PUNCT
iajs-2645	209	15	murray	murray	PROPN
iajs-2645	209	16	,	,	PUNCT
iajs-2645	209	17	f.e	f.e	PROPN
iajs-2645	209	18	.	.	PROPN
iajs-2645	209	19	clinical	clinical	ADJ
iajs-2645	209	20	presentation	presentation	NOUN
iajs-2645	209	21	of	of	ADP
iajs-2645	209	22	adult	adult	NOUN
iajs-2645	209	23	coeliac	coeliac	NOUN
iajs-2645	209	24	disease	disease	NOUN
iajs-2645	209	25	.	.	PUNCT
iajs-2645	210	1	irish	irish	PROPN
iajs-2645	210	2	med	med	PROPN
iajs-2645	210	3	.	.	PUNCT
iajs-2645	211	1	j.	j.	PROPN
iajs-2645	211	2	2011	2011	NUM
iajs-2645	211	3	,	,	PUNCT
iajs-2645	211	4	18	18	NUM
iajs-2645	211	5	,	,	PUNCT
iajs-2645	211	6	30	30	NUM
iajs-2645	211	7	.	.	NOUN
iajs-2645	211	8	19	19	NUM
iajs-2645	211	9	.	.	PUNCT
iajs-2645	211	10	siddh	siddh	PROPN
iajs-2645	211	11	,	,	PUNCT
iajs-2645	211	12	l.	l.	PROPN
iajs-2645	211	13	;	;	PUNCT
iajs-2645	211	14	sengar	sengar	NOUN
iajs-2645	211	15	,	,	PUNCT
iajs-2645	211	16	g.s	g.s	PROPN
iajs-2645	211	17	.	.	PROPN
iajs-2645	211	18	;	;	PUNCT
iajs-2645	211	19	nagraj	nagraj	ADJ
iajs-2645	211	20	,	,	PUNCT
iajs-2645	211	21	n.	n.	PROPN
iajs-2645	211	22	;	;	PUNCT
iajs-2645	211	23	shyam	shyam	PROPN
iajs-2645	211	24	,	,	PUNCT
iajs-2645	211	25	r.	r.	PROPN
iajs-2645	211	26	;	;	PUNCT
iajs-2645	211	27	garg	garg	NOUN
iajs-2645	211	28	,	,	PUNCT
iajs-2645	211	29	p.	p.	NOUN
iajs-2645	211	30	body	body	NOUN
iajs-2645	211	31	mass	mass	PROPN
iajs-2645	211	32	index	index	NOUN
iajs-2645	211	33	in	in	ADP
iajs-2645	211	34	celiac	celiac	ADJ
iajs-2645	211	35	disease	disease	NOUN
iajs-2645	211	36	and	and	CCONJ
iajs-2645	211	37	effect	effect	NOUN
iajs-2645	211	38	of	of	ADP
iajs-2645	211	39	a	a	DET
iajs-2645	211	40	gluten	gluten	ADJ
iajs-2645	211	41	-	-	PUNCT
iajs-2645	211	42	free	free	ADJ
iajs-2645	211	43	diet	diet	NOUN
iajs-2645	211	44	on	on	ADP
iajs-2645	211	45	body	body	NOUN
iajs-2645	211	46	mass	mass	PROPN
iajs-2645	211	47	index	index	NOUN
iajs-2645	211	48	.	.	PUNCT
iajs-2645	212	1	home	home	NOUN
iajs-2645	212	2	2016	2016	NUM
iajs-2645	212	3	,	,	PUNCT
iajs-2645	212	4	4	4	NUM
iajs-2645	212	5	,	,	PUNCT
iajs-2645	212	6	20	20	NUM
iajs-2645	212	7	.	.	NOUN
iajs-2645	212	8	20	20	NUM
iajs-2645	212	9	.	.	PUNCT
iajs-2645	213	1	dehghani	dehghani	PROPN
iajs-2645	213	2	,	,	PUNCT
iajs-2645	213	3	s.m	s.m	PROPN
iajs-2645	213	4	.	.	PROPN
iajs-2645	213	5	prevalence	prevalence	NOUN
iajs-2645	213	6	of	of	ADP
iajs-2645	213	7	celiac	celiac	ADJ
iajs-2645	213	8	disease	disease	NOUN
iajs-2645	213	9	in	in	ADP
iajs-2645	213	10	healthy	healthy	ADJ
iajs-2645	213	11	iranian	iranian	ADJ
iajs-2645	213	12	school	school	NOUN
iajs-2645	213	13	children	child	NOUN
iajs-2645	213	14	.	.	PUNCT
iajs-2645	214	1	ann	ann	PROPN
iajs-2645	214	2	.	.	PUNCT
iajs-2645	215	1	saudi	saudi	PROPN
iajs-2645	215	2	med	med	PROPN
iajs-2645	215	3	.	.	PROPN
iajs-2645	216	1	2018	2018	NUM
iajs-2645	216	2	,	,	PUNCT
iajs-2645	216	3	33	33	NUM
iajs-2645	216	4	,	,	PUNCT
iajs-2645	216	5	159	159	NUM
iajs-2645	216	6	.	.	X
iajs-2645	217	1	21	21	NUM
iajs-2645	217	2	.	.	X
iajs-2645	217	3	meazza	meazza	PROPN
iajs-2645	217	4	,	,	PUNCT
iajs-2645	217	5	c.	c.	PROPN
iajs-2645	217	6	;	;	PUNCT
iajs-2645	217	7	pagani	pagani	PROPN
iajs-2645	217	8	,	,	PUNCT
iajs-2645	217	9	s.	s.	PROPN
iajs-2645	217	10	;	;	PUNCT
iajs-2645	217	11	diletta	diletta	PROPN
iajs-2645	217	12	,	,	PUNCT
iajs-2645	217	13	g.	g.	PROPN
iajs-2645	217	14	;	;	PUNCT
iajs-2645	217	15	laarej	laarej	PROPN
iajs-2645	217	16	.	.	PUNCT
iajs-2645	217	17	,	,	PUNCT
iajs-2645	217	18	k.	k.	PROPN
iajs-2645	217	19	growth	growth	PROPN
iajs-2645	217	20	retardation	retardation	NOUN
iajs-2645	217	21	in	in	ADP
iajs-2645	217	22	children	child	NOUN
iajs-2645	217	23	with	with	ADP
iajs-2645	217	24	celiac	celiac	ADJ
iajs-2645	217	25	disease	disease	NOUN
iajs-2645	217	26	.	.	PUNCT
iajs-2645	218	1	curr.ped	curr.ped	X
iajs-2645	218	2	.	.	PUNCT
iajs-2645	219	1	rev	rev	PROPN
iajs-2645	219	2	.	.	PROPN
iajs-2645	219	3	2008	2008	NUM
iajs-2645	219	4	,	,	PUNCT
iajs-2645	219	5	4	4	NUM
iajs-2645	219	6	,	,	PUNCT
iajs-2645	219	7	174	174	NUM
iajs-2645	219	8	.	.	PUNCT
iajs-2645	220	1	22	22	NUM
iajs-2645	220	2	.	.	PUNCT
iajs-2645	221	1	van	van	PROPN
iajs-2645	221	2	der	der	ADJ
iajs-2645	221	3	pals	pal	NOUN
iajs-2645	221	4	,	,	PUNCT
iajs-2645	221	5	m.	m.	NOUN
iajs-2645	221	6	;	;	PUNCT
iajs-2645	221	7	myléus	myléus	NOUN
iajs-2645	221	8	,	,	PUNCT
iajs-2645	221	9	a.	a.	NOUN
iajs-2645	221	10	;	;	PUNCT
iajs-2645	221	11	norström	norström	PROPN
iajs-2645	221	12	,	,	PUNCT
iajs-2645	221	13	f.	f.	PROPN
iajs-2645	221	14	;	;	PUNCT
iajs-2645	221	15	hammarroth	hammarroth	PROPN
iajs-2645	221	16	,	,	PUNCT
iajs-2645	221	17	s.	s.	PROPN
iajs-2645	221	18	;	;	PUNCT
iajs-2645	221	19	högberg	högberg	PROPN
iajs-2645	221	20	,	,	PUNCT
iajs-2645	221	21	l.	l.	PROPN
iajs-2645	221	22	;	;	PUNCT
iajs-2645	221	23	rosén	rosén	NOUN
iajs-2645	221	24	,	,	PUNCT
iajs-2645	221	25	a.	a.	NOUN
iajs-2645	221	26	;	;	PUNCT
iajs-2645	221	27	ivarsson	ivarsson	PROPN
iajs-2645	221	28	,	,	PUNCT
iajs-2645	221	29	a.	a.	PROPN
iajs-2645	221	30	;	;	PUNCT
iajs-2645	221	31	carlsson	carlsson	PROPN
iajs-2645	221	32	,	,	PUNCT
iajs-2645	221	33	a.	a.	NOUN
iajs-2645	221	34	body	body	PROPN
iajs-2645	221	35	mass	mass	PROPN
iajs-2645	221	36	index	index	NOUN
iajs-2645	221	37	is	be	AUX
iajs-2645	221	38	not	not	PART
iajs-2645	221	39	a	a	DET
iajs-2645	221	40	reliable	reliable	ADJ
iajs-2645	221	41	tool	tool	NOUN
iajs-2645	221	42	in	in	ADP
iajs-2645	221	43	predicting	predict	VERB
iajs-2645	221	44	celiac	celiac	ADJ
iajs-2645	221	45	disease	disease	NOUN
iajs-2645	221	46	in	in	ADP
iajs-2645	221	47	children	child	NOUN
iajs-2645	221	48	.	.	PUNCT
iajs-2645	222	1	bmc	bmc	ADJ
iajs-2645	222	2	pediatr	pediatr	NOUN
iajs-2645	222	3	.	.	PUNCT
iajs-2645	222	4	2014	2014	NUM
iajs-2645	222	5	,	,	PUNCT
iajs-2645	222	6	14	14	NUM
iajs-2645	222	7	,	,	PUNCT
iajs-2645	222	8	165	165	NUM
iajs-2645	222	9	.	.	NOUN
iajs-2645	222	10	23	23	NUM
iajs-2645	222	11	.	.	PUNCT
iajs-2645	223	1	osman	osman	PROPN
iajs-2645	223	2	,	,	PUNCT
iajs-2645	223	3	m.	m.	NOUN
iajs-2645	223	4	;	;	PUNCT
iajs-2645	223	5	taha	taha	PROPN
iajs-2645	223	6	,	,	PUNCT
iajs-2645	223	7	b.	b.	PROPN
iajs-2645	223	8	;	;	PUNCT
iajs-2645	223	9	al	al	PROPN
iajs-2645	223	10	-	-	PUNCT
iajs-2645	223	11	duboni	duboni	PROPN
iajs-2645	223	12	,	,	PUNCT
iajs-2645	223	13	g.	g.	PROPN
iajs-2645	223	14	assessment	assessment	NOUN
iajs-2645	223	15	of	of	ADP
iajs-2645	223	16	the	the	DET
iajs-2645	223	17	response	response	NOUN
iajs-2645	223	18	to	to	ADP
iajs-2645	223	19	gluten	gluten	VERB
iajs-2645	223	20	-	-	PUNCT
iajs-2645	223	21	free	free	ADJ
iajs-2645	223	22	diet	diet	NOUN
iajs-2645	223	23	in	in	ADP
iajs-2645	223	24	an	an	DET
iajs-2645	223	25	iraqi	iraqi	ADJ
iajs-2645	223	26	population	population	NOUN
iajs-2645	223	27	with	with	ADP
iajs-2645	223	28	coeliac	coeliac	NOUN
iajs-2645	223	29	disease	disease	NOUN
iajs-2645	223	30	.	.	PUNCT
iajs-2645	224	1	a	a	DET
iajs-2645	224	2	histological	histological	ADJ
iajs-2645	224	3	and	and	CCONJ
iajs-2645	224	4	serological	serological	ADJ
iajs-2645	224	5	follow	follow	NOUN
iajs-2645	224	6	-	-	PUNCT
iajs-2645	224	7	up	up	ADP
iajs-2645	224	8	study	study	NOUN
iajs-2645	224	9	.	.	PUNCT
iajs-2645	225	1	arch	arch	PROPN
iajs-2645	225	2	.	.	PUNCT
iajs-2645	226	1	med	med	PROPN
iajs-2645	226	2	sci	sci	PROPN
iajs-2645	226	3	.	.	PROPN
iajs-2645	226	4	2014	2014	NUM
iajs-2645	226	5	,	,	PUNCT
iajs-2645	226	6	10	10	NUM
iajs-2645	226	7	,	,	PUNCT
iajs-2645	226	8	294	294	NUM
iajs-2645	226	9	.	.	X
iajs-2645	227	1	24	24	NUM
iajs-2645	227	2	.	.	PUNCT
iajs-2645	227	3	bekdas	bekda	NOUN
iajs-2645	227	4	,	,	PUNCT
iajs-2645	227	5	m.	m.	NOUN
iajs-2645	227	6	investigation	investigation	NOUN
iajs-2645	227	7	of	of	ADP
iajs-2645	227	8	celiac	celiac	ADJ
iajs-2645	227	9	disease	disease	NOUN
iajs-2645	227	10	according	accord	VERB
iajs-2645	227	11	to	to	ADP
iajs-2645	227	12	marsh	marsh	ADJ
iajs-2645	227	13	classification	classification	NOUN
iajs-2645	227	14	in	in	ADP
iajs-2645	227	15	childhood	childhood	NOUN
iajs-2645	227	16	.	.	PUNCT
iajs-2645	228	1	bangladesh	bangladesh	PROPN
iajs-2645	228	2	j.	j.	PROPN
iajs-2645	228	3	med	med	PROPN
iajs-2645	228	4	.	.	PUNCT
iajs-2645	229	1	sci	sci	PROPN
iajs-2645	229	2	.	.	PROPN
iajs-2645	229	3	2017	2017	NUM
iajs-2645	229	4	,	,	PUNCT
iajs-2645	229	5	16	16	NUM
iajs-2645	229	6	,	,	PUNCT
iajs-2645	229	7	259	259	NUM
iajs-2645	229	8	.	.	NOUN
iajs-2645	229	9	25	25	NUM
iajs-2645	229	10	.	.	X
iajs-2645	229	11	dipper	dipper	NOUN
iajs-2645	229	12	,	,	PUNCT
iajs-2645	229	13	c.	c.	PROPN
iajs-2645	229	14	;	;	PUNCT
iajs-2645	229	15	maitra	maitra	PROPN
iajs-2645	229	16	,	,	PUNCT
iajs-2645	229	17	s.	s.	PROPN
iajs-2645	229	18	;	;	PUNCT
iajs-2645	229	19	andrew	andrew	PROPN
iajs-2645	229	20	,	,	PUNCT
iajs-2645	229	21	c.	c.	PROPN
iajs-2645	229	22	;	;	PUNCT
iajs-2645	229	23	thomas	thomas	PROPN
iajs-2645	229	24	,	,	PUNCT
iajs-2645	229	25	l.r	l.r	PROPN
iajs-2645	229	26	.	.	PUNCT
iajs-2645	229	27	anti	anti	ADJ
iajs-2645	229	28	-	-	ADJ
iajs-2645	229	29	tissue	tissue	ADJ
iajs-2645	229	30	transglutaminase	transglutaminase	NOUN
iajs-2645	229	31	antibodies	antibodie	VERB
iajs-2645	229	32	in	in	ADP
iajs-2645	229	33	the	the	DET
iajs-2645	229	34	follow	follow	NOUN
iajs-2645	229	35	-	-	PUNCT
iajs-2645	229	36	up	up	NOUN
iajs-2645	229	37	of	of	ADP
iajs-2645	229	38	adult	adult	NOUN
iajs-2645	229	39	coeliac	coeliac	NOUN
iajs-2645	229	40	disease	disease	NOUN
iajs-2645	229	41	.	.	PUNCT
iajs-2645	230	1	aliment	aliment	NOUN
iajs-2645	230	2	.	.	PUNCT
iajs-2645	231	1	pharmacol	pharmacol	PROPN
iajs-2645	231	2	.	.	PUNCT
iajs-2645	232	1	therap	therap	NOUN
iajs-2645	232	2	.	.	PUNCT
iajs-2645	233	1	2009	2009	NUM
iajs-2645	233	2	,	,	PUNCT
iajs-2645	233	3	30	30	NUM
iajs-2645	233	4	,	,	PUNCT
iajs-2645	233	5	236	236	NUM
iajs-2645	233	6	.	.	NOUN
iajs-2645	233	7	26	26	NUM
iajs-2645	233	8	.	.	PUNCT
iajs-2645	234	1	hopper	hopper	NOUN
iajs-2645	234	2	,	,	PUNCT
iajs-2645	234	3	a.d	a.d	PROPN
iajs-2645	234	4	.	.	PROPN
iajs-2645	234	5	;	;	PUNCT
iajs-2645	234	6	hadjivassiliou	hadjivassiliou	NOUN
iajs-2645	234	7	,	,	PUNCT
iajs-2645	234	8	m.	m.	NOUN
iajs-2645	234	9	;	;	PUNCT
iajs-2645	234	10	hurlstone	hurlstone	PROPN
iajs-2645	234	11	,	,	PUNCT
iajs-2645	234	12	d.p	d.p	PROPN
iajs-2645	234	13	.	.	PROPN
iajs-2645	234	14	lobo	lobo	PROPN
iajs-2645	234	15	,	,	PUNCT
iajs-2645	234	16	a.g	a.g	PROPN
iajs-2645	234	17	.	.	PROPN
iajs-2645	234	18	;	;	PUNCT
iajs-2645	234	19	mcalindon	mcalindon	ADJ
iajs-2645	234	20	,	,	PUNCT
iajs-2645	234	21	m.e	m.e	PROPN
iajs-2645	234	22	.	.	PROPN
iajs-2645	234	23	;	;	PUNCT
iajs-2645	234	24	egner	egner	NOUN
iajs-2645	234	25	.	.	PUNCT
iajs-2645	235	1	w.	w.	PROPN
iajs-2645	235	2	;	;	PUNCT
iajs-2645	235	3	wild	wild	PROPN
iajs-2645	235	4	,	,	PUNCT
iajs-2645	235	5	g.	g.	PROPN
iajs-2645	235	6	;	;	PUNCT
iajs-2645	235	7	sanders	sanders	PROPN
iajs-2645	235	8	.	.	PUNCT
iajs-2645	236	1	d.s	d.s	PROPN
iajs-2645	236	2	.	.	PUNCT
iajs-2645	237	1	what	what	PRON
iajs-2645	237	2	is	be	AUX
iajs-2645	237	3	the	the	DET
iajs-2645	237	4	role	role	NOUN
iajs-2645	237	5	of	of	ADP
iajs-2645	237	6	serologic	serologic	ADJ
iajs-2645	237	7	testing	testing	NOUN
iajs-2645	237	8	in	in	ADP
iajs-2645	237	9	celiac	celiac	ADJ
iajs-2645	237	10	disease	disease	NOUN
iajs-2645	237	11	?	?	PUNCT
iajs-2645	238	1	a	a	DET
iajs-2645	238	2	prospective	prospective	ADJ
iajs-2645	238	3	,	,	PUNCT
iajs-2645	238	4	biopsy	biopsy	NOUN
iajs-2645	238	5	-	-	PUNCT
iajs-2645	238	6	confirmed	confirm	VERB
iajs-2645	238	7	study	study	NOUN
iajs-2645	238	8	with	with	ADP
iajs-2645	238	9	economic	economic	ADJ
iajs-2645	238	10	analysis	analysis	NOUN
iajs-2645	238	11	.	.	PUNCT
iajs-2645	239	1	clin	clin	PROPN
iajs-2645	239	2	.	.	PUNCT
iajs-2645	239	3	gastroenterol	gastroenterol	PROPN
iajs-2645	239	4	.	.	PUNCT
iajs-2645	240	1	hepatol	hepatol	ADJ
iajs-2645	240	2	.	.	PUNCT
iajs-2645	241	1	2008	2008	NUM
iajs-2645	241	2	,	,	PUNCT
iajs-2645	241	3	6	6	NUM
iajs-2645	241	4	,	,	PUNCT
iajs-2645	241	5	314	314	NUM
iajs-2645	241	6	.	.	PUNCT
iajs-2645	242	1	27	27	NUM
iajs-2645	242	2	.	.	PUNCT
iajs-2645	243	1	al	al	PROPN
iajs-2645	243	2	-	-	PUNCT
iajs-2645	243	3	kazraji	kazraji	PROPN
iajs-2645	243	4	,	,	PUNCT
iajs-2645	243	5	k.	k.	PROPN
iajs-2645	243	6	celiac	celiac	PROPN
iajs-2645	243	7	disease	disease	PROPN
iajs-2645	243	8	:	:	PUNCT
iajs-2645	243	9	presentation	presentation	NOUN
iajs-2645	243	10	with	with	ADP
iajs-2645	243	11	clinical	clinical	ADJ
iajs-2645	243	12	and	and	CCONJ
iajs-2645	243	13	serological	serological	ADJ
iajs-2645	243	14	response	response	NOUN
iajs-2645	243	15	.	.	PUNCT
iajs-2645	244	1	med	med	PROPN
iajs-2645	244	2	.	.	PUNCT
iajs-2645	245	1	j.	j.	PROPN
iajs-2645	245	2	tikrit	tikrit	PROPN
iajs-2645	245	3	university	university	PROPN
iajs-2645	245	4	2009	2009	NUM
iajs-2645	245	5	,	,	PUNCT
iajs-2645	245	6	2	2	NUM
iajs-2645	245	7	,	,	PUNCT
iajs-2645	245	8	145	145	NUM
iajs-2645	245	9	.	.	PUNCT
iajs-2645	245	10	28	28	NUM
iajs-2645	245	11	.	.	PUNCT
iajs-2645	246	1	benson	benson	PROPN
iajs-2645	246	2	,	,	PUNCT
iajs-2645	246	3	b.c	b.c	PROPN
iajs-2645	246	4	.	.	PROPN
iajs-2645	246	5	;	;	PUNCT
iajs-2645	246	6	mulder	mulder	PROPN
iajs-2645	246	7	,	,	PUNCT
iajs-2645	246	8	c.j	c.j	PROPN
iajs-2645	246	9	.	.	PROPN
iajs-2645	246	10	;	;	PUNCT
iajs-2645	246	11	laczek	laczek	PROPN
iajs-2645	246	12	,	,	PUNCT
iajs-2645	246	13	j.t	j.t	PROPN
iajs-2645	246	14	.	.	PROPN
iajs-2645	246	15	anti	anti	ADJ
iajs-2645	246	16	-	-	ADJ
iajs-2645	246	17	gliadin	gliadin	ADJ
iajs-2645	246	18	antibodies	antibody	NOUN
iajs-2645	246	19	identify	identify	VERB
iajs-2645	246	20	celiac	celiac	ADJ
iajs-2645	246	21	patients	patient	NOUN
iajs-2645	246	22	overlooked	overlook	VERB
iajs-2645	246	23	by	by	ADP
iajs-2645	246	24	tissue	tissue	NOUN
iajs-2645	246	25	transglutaminase	transglutaminase	NOUN
iajs-2645	246	26	antibodies	antibodie	VERB
iajs-2645	246	27	hawaii	hawaii	PROPN
iajs-2645	246	28	.	.	PUNCT
iajs-2645	247	1	j.	j.	PROPN
iajs-2645	247	2	med	med	PROPN
iajs-2645	247	3	.	.	PUNCT
iajs-2645	248	1	public	public	ADJ
iajs-2645	248	2	health	health	NOUN
iajs-2645	248	3	2013	2013	NUM
iajs-2645	248	4	,	,	PUNCT
iajs-2645	248	5	72	72	NUM
iajs-2645	248	6	,	,	PUNCT
iajs-2645	248	7	14	14	NUM
iajs-2645	248	8	.	.	NOUN
iajs-2645	248	9	29	29	NUM
iajs-2645	248	10	.	.	PUNCT
iajs-2645	249	1	aldaghi	aldaghi	PROPN
iajs-2645	249	2	,	,	PUNCT
iajs-2645	249	3	m.a	m.a	PROPN
iajs-2645	249	4	.	.	PROPN
iajs-2645	249	5	evaluation	evaluation	NOUN
iajs-2645	249	6	of	of	ADP
iajs-2645	249	7	the	the	DET
iajs-2645	249	8	correlation	correlation	NOUN
iajs-2645	249	9	between	between	ADP
iajs-2645	249	10	ttg	ttg	PROPN
iajs-2645	249	11	-	-	PUNCT
iajs-2645	249	12	iga	iga	PROPN
iajs-2645	249	13	titer	titer	NOUN
iajs-2645	249	14	and	and	CCONJ
iajs-2645	249	15	duodenal	duodenal	ADJ
iajs-2645	249	16	biopsy	biopsy	NOUN
iajs-2645	249	17	findings	finding	NOUN
iajs-2645	249	18	in	in	ADP
iajs-2645	249	19	children	child	NOUN
iajs-2645	249	20	with	with	ADP
iajs-2645	249	21	suspected	suspect	VERB
iajs-2645	249	22	celiac	celiac	ADJ
iajs-2645	249	23	disease	disease	NOUN
iajs-2645	249	24	.	.	PUNCT
iajs-2645	250	1	iranian	iranian	PROPN
iajs-2645	250	2	j.	j.	PROPN
iajs-2645	250	3	pediatr	pediatr	PROPN
iajs-2645	250	4	.	.	PUNCT
iajs-2645	250	5	2016	2016	NUM
iajs-2645	250	6	,	,	PUNCT
iajs-2645	250	7	26	26	NUM
iajs-2645	250	8	,	,	PUNCT
iajs-2645	250	9	1	1	NUM
iajs-2645	250	10	.	.	SYM
iajs-2645	250	11	30	30	NUM
iajs-2645	250	12	.	.	PUNCT
iajs-2645	251	1	bizzaro	bizzaro	PROPN
iajs-2645	251	2	,	,	PUNCT
iajs-2645	251	3	n.	n.	NOUN
iajs-2645	251	4	;	;	PUNCT
iajs-2645	251	5	tonutti	tonutti	PROPN
iajs-2645	251	6	,	,	PUNCT
iajs-2645	251	7	e.	e.	PROPN
iajs-2645	251	8	anti	anti	PROPN
iajs-2645	251	9	-	-	ADJ
iajs-2645	251	10	gliadin	gliadin	ADJ
iajs-2645	251	11	antibodies	antibody	NOUN
iajs-2645	251	12	in	in	ADP
iajs-2645	251	13	autoantibodies	autoantibody	NOUN
iajs-2645	251	14	2nd	2nd	PROPN
iajs-2645	251	15	elsevier	elsevier	NOUN
iajs-2645	251	16	2007	2007	NUM
iajs-2645	251	17	451pp	451pp	PROPN
iajs-2645	251	18	.	.	PUNCT
iajs-2645	252	1	31	31	NUM
iajs-2645	252	2	.	.	PUNCT
iajs-2645	252	3	björck	björck	PROPN
iajs-2645	252	4	,	,	PUNCT
iajs-2645	252	5	s.	s.	PROPN
iajs-2645	252	6	;	;	PUNCT
iajs-2645	252	7	lindehammer	lindehammer	PROPN
iajs-2645	252	8	,	,	PUNCT
iajs-2645	252	9	s.r	s.r	PROPN
iajs-2645	252	10	.	.	PROPN
iajs-2645	252	11	;	;	PUNCT
iajs-2645	252	12	fex	fex	PROPN
iajs-2645	252	13	,	,	PUNCT
iajs-2645	252	14	m.	m.	NOUN
iajs-2645	252	15	;	;	PUNCT
iajs-2645	252	16	agardh	agardh	PROPN
iajs-2645	252	17	,	,	PUNCT
iajs-2645	252	18	d.	d.	PROPN
iajs-2645	252	19	serum	serum	PROPN
iajs-2645	252	20	cytokine	cytokine	NOUN
iajs-2645	252	21	pattern	pattern	NOUN
iajs-2645	252	22	in	in	ADP
iajs-2645	252	23	young	young	ADJ
iajs-2645	252	24	children	child	NOUN
iajs-2645	252	25	with	with	ADP
iajs-2645	252	26	screening	screen	VERB
iajs-2645	252	27	detected	detect	VERB
iajs-2645	252	28	coeliac	coeliac	NOUN
iajs-2645	252	29	disease	disease	NOUN
iajs-2645	252	30	.	.	PUNCT
iajs-2645	253	1	clin	clin	PROPN
iajs-2645	253	2	.	.	PUNCT
iajs-2645	254	1	exp	exp	PROPN
iajs-2645	254	2	.	.	PUNCT
iajs-2645	254	3	immunol	immunol	NOUN
iajs-2645	254	4	.	.	PUNCT
iajs-2645	255	1	2015	2015	NUM
iajs-2645	255	2	,	,	PUNCT
iajs-2645	255	3	179	179	NUM
iajs-2645	255	4	,	,	PUNCT
iajs-2645	255	5	230	230	NUM
iajs-2645	255	6	.	.	X
iajs-2645	256	1	32	32	NUM
iajs-2645	256	2	.	.	PUNCT
iajs-2645	257	1	oertelt	oertelt	ADJ
iajs-2645	257	2	-	-	PUNCT
iajs-2645	257	3	prigione	prigione	NOUN
iajs-2645	257	4	,	,	PUNCT
iajs-2645	257	5	s	s	VERB
iajs-2645	257	6	the	the	DET
iajs-2645	257	7	influence	influence	NOUN
iajs-2645	257	8	of	of	ADP
iajs-2645	257	9	sex	sex	NOUN
iajs-2645	257	10	and	and	CCONJ
iajs-2645	257	11	gender	gender	NOUN
iajs-2645	257	12	on	on	ADP
iajs-2645	257	13	the	the	DET
iajs-2645	257	14	immune	immune	ADJ
iajs-2645	257	15	response	response	NOUN
iajs-2645	257	16	.	.	PUNCT
iajs-2645	258	1	autoimmun	autoimmun	PROPN
iajs-2645	258	2	.	.	PUNCT
iajs-2645	259	1	rev	rev	PROPN
iajs-2645	259	2	.	.	PROPN
iajs-2645	259	3	2011	2011	NUM
iajs-2645	259	4	,	,	PUNCT
iajs-2645	259	5	11	11	NUM
iajs-2645	259	6	,	,	PUNCT
iajs-2645	259	7	a479	a479	PROPN
iajs-2645	259	8	.	.	PUNCT
iajs-2645	260	1	http://ihicps.com/	http://ihicps.com/	NOUN